Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731589	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 626.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 947.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"		NA	NA		71000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	176.5	160.8	22.9	63.9	42.0	74.2	151.4	42.9	42.2	165.2	58.5	168.5	128.7	269.4	11.8	232.8	163.2	46.8	89.0	19.5	27.8	166.7	85.0	174.7	37.5	45.9	42.4	102.5	90.6	42.2	80.0	85.7	44.8	115.6	42.2	26.0	148.1	59.0	52.2	183.4	150.3	73.1	30.2	118.1	120.9	23.6	38.1	18.5	105.4	18.8	24.2	150.2	181.3	63.4	364.6	947.0	92.9	48.6	37.7	50.6	237.2	198.7	162.5	178.8	143.9	335.9	265.1	99.0	409.1	260.6	117.4	185.1	57.4	203.8	38.3	238.3	69.5	139.7	356.1	240.4	103.4	101.7	145.2	95.3	63.4	157.5	79.6	146.9	116.4	26.3	165.0	71.8	127.5	221.2	27.2	44.1	78.4	197.8	177.3	89.5	109.4	43.8	174.6	396.3	83.0	49.8	366.3	210.5	94.7	64.0	94.5	78.8	309.7	249.3	138.7	135.3	476.1	44.1	84.5	67.8	231.7	90.6	476.7	7.6	8.1	17.8	13.2	7.7	9.8	3.2	5.7	13.2	7.0	3.0	0.9	4.4	16.9	24.8	6.7	10.8	9.5	10.6	22.9	42.0	42.9	42.2	19.5	27.8	45.9	42.4	44.8	30.2	38.1	63.4	315.2	179.5	120.0	21.5	45.8	234.8	266.4	155.1	153.7	25.6	134.0	148.1	9.2	143.0	119.4	152.6	14.6	123.7	150.7	626.1	19.6	413.5	2.5	272.0	145.7	206.2	162.0	59.3	46.0	419.3	256.7	77.3	219.7	346.4	73.5	75.9	130.6	108.5	72.6	23.5	22.6	365.5	73.2	65.9	103.7	4.5	41.3	75.4	46.2	48.7	162.2	122.4	120.5	35.2	83.6	532.3	425.2	71.5	91.2	322.1	315.5	104.0	122.1	32.3	190.7	97.2	251.0	36.2	23.7	189.3	202.7	168.0	119.4	115.3	280.6	284.7
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AL031681.2		ENSG00000288000	"Novel protein"		20	43458054-43541881	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059648			Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA							Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280220-85301784	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.9;kidney: 6.1"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 32.0"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	0.2	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.3	1.0	0.4	0.0	0.0	0.7	3.9	0.0	2.3	0.0	0.0	0.2	0.3	6.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.2	1.9	0.9	0.0	1.6	0.0	0.3	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.8	0.0	0.4	0.3	0.2	0.0	6.0	0.0	0.0	0.7	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.6	0.0	10.4	0.5	0.0	0.0	23.3	0.0	4.1	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	9.3	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.7	5.8	0.0	0.0	29.5	4.1	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	2.2	0.2	1.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205708	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 15.3"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Theca cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: AB_2685435, HPA065265: AB_2685450"	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	1.1	1.4	1.6	1.3	1.5	1.2	1.3	1.8	1.6	1.9	0.1	1.5	1.5	1.9	4.0	2.8	2.2	1.0	1.3	1.0	1.6	1.8	2.1	1.2	1.2	1.5	1.4	6.3	2.0	1.6	0.7	0.8	1.5	1.7	1.3	1.3	2.2	2.2	4.1	2.2	1.3	2.8	0.7	1.3	1.6	0.4	1.9	1.6	1.4	15.3	1.6	1.3	1.3	1.0	3.1	2.2	5.8	4.6	2.2	2.1	4.7	1.4	1.2	2.1	1.3	7.3	1.1	5.9	1.8	3.0	1.6	4.3	12.5	4.1	2.0	2.5	2.5	3.7	4.9	4.9	1.6	7.7	0.9	3.0	5.3	1.6	3.2	1.7	1.2	4.6	5.6	5.9	1.1	3.7	5.2	4.0	15.6	4.0	4.4	11.7	9.4	4.3	0.9	1.0	2.6	3.9	3.7	5.0	1.9	4.8	1.6	2.1	0.8	2.5	5.8	6.7	1.9	3.0	2.2	4.4	1.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	1.5	1.8	1.6	1.0	1.6	1.5	1.4	1.5	0.7	1.9	1.0	0.9	0.0	0.0	1.0	1.5	2.2	0.6	0.9	2.8	5.0	1.7	1.5	2.6	4.3	0.3	0.0	2.1	1.1	3.4	1.1	0.0	1.2	0.1	3.3	2.6	1.5	1.2	0.8	0.8	1.6	0.8	1.8	3.6	2.0	0.0	3.9	1.4	2.6	0.4	0.0	1.3	1.0	0.0	1.0	0.3	0.2	2.5	0.5	1.8	1.0	1.2	0.2	0.0	1.0	0.6	0.7	0.5	4.1	2.4	1.2	0.8	0.8	0.0	1.0	6.6	2.3	4.4	0.0	0.2	3.6	2.6	0.7	0.9	6.4	1.6	0.7
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755540-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 14.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.0	0.6	4.0	0.0	4.5	0.1	0.0	14.6	8.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.8	0.0	1.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	4.5	14.6	8.1	3.7	3.2	1.2	0.2	1.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68205481-68257712	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	52.3	51.8	54.5	32.6	66.4	36.4	45.0	57.1	87.2	41.2	50.0	57.8	26.2	44.5	53.4	38.4	52.5	37.9	77.0	59.5	56.6	59.2	38.1	32.9	54.0	58.8	56.7	48.7	45.3	64.4	59.1	29.5	58.0	41.6	32.9	78.5	40.0	51.2	95.6	43.1	36.9	41.7	55.3	43.3	39.7	194.4	60.0	53.2	53.3	86.8	51.7	48.5	36.5	61.4	94.6	98.9	87.5	72.9	65.6	113.4	140.0	71.0	88.3	116.1	93.7	42.3	60.4	142.6	74.9	104.8	107.0	46.0	68.6	198.5	154.0	50.2	67.7	52.8	38.6	83.1	124.9	49.8	86.9	96.9	213.9	107.5	206.2	113.0	118.9	121.7	54.6	86.5	150.9	67.3	110.2	45.4	43.5	51.1	98.5	41.3	238.9	106.7	71.2	50.1	85.7	67.2	64.8	125.5	130.9	184.6	100.7	33.5	65.2	143.8	72.0	55.8	74.8	121.9	121.9	255.7	105.1	69.0	79.1	76.6	25.2	35.3	34.8	30.3	46.2	30.7	43.2	46.0	30.3	41.3	37.8	40.4	45.1	63.7	40.9	28.1	58.3	36.9	54.5	66.4	57.1	87.2	59.5	56.6	58.8	56.7	58.0	55.3	60.0	61.4	18.5	12.8	15.6	477.3	38.7	18.6	31.6	58.4	30.1	13.8	29.7	34.3	81.4	21.5	32.8	23.9	8.4	64.0	58.0	9.4	109.5	28.8	736.8	28.4	17.2	24.4	21.1	21.0	36.4	26.0	66.9	28.2	14.8	18.5	34.1	28.9	21.4	15.5	41.8	18.5	30.0	16.7	40.7	26.1	71.0	1665.0	36.1	39.0	56.9	27.2	46.4	65.7	69.0	56.8	47.7	25.4	10.8	32.7	46.2	17.7	15.2	69.0	61.8	12.8	19.7	26.5	26.8	274.4	59.4	26.4	22.6	34.2	49.3	26.1	15.1	24.5
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015867	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	7.5	6.6	13.1	6.9	14.9	6.4	10.4	11.1	14.7	7.9	9.2	6.6	5.2	8.6	8.1	5.9	7.4	6.1	5.8	12.8	11.1	7.7	8.0	6.6	10.5	10.6	10.8	10.8	6.7	7.8	6.2	6.5	10.1	8.2	6.4	9.2	6.0	6.2	7.3	9.1	7.2	7.1	10.1	9.8	6.3	5.5	13.1	10.2	8.1	7.1	9.2	7.1	6.3	11.6	12.2	9.6	15.2	13.2	11.5	16.8	13.6	9.8	16.3	15.4	15.3	6.3	8.9	11.8	8.8	9.7	8.5	9.4	17.8	9.4	15.5	22.3	10.6	11.9	7.4	6.3	12.5	11.8	13.6	10.4	11.9	12.1	12.2	13.1	13.2	10.4	13.9	11.8	18.0	4.0	13.6	7.9	36.4	6.6	6.8	6.9	27.4	12.4	12.1	8.2	7.5	21.7	11.9	15.7	18.3	16.2	12.2	8.6	9.8	12.7	6.7	15.7	15.1	8.6	8.9	7.9	14.2	8.7	11.9	6.6	4.4	5.9	5.1	4.3	6.5	5.7	6.4	5.4	5.5	3.5	6.7	5.7	2.7	10.9	3.5	3.3	8.9	5.2	13.1	14.9	11.1	14.7	12.8	11.1	10.6	10.8	10.1	10.1	13.1	11.6	23.1	48.1	9.8	26.8	23.8	6.9	8.5	11.7	12.5	21.2	14.6	10.2	15.2	17.2	14.5	12.9	10.4	14.8	26.2	7.6	11.7	10.3	1.5	11.3	19.8	15.9	6.7	18.1	33.2	10.5	15.0	18.0	14.3	11.7	17.1	28.8	16.1	12.5	11.8	28.6	26.3	8.4	14.2	20.4	10.5	2.6	15.5	17.1	3.6	30.0	17.3	11.6	16.5	30.2	49.3	10.2	6.4	13.9	24.2	10.8	10.7	16.9	22.5	17.8	19.7	21.7	16.1	9.5	16.6	12.7	7.0	10.9	25.8	17.9	8.0	7.4
ANKMY1	"FLJ20499, ZMYND13"	ENSG00000144504	"Ankyrin repeat and MYND domain containing 1"	Q9P2S6	2	240479422-240569209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 187.5;Late spermatids: 213.1;Respiratory ciliated cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026620, HPA048869"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026620: AB_1844834, HPA048869: "	"unprognostic (2.89e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.46e-1)"	"unprognostic (3.97e-5)"	"unprognostic (8.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.59e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.20e-4)"	4.9	4.4	6.4	5.7	7.6	12.5	6.3	6.0	7.3	7.5	6.1	6.0	6.5	5.4	8.7	5.8	24.6	4.7	3.4	5.4	4.9	5.0	6.2	6.9	9.0	8.1	12.3	7.4	8.6	6.2	4.5	3.9	8.0	6.6	5.5	3.8	5.1	5.2	3.5	8.2	7.2	3.0	8.0	8.2	9.6	67.9	7.1	7.1	6.5	2.1	6.7	5.7	6.4	11.1	7.0	15.2	3.2	6.0	2.9	4.1	13.4	3.3	5.0	2.7	3.6	4.9	14.2	7.0	0.6	3.7	4.1	7.6	6.2	7.8	3.2	12.9	5.2	13.9	8.6	13.0	2.4	7.8	12.8	6.6	18.7	2.5	17.7	8.2	2.8	11.0	13.2	8.8	4.6	6.7	7.2	12.8	2.7	12.1	9.0	20.1	9.8	11.1	4.1	15.0	7.5	5.6	2.7	7.2	10.0	3.9	6.2	11.9	3.6	10.0	3.3	4.0	5.9	20.0	5.5	7.0	5.7	11.8	7.9	0.0	2.1	4.5	4.6	1.8	2.7	2.8	2.8	2.9	2.7	4.1	4.1	3.0	0.9	1.3	2.3	1.8	0.9	2.4	6.4	7.6	6.0	7.3	5.4	4.9	8.1	12.3	8.0	8.0	7.1	11.1	3.0	0.0	8.1	23.8	7.2	0.9	1.8	5.3	13.1	3.5	4.3	3.7	2.2	1.5	10.1	3.7	4.2	3.0	8.1	4.8	1.9	2.7	187.5	40.8	3.6	3.5	4.2	6.5	17.0	4.3	1.7	2.8	16.8	4.5	5.7	4.8	2.9	6.4	2.7	3.3	25.4	4.5	6.1	7.6	2.0	213.1	4.1	6.7	0.0	38.4	5.5	2.6	7.2	21.1	42.9	3.2	2.2	3.0	3.4	2.8	5.7	2.9	62.6	4.0	0.0	2.2	3.5	28.8	8.9	5.0	2.3	2.9	8.6	2.9	4.7	2.0
ANKRD62	DKFZp779B1634	ENSG00000181626	"Ankyrin repeat domain 62"	A6NC57	18	12093843-12129764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;pancreas: 1.0;testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 92.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059835	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies,Actin filaments"		NA	NA				"Cluster 22: Non-specific - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Actin filaments"	"HPA059835: AB_2684136"	"unprognostic (2.45e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.37e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.98e-1)"		"unprognostic (6.61e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.70e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.6	0.0	0.7	0.0	0.0	0.4	0.1	0.0	1.3	0.3	0.1	0.4	0.3	0.0	0.0	1.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.2	0.1	0.2	0.5	0.0	0.0	16.5	1.7	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.6	0.8	2.6	0.6	0.2	0.0	1.0	0.0	0.1	1.0	1.0	0.2	0.5	1.1	0.4	0.0	0.8	0.2	0.0	0.0	0.9	0.0	1.3	0.3	92.8	15.8	0.5	1.1	0.0	0.2	0.1	0.2	0.5
ANKZF1	"FLJ10415, Vms1, ZNF744"	ENSG00000163516	"Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1"	Q9H8Y5	2	219229783-219236679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035208	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035208: AB_10602229"	"unprognostic (5.23e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.27e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (3.87e-2)"	"unprognostic (9.68e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-3)"	9.1	9.2	7.8	8.8	8.6	7.8	10.8	9.9	9.8	13.8	9.6	13.1	9.6	10.1	3.2	15.2	13.5	6.1	14.1	7.9	8.0	13.9	14.4	10.7	13.7	10.1	8.5	16.0	15.6	6.4	12.5	5.9	9.3	15.1	5.2	8.2	15.3	5.6	16.9	17.3	15.2	4.6	7.9	18.1	14.2	7.9	8.7	11.9	11.9	8.1	8.3	12.4	15.0	10.5	31.6	6.1	8.1	11.8	10.6	8.8	32.5	10.1	10.0	13.6	17.2	14.9	13.2	6.6	18.0	4.3	15.3	22.7	10.5	17.5	10.0	13.9	11.0	14.6	19.1	13.9	10.6	9.6	13.7	8.9	33.1	10.1	15.9	22.6	9.4	17.0	24.8	14.9	6.9	13.6	14.1	24.1	13.5	13.7	10.9	14.3	9.9	21.4	7.6	7.9	10.3	10.5	11.9	23.9	19.8	19.5	6.4	23.7	10.3	11.4	8.7	10.1	13.3	31.6	19.9	12.9	19.4	13.8	5.1	9.9	9.1	11.0	16.1	9.0	17.4	13.0	16.3	16.2	9.4	13.3	19.0	18.0	12.3	24.4	14.0	9.8	17.1	13.6	7.8	8.6	9.9	9.8	7.9	8.0	10.1	8.5	9.3	7.9	8.7	10.5	10.2	16.0	17.2	24.2	28.0	9.3	14.5	28.9	9.6	39.8	14.4	13.6	9.2	11.5	24.8	12.9	31.3	10.5	32.7	17.3	13.7	20.5	4.4	28.2	9.7	11.8	9.6	19.6	19.0	12.6	27.2	8.9	17.9	13.0	21.6	21.4	8.6	13.1	7.7	32.0	21.0	19.1	20.3	8.2	5.3	4.0	23.9	10.9	10.6	6.5	15.6	18.0	43.3	13.6	25.3	14.2	16.0	16.6	17.7	13.6	25.2	16.5	65.1	55.4	6.6	13.2	12.8	10.1	17.0	8.3	9.9	11.6	30.0	21.3	17.6	11.1
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648446-35668404	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.9;NK-cells: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (6.61e-4)"	23.4	7.3	4.1	15.8	4.3	16.1	10.0	3.4	4.0	6.8	3.3	13.2	19.2	5.5	5.5	5.9	6.6	9.1	4.2	3.9	5.1	6.4	46.5	15.5	15.5	8.7	5.0	12.2	2.9	2.6	2.4	7.8	5.8	7.9	11.8	2.6	14.0	5.1	3.1	4.5	19.7	7.4	6.7	18.2	14.0	2.3	4.9	10.1	8.5	3.9	10.4	13.2	3.7	5.4	12.8	4.1	0.3	1.5	30.1	15.0	17.3	5.3	14.2	17.3	21.7	2.0	14.2	17.7	2.6	14.0	12.6	16.2	0.1	8.6	4.5	33.6	0.1	7.4	2.6	4.0	23.7	10.4	12.4	19.3	5.7	5.9	3.3	3.9	3.6	8.0	0.8	31.2	3.2	1.3	14.6	3.2	0.5	0.9	5.3	6.1	6.8	8.7	7.6	28.9	0.4	0.2	8.5	7.2	10.0	1.1	1.2	12.1	3.9	4.3	2.6	3.0	2.8	16.4	14.2	1.7	8.1	16.2	6.1	7.5	4.8	2.6	7.3	7.6	6.1	1.0	4.8	5.8	2.4	0.7	4.6	5.3	7.5	5.0	8.5	0.3	5.5	4.2	4.1	4.3	3.4	4.0	3.9	5.1	8.7	5.0	5.8	6.7	4.9	5.4	58.6	70.5	34.3	6.8	15.7	8.0	10.8	14.7	13.6	0.2	16.8	10.8	7.3	34.3	38.6	12.9	0.0	8.3	79.1	101.1	9.8	33.6	10.5	18.4	48.9	33.4	47.3	11.6	0.2	41.9	35.6	33.4	41.8	17.2	36.8	12.2	39.3	135.9	34.9	0.0	1.3	55.3	20.3	58.1	19.9	7.4	26.1	50.5	8.8	17.8	68.5	3.8	126.7	9.5	2.1	45.7	43.7	18.8	51.0	43.2	88.6	31.6	47.4	0.0	0.0	25.3	22.0	0.5	0.2	15.6	5.3	2.5	67.7	6.0	35.9	62.0
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		410000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	17.1	16.0	8.5	15.3	9.5	5.5	25.0	9.6	12.2	16.1	8.3	16.6	18.9	16.0	16.1	12.0	12.6	11.3	16.8	8.6	10.0	41.5	37.6	19.5	21.0	9.0	9.1	11.9	6.8	11.6	5.3	22.2	9.1	12.2	17.6	16.4	7.6	11.1	19.0	8.8	14.5	14.9	9.6	12.8	14.1	14.1	9.8	15.6	27.7	22.6	18.5	17.3	8.1	9.0	24.6	18.4	37.9	34.2	30.3	47.4	60.9	44.8	39.1	36.9	48.4	47.8	19.7	36.2	29.5	31.8	33.7	24.2	112.7	33.5	61.7	40.6	34.9	26.0	21.7	55.9	37.8	50.1	31.7	38.2	23.3	49.3	29.2	30.6	52.8	27.0	38.5	44.3	46.4	101.8	31.7	47.4	64.4	23.7	15.3	41.0	32.7	28.6	112.6	31.2	15.6	10.2	37.5	34.9	23.8	67.4	98.9	38.6	44.6	17.9	25.0	66.8	36.3	21.1	28.5	43.7	31.7	60.7	21.6	53.8	26.9	52.0	13.5	34.5	18.1	17.5	17.4	14.5	22.9	14.7	15.9	14.8	22.1	21.0	33.4	8.5	25.1	21.1	8.5	9.5	9.6	12.2	8.6	10.0	9.0	9.1	9.1	9.6	9.8	9.0	16.3	25.6	40.4	6.5	13.2	0.0	8.4	0.0	11.4	10.0	33.5	16.3	18.6	14.3	6.2	23.9	8.4	31.7	12.6	10.6	45.0	19.5	1.4	19.4	29.3	10.6	4.9	6.5	11.4	17.8	39.0	14.2	12.2	23.3	3.8	7.7	15.4	48.7	35.4	8.4	9.8	8.9	0.0	34.0	0.0	3.1	19.3	23.6	0.0	5.6	36.0	17.3	18.6	6.6	8.9	19.5	7.2	14.7	15.2	5.4	18.6	79.3	10.9	20.9	0.0	6.7	14.3	25.2	14.8	11.1	0.0	36.0	14.0	15.5	10.7	9.6
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267376-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	45.8	54.1	51.9	40.0	55.4	70.4	46.8	44.7	66.7	49.9	39.4	60.6	41.6	50.3	28.7	48.3	44.5	28.9	72.1	58.3	53.9	53.3	55.3	42.8	55.4	50.4	51.5	44.2	49.9	46.8	32.2	46.7	54.1	48.0	36.3	26.4	50.2	37.1	134.1	46.1	50.6	37.3	44.0	60.7	54.2	41.6	51.4	51.3	37.3	96.9	51.3	49.2	43.4	54.7	126.8	69.5	68.8	66.0	72.9	51.9	154.9	73.5	96.0	143.2	142.1	78.2	146.5	87.8	172.1	102.2	64.9	61.2	79.7	102.2	89.1	127.5	130.9	78.6	91.6	99.0	60.4	142.4	96.0	79.6	68.3	96.4	56.1	79.3	122.5	123.9	132.9	101.1	103.3	104.1	138.7	135.8	182.0	106.3	147.0	95.5	92.2	119.4	104.1	62.1	66.3	120.3	90.5	92.8	84.6	77.2	81.4	115.2	91.7	87.8	55.7	108.8	124.3	133.1	172.5	119.7	125.6	187.0	85.5	201.3	154.3	167.7	132.9	148.1	128.3	141.9	121.7	129.2	161.3	143.4	111.8	109.9	37.9	114.3	147.8	134.3	180.2	214.1	51.9	55.4	44.7	66.7	58.3	53.9	50.4	51.5	54.1	44.0	51.4	54.7	40.8	12.8	29.7	11.1	45.0	34.9	41.5	63.4	19.4	21.9	53.9	60.7	37.8	41.5	44.9	35.0	14.6	172.4	51.0	51.1	101.8	70.1	65.8	18.4	30.4	39.9	43.8	78.5	18.6	72.4	155.4	41.4	26.0	28.1	46.3	54.3	40.0	50.4	98.7	16.8	16.2	60.6	48.8	46.8	45.6	106.3	36.7	43.2	65.8	8.4	80.4	35.3	68.0	8.5	12.3	69.8	63.8	44.4	51.7	44.6	68.1	89.3	23.5	18.5	39.5	34.7	52.5	57.8	74.2	27.9	41.3	158.0	46.4	43.0	64.7	45.5
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		7900000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	41.6	5.8	15.8	10.4	15.5	0.2	29.8	13.1	12.1	26.0	33.2	49.1	4.9	46.6	10.1	24.9	63.2	19.3	14.3	17.1	15.2	9.7	1.0	6.6	3.6	53.2	30.1	35.2	16.1	2.7	20.8	2.2	23.2	33.8	4.6	3.2	23.8	21.3	6.3	34.9	18.3	32.6	32.3	4.6	19.0	5.0	26.3	5.7	24.6	9.0	3.1	32.5	25.8	23.4	0.0	7.6	27.6	79.2	113.6	6.0	0.9	12.8	41.9	3.2	2.7	0.0	0.0	0.1	7.8	21.8	1.7	0.0	5.6	2.7	1.1	0.0	3.4	0.0	2.3	0.0	0.6	0.3	0.2	19.7	1.8	1.7	0.2	25.7	0.0	0.0	0.1	0.0	0.6	2.1	0.2	1.4	7.0	0.0	6.9	0.2	12.3	0.0	0.7	0.1	8.2	11.7	0.1	0.5	0.3	8.1	3.4	0.4	0.0	4.5	7.3	0.1	4.2	0.0	0.0	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	15.5	13.1	12.1	17.1	15.2	53.2	30.1	23.2	32.3	26.3	23.4	9.6	0.0	0.5	71.8	0.0	21.2	3.1	3.6	112.1	0.6	3.7	17.3	1.1	1.5	0.7	5.5	0.0	4.8	0.2	0.0	0.0	0.1	1.4	12.6	10.5	5.6	1.8	0.0	8.8	0.0	4.3	55.4	0.5	11.7	0.0	5.7	3.3	0.1	0.8	0.0	2.5	0.0	0.0	0.3	5.5	3.3	84.8	1.0	10.6	6.5	0.0	12.2	0.0	24.1	0.7	0.3	0.0	47.8	0.6	3.3	0.0	0.0	0.3	0.5	0.0	18.0	13.5	1.5	3.2	11.5	11.1	1.9	0.8	1.1	0.0	0.9
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135400-74147912	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 173.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 313.2;Distal tubular cells: 352.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	35.6	39.3	52.1	22.6	54.3	40.8	31.4	58.9	66.1	20.2	55.0	46.5	33.8	24.5	25.1	31.7	20.8	11.9	101.0	52.7	56.5	59.8	33.7	23.5	22.2	57.0	53.8	16.6	44.7	56.2	29.6	14.2	56.0	25.4	37.6	35.7	39.7	23.7	117.8	16.6	28.9	22.6	54.7	21.9	41.1	15.8	53.7	24.8	28.8	173.9	21.6	27.1	24.3	55.3	102.8	134.0	44.8	46.2	81.5	78.3	113.9	92.5	54.5	104.0	72.0	176.6	45.4	67.2	79.7	82.4	99.3	53.2	107.9	135.4	95.8	126.5	172.8	85.4	88.3	269.8	76.1	167.3	39.0	62.2	96.6	100.9	124.2	45.9	79.4	144.3	183.2	73.7	116.0	163.6	136.4	123.1	66.9	196.8	198.6	88.5	120.1	132.0	138.8	106.2	70.4	40.7	68.3	106.8	123.3	62.0	62.6	102.8	42.6	83.9	142.9	93.8	185.4	67.5	135.3	92.7	87.6	131.8	73.8	14.7	14.2	3.9	68.3	29.9	75.7	45.4	92.7	72.6	37.8	44.5	79.3	68.7	3.0	51.7	33.5	65.1	91.2	40.6	52.1	54.3	58.9	66.1	52.7	56.5	57.0	53.8	56.0	54.7	53.7	55.3	54.7	9.6	29.8	8.5	33.2	22.7	44.5	111.8	43.3	29.9	82.0	109.5	313.2	44.3	50.1	84.6	16.7	54.9	42.8	125.4	352.1	93.2	20.0	67.0	46.2	45.5	76.1	138.2	14.3	111.4	167.5	48.6	58.1	61.5	25.4	31.9	36.4	113.3	113.9	26.9	15.0	128.3	83.4	32.1	28.9	10.2	32.9	32.2	99.6	3.7	59.4	61.8	62.8	7.5	7.7	95.0	70.9	46.3	76.1	50.9	85.6	266.4	51.2	52.6	19.7	39.6	64.4	66.8	80.5	101.0	16.9	22.3	45.1	83.0	176.2	52.0
C1orf100		ENSG00000173728	"Chromosome 1 open reading frame 100"	Q5SVJ3	1	244352635-244389663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 35.0"	"Group enriched"	"Detected in some"	151	"Early spermatids: 1207.7;Late spermatids: 851.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"K-562: 5.9"	"Not detected"	"Not detected"							"HPA031179, HPA031180"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA031179: AB_10599995, HPA031180: AB_10599026"	"unprognostic (9.84e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.37e-2)"	"unprognostic (9.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-5)"	"unprognostic (1.85e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1207.7	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	851.9	5.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 21.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.4;SiHa: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.1	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.2	1.2	0.1	0.1	0.3	0.1	0.5	0.3	0.0	0.5	0.0	0.3	0.2	0.0	1.5	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.4	21.4	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.6	0.6	0.9	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.8	0.3	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.1	1.2	0.5	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.5	0.8	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.5	0.2	0.0	0.6	2.4	0.4	1.8	0.4	0.2	0.1	0.4	0.4	1.1	0.5	0.8	0.3	0.4	0.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	94.1	0.3	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	14.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 17.4;skin 1: 26.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4;U-698: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.2	1.0	0.1	1.2	0.2	0.6	2.7	0.2	0.3	0.7	0.2	7.5	3.3	0.9	0.0	2.6	0.7	5.0	4.0	0.2	0.1	4.8	0.3	3.8	1.2	0.0	0.1	0.2	17.4	0.0	2.0	3.3	0.1	1.7	13.7	0.1	3.8	3.4	0.5	26.3	5.2	0.9	0.1	0.7	13.7	0.9	0.3	6.6	7.6	0.1	2.0	5.8	1.6	0.1	11.0	2.0	4.2	0.0	0.6	0.0	1.8	15.5	6.7	10.1	11.3	26.4	10.1	0.4	1.9	3.1	4.4	8.7	6.1	0.3	19.4	0.0	2.8	7.9	1.8	1.9	4.6	0.0	0.1	0.6	8.7	5.2	15.0	5.4	2.2	0.0	2.8	2.8	7.5	1.7	0.3	0.0	12.3	7.9	0.6	0.3	13.2	0.0	18.1	16.5	0.5	0.9	2.4	5.2	6.3	6.8	9.5	0.0	5.8	3.6	5.5	0.0	0.0	3.9	0.0	30.1	2.7	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.8	16.0	10.0	0.3	1.6	32.5	129.6	10.0	45.5	0.0	14.8	3.3	2.1	4.3	19.3	18.4	0.0	18.1	0.7	30.4	0.0	26.3	24.2	24.8	3.1	3.5	11.9	0.0	3.2	35.9	25.6	4.7	64.2	44.1	0.0	0.4	0.4	0.0	1.9	0.0	0.6	56.6	8.2	0.3	2.7	23.3	0.3	1.0	1.8	1.0	2.6	0.0	0.0	0.5	0.3	82.8	30.7	0.4	4.6	75.6	7.8	2.1	14.8	0.0	0.0	4.6	4.7	3.2	5.3	44.0	33.5	75.0	2.0	3.0	8.9	132.5
CABLES2	"C20orf150, dJ908M14.2, ik3-2"	ENSG00000149679	"Cdk5 and Abl enzyme substrate 2"	Q9BTV7	20	62388632-62407285	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.3;Late spermatids: 25.6;Spermatocytes: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052138			Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear bodies"	"Nucleoplasm, Cell Junctions"	"HPA052138: AB_2681743"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.26e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.37e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.94e-2)"	2.4	3.0	6.8	4.2	7.2	8.1	2.8	11.5	9.1	3.9	3.5	4.4	2.9	3.5	2.6	3.2	4.8	2.2	10.6	7.1	7.4	2.6	4.0	2.9	5.1	7.9	6.6	4.3	3.2	3.9	5.9	2.8	7.8	4.3	3.2	5.6	3.3	3.1	5.8	4.3	4.4	3.3	5.9	4.2	4.0	31.0	7.5	5.3	5.1	4.1	4.4	3.7	3.3	7.2	16.3	12.0	20.4	20.9	3.1	4.4	2.8	9.2	8.9	24.8	11.4	43.6	9.1	16.3	7.6	5.9	33.9	10.1	12.6	6.0	9.6	7.3	6.9	19.0	6.3	10.6	5.5	7.8	9.4	2.7	6.7	7.1	2.6	4.4	5.8	20.8	4.9	13.9	5.6	20.0	20.6	6.2	6.8	16.4	13.7	28.1	17.2	7.1	3.7	10.6	11.1	16.8	13.3	17.4	3.6	7.6	11.9	11.7	6.0	22.7	6.8	30.3	9.5	13.3	11.7	19.4	20.4	8.8	12.1	0.0	0.2	0.0	0.7	0.3	0.4	0.5	0.4	0.5	0.3	0.2	0.2	0.3	0.2	0.4	0.3	0.2	1.3	0.1	6.8	7.2	11.5	9.1	7.1	7.4	7.9	6.6	7.8	5.9	7.5	7.2	1.5	3.2	1.7	2.0	2.1	0.9	0.5	1.7	2.8	6.0	2.9	2.4	10.7	2.8	2.5	0.0	4.2	1.3	3.1	3.5	1.9	2.2	51.3	1.1	1.2	1.6	3.5	1.7	4.4	2.4	0.7	2.6	3.6	2.2	0.0	5.3	2.2	1.4	2.1	13.5	5.2	4.1	0.0	1.6	3.0	25.6	1.8	2.0	0.0	1.0	1.0	1.9	1.0	3.5	3.3	2.1	2.3	3.4	2.5	0.7	1.8	0.7	0.2	3.4	0.0	3.0	1.3	21.8	6.9	1.3	2.0	2.3	2.0	1.0	2.8	0.6
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 275.7;Late spermatids: 277.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: AB_2682558"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (9.46e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (8.62e-4)"	15.7	43.4	29.3	17.3	33.8	32.6	18.2	28.9	41.0	30.0	29.2	25.8	22.9	22.5	24.9	18.2	24.0	20.6	21.8	32.3	31.3	25.9	36.0	22.8	20.9	34.4	31.3	31.3	23.3	39.5	33.5	9.3	33.4	45.1	11.8	12.4	21.6	18.5	6.1	19.0	24.0	13.8	27.4	41.8	26.2	43.2	34.2	12.4	30.4	6.7	14.5	24.2	21.7	38.1	3.7	3.2	2.6	8.0	10.3	14.8	2.7	5.8	6.0	6.7	8.9	1.0	3.8	3.0	14.7	11.0	2.0	3.0	1.5	9.2	4.1	15.0	2.2	7.2	2.5	3.9	17.9	2.8	10.4	17.8	24.0	4.9	6.5	7.1	19.2	5.3	6.5	33.6	3.4	4.5	4.5	6.0	1.4	5.0	11.5	4.8	0.0	19.6	6.1	5.3	1.1	4.3	5.9	6.6	11.0	4.6	9.8	11.9	12.8	5.3	1.6	9.3	5.5	30.8	8.0	6.2	7.2	14.7	7.9	51.5	52.8	38.5	21.5	46.3	21.1	16.0	14.6	20.2	31.6	20.4	13.2	10.4	25.3	30.2	33.8	8.4	31.5	23.5	29.3	33.8	28.9	41.0	32.3	31.3	34.4	31.3	33.4	27.4	34.2	38.1	10.7	16.0	13.6	7.5	14.5	7.5	15.4	14.9	10.8	11.3	12.5	8.9	9.8	12.8	16.7	18.4	41.7	5.1	12.4	13.0	25.4	8.2	275.7	9.0	8.8	10.3	10.8	4.6	4.5	9.5	5.5	8.1	30.5	10.0	34.2	11.5	12.8	10.9	23.3	6.7	3.0	12.5	10.2	26.7	14.8	277.4	11.5	20.3	12.4	2.8	28.9	16.6	39.1	2.0	10.2	8.7	24.0	13.5	15.0	16.6	29.2	38.6	16.9	27.9	0.0	5.2	8.4	4.7	3.9	11.0	8.1	6.0	17.9	20.1	9.5	19.7
CCDC63	"FLJ35843, ODA5"	ENSG00000173093	"Coiled-coil domain containing 63"	Q8NA47	12	110846769-110907535	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.3"	"Group enriched"	"Detected in some"	32	"Early spermatids: 305.6;Late spermatids: 241.7"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"MCF7: 4.4"									HPA061568			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA061568: AB_2684561"					"unprognostic (1.98e-2)"	"unprognostic (1.05e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.65e-1)"					"unprognostic (5.59e-2)"	"unprognostic (1.09e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	241.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	4.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96349241-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 493.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	22.2	15.1	16.5	19.6	19.7	17.1	17.6	32.0	26.6	15.9	8.7	18.1	13.0	18.4	13.9	10.4	15.9	16.8	13.7	17.4	24.6	16.6	22.1	17.9	23.4	18.2	16.5	18.3	13.8	11.8	18.2	17.4	19.5	13.0	13.3	43.2	12.8	15.8	14.3	14.3	16.9	13.8	12.4	20.3	16.7	23.7	17.9	22.3	17.9	14.9	20.1	16.7	14.5	31.1	12.9	17.9	52.4	21.0	35.9	30.0	20.8	47.0	28.0	29.9	42.4	31.1	41.3	26.1	42.8	23.1	50.5	29.1	17.5	14.7	42.5	44.5	11.7	49.1	42.7	26.0	25.6	41.5	33.2	18.3	9.2	58.9	22.8	28.0	35.9	25.3	31.4	28.1	40.5	1.1	34.9	40.2	12.0	21.6	12.7	23.7	44.2	21.0	22.6	32.9	9.6	22.7	26.6	2.7	23.0	35.5	5.0	19.5	42.6	50.1	28.1	43.7	25.3	9.5	29.9	36.0	16.2	30.7	38.6	59.4	12.5	25.1	23.7	15.2	24.5	22.5	24.7	23.6	14.0	19.3	26.9	25.5	17.9	35.7	16.2	18.7	28.5	17.9	16.5	19.7	32.0	26.6	17.4	24.6	18.2	16.5	19.5	12.4	17.9	31.1	57.9	19.2	31.4	30.7	32.9	30.5	27.0	31.5	19.4	58.9	14.0	18.5	37.2	18.6	28.9	31.3	100.1	16.6	55.1	10.7	27.4	34.6	493.8	57.6	37.0	53.6	19.8	16.4	67.0	17.5	20.5	44.9	13.7	26.4	40.4	36.4	38.6	32.1	25.2	32.0	67.0	9.0	24.4	27.4	38.4	76.8	43.8	32.5	26.6	23.4	37.2	41.6	42.2	54.3	119.7	32.3	12.2	42.9	27.2	14.5	8.8	40.1	71.8	50.6	32.9	45.4	48.4	85.4	57.0	13.0	20.5	8.2	40.7	24.9	10.3	18.7
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047155-77076309	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	176.7	98.4	182.1	109.8	191.0	222.9	183.6	253.4	218.2	234.8	131.4	182.7	100.0	211.0	249.1	177.9	196.5	150.7	195.7	148.1	171.8	183.8	133.7	144.8	185.2	184.0	185.9	341.6	155.2	145.2	71.1	138.0	188.6	198.9	129.8	213.2	183.0	208.9	225.8	136.4	120.8	195.6	167.5	149.1	149.0	131.7	186.1	229.2	273.5	177.8	238.8	186.6	170.5	220.7	163.3	96.0	305.0	268.6	447.6	406.7	117.0	122.5	298.4	189.9	181.5	119.3	240.6	300.1	183.2	309.4	118.9	83.4	211.7	428.9	300.2	214.0	83.7	180.3	102.1	114.0	438.1	312.0	346.4	320.4	502.6	175.1	426.2	542.6	270.1	154.3	157.2	315.9	273.4	187.7	406.3	292.5	135.2	113.9	59.0	250.7	290.0	126.5	283.5	182.7	387.3	211.8	162.9	247.2	209.2	212.6	141.2	131.6	184.6	231.0	137.0	249.0	170.4	173.7	86.1	310.9	195.4	210.6	153.3	160.7	113.2	236.7	95.6	108.0	131.2	148.2	157.0	142.0	119.5	153.7	165.2	143.8	145.8	109.3	134.0	135.3	149.7	100.0	182.1	191.0	253.4	218.2	148.1	171.8	184.0	185.9	188.6	167.5	186.1	220.7	368.4	173.1	231.3	59.7	606.6	422.9	633.0	489.3	578.8	629.5	550.2	523.5	460.5	323.1	238.7	196.8	68.8	273.7	441.5	258.8	794.3	400.9	71.0	250.5	321.3	405.5	412.3	510.9	125.8	334.3	427.4	510.9	220.2	231.2	278.4	300.9	382.7	121.5	337.0	181.7	150.3	346.6	329.6	685.1	676.5	147.5	604.0	490.4	402.0	77.8	613.0	403.2	390.3	52.3	69.1	515.1	317.6	989.2	500.8	854.8	468.4	596.6	161.4	228.7	552.2	373.3	510.8	200.4	745.5	466.1	394.8	379.5	497.3	326.5	345.9	747.1
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885775	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 206.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 155.1;non-classical monocyte: 376.4"	"Lineage enriched"	"Detected in many"	14	"monocytes: 376.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	127.4	182.9	8.2	3.3	38.0	1.7	92.5	43.3	18.7	73.7	6.5	48.1	1.4	70.6	0.2	29.9	70.7	0.8	82.6	11.7	18.8	149.5	8.3	34.5	0.2	55.1	33.5	206.4	28.5	0.2	27.8	28.1	45.0	33.1	0.2	0.5	21.7	1.5	60.3	26.6	25.0	0.4	31.8	20.6	54.1	8.6	34.3	0.2	17.0	0.9	0.4	75.0	49.4	95.3	0.1	0.1	1.6	0.0	0.4	0.5	1.8	0.3	0.6	0.3	0.0	3.3	0.4	0.0	12.0	0.2	0.1	0.5	0.3	0.3	0.1	5.6	1.2	0.1	12.8	0.0	3.3	0.0	1.4	2.4	1.6	0.0	0.2	0.1	0.3	0.1	2.7	0.8	0.5	0.1	0.0	6.0	10.6	0.5	4.0	2.2	0.0	18.7	0.7	0.0	3.5	33.0	25.2	0.3	15.2	0.9	0.2	2.8	0.4	0.0	2.2	0.0	0.1	7.3	0.0	0.1	0.0	1.8	6.8	9.1	1.2	0.9	0.4	155.1	1.8	0.0	0.4	0.6	26.9	0.3	1.0	0.3	2.2	0.0	376.4	0.2	0.7	14.7	8.2	38.0	43.3	18.7	11.7	18.8	55.1	33.5	45.0	31.8	34.3	95.3	357.3	3.2	5.8	1.0	11.6	10.7	81.7	4.9	30.7	11.9	81.0	150.5	45.3	61.5	10.8	31.3	6.2	575.3	46.9	20.3	15.6	9.8	176.5	38.8	101.5	100.8	106.5	0.8	0.6	0.6	1531.7	141.0	17.9	56.2	0.0	31.2	74.6	4.0	91.0	8.4	1.2	25.0	12.2	23.5	23.2	276.4	74.3	54.9	35.6	4.7	14.1	68.3	0.0	3.5	65.7	4.3	4.2	44.4	12.9	64.6	4.0	78.5	7.5	27.4	32.9	238.3	71.4	2.1	3.5	17.3	11.8	2241.2	25.1	781.8	15.2	71.8
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314482-114337626	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	9.9	7.1	3.4	9.8	3.3	14.2	9.5	6.6	5.2	8.1	3.8	8.7	10.0	8.5	8.0	6.4	9.8	7.6	6.2	3.0	4.3	8.9	15.2	8.9	15.7	2.7	3.4	12.1	15.4	9.3	3.6	9.9	3.4	10.0	9.9	9.1	8.4	9.3	7.9	9.2	8.0	10.1	2.3	9.6	7.7	6.9	2.7	16.5	10.7	9.7	17.3	7.5	4.4	3.1	36.9	15.8	56.6	24.2	20.1	30.9	24.3	38.2	32.0	35.6	39.4	23.5	22.0	75.2	15.1	30.0	22.3	23.0	41.8	30.6	52.7	29.8	50.0	49.7	21.8	20.7	22.5	73.3	28.3	30.4	18.8	27.8	27.3	12.6	17.4	25.8	32.1	20.3	46.1	14.6	48.6	21.4	43.1	45.2	20.2	48.1	26.9	26.0	27.0	22.2	27.5	32.8	22.2	49.2	36.7	39.1	28.2	61.3	19.3	19.5	30.8	20.7	23.6	25.7	27.9	80.4	38.6	42.7	38.1	7.5	3.3	4.4	3.7	4.0	4.6	5.4	3.3	3.7	3.9	5.8	2.6	3.0	0.8	3.5	6.6	12.5	2.4	2.1	3.4	3.3	6.6	5.2	3.0	4.3	2.7	3.4	3.4	2.3	2.7	3.1	11.2	9.6	9.6	3.6	13.9	3.3	6.6	7.6	10.8	12.5	11.3	10.8	5.7	11.5	4.1	12.9	4.2	14.2	18.1	9.3	13.7	11.7	1.0	8.5	14.8	10.9	10.8	24.4	6.1	11.4	18.1	11.5	10.2	8.3	10.1	13.1	13.9	21.6	21.7	15.2	7.8	12.5	6.1	20.7	7.8	1.6	11.8	13.0	12.4	7.5	18.4	8.8	17.5	4.0	8.0	10.9	7.8	11.3	17.6	13.2	12.5	17.0	7.6	10.9	6.6	11.7	10.5	10.6	20.7	13.1	3.8	7.9	11.4	12.4	11.4	3.5
CLBA1	C14orf79	ENSG00000140104	"Clathrin binding box of aftiphilin containing 1"	Q96F83	14	104985775-105010482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042052, HPA061117"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA042052: AB_2677822, HPA061117: AB_2684434"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	3.6	7.8	5.7	1.3	6.0	1.6	5.8	3.7	6.4	8.0	11.1	5.6	1.7	7.6	11.5	7.8	14.9	3.4	3.0	6.2	7.5	15.9	6.9	5.8	1.5	5.5	6.5	7.1	14.4	9.3	21.7	1.8	4.4	9.6	2.6	3.1	8.1	6.1	1.8	7.6	3.1	3.3	5.0	3.2	5.9	23.9	7.0	1.3	18.2	1.2	1.2	6.0	5.4	4.2	5.1	8.9	2.7	8.3	2.6	3.8	4.1	4.0	3.7	4.7	2.1	0.8	8.7	0.5	8.3	4.0	2.5	10.9	1.0	6.0	3.0	4.2	3.2	0.3	8.9	0.4	9.2	2.3	2.2	2.3	13.6	5.1	10.1	8.0	2.7	4.2	3.1	1.4	2.8	17.5	0.9	6.6	3.4	5.0	8.5	3.2	1.5	2.9	10.4	2.9	17.1	8.9	5.7	2.5	5.0	1.7	18.0	3.1	3.0	5.9	2.7	12.0	3.1	1.6	1.1	0.5	7.6	0.7	4.2	0.4	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.1	5.7	6.0	3.7	6.4	6.2	7.5	5.5	6.5	4.4	5.0	7.0	4.2	1.0	16.0	3.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	7.4	7.4	0.0	0.0	2.5	16.5	0.0	1.8	0.4	0.0	3.9	7.9	0.0	29.9	8.1	0.9	0.0	0.0	0.0	1.3	0.8	1.3	0.0	8.8	2.5	3.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	6.5	19.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.4	6.5	0.0	0.0
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938199-56961050	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	7.7	7.2	6.6	8.8	6.8	19.9	12.2	9.7	8.9	9.2	7.3	9.2	10.2	10.4	11.6	9.7	9.8	7.1	8.0	6.6	7.0	8.7	13.0	7.6	12.8	6.7	6.7	11.9	8.7	12.3	6.2	13.0	7.4	9.3	10.6	12.6	9.8	7.7	11.5	9.8	10.0	8.5	6.8	10.3	9.2	98.5	6.6	13.2	12.1	9.1	13.5	9.3	8.7	8.1	25.0	18.6	37.4	14.5	12.5	14.9	25.8	17.5	16.4	26.1	27.7	25.6	21.0	29.9	34.6	14.0	19.5	14.1	25.6	20.2	37.1	36.1	32.3	48.7	17.4	29.2	13.5	41.5	28.5	13.9	24.7	19.7	21.1	15.5	22.6	17.4	42.9	24.3	24.8	31.6	32.9	26.3	22.0	27.4	18.4	15.5	45.9	23.9	18.1	24.7	31.6	31.2	11.7	11.5	30.1	21.5	41.8	40.0	16.0	30.2	22.7	14.8	23.0	35.6	47.7	34.5	15.8	22.7	18.8	22.3	13.3	17.5	15.5	12.6	17.5	27.6	17.0	16.6	13.5	25.0	19.5	18.9	8.1	16.0	17.2	16.4	18.6	10.1	6.6	6.8	9.7	8.9	6.6	7.0	6.7	6.7	7.4	6.8	6.6	8.1	21.3	12.8	21.0	6.8	26.5	18.7	39.5	34.0	21.1	35.9	21.6	22.5	14.1	22.8	28.3	14.7	37.5	42.2	26.2	12.5	13.7	30.1	249.2	22.7	23.1	26.6	23.9	17.5	8.8	27.7	32.3	23.5	18.3	19.9	22.2	20.3	22.5	23.9	22.7	25.2	10.9	16.5	16.2	16.5	10.4	591.1	42.3	12.3	3.6	10.3	19.6	28.5	34.0	9.5	13.3	23.5	17.3	30.5	15.1	32.2	16.6	23.0	22.0	52.4	13.1	24.9	21.9	142.2	46.8	20.3	22.7	29.1	23.3	17.1	20.8	29.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 5.4;testis: 10.4"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 77.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 104.1;K-562: 140.6;OE19: 203.6;RPMI-8226: 311.3;SK-BR-3: 195.4;U-266/84: 356.9"									"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavorable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.3	0.8	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.8	1.5	0.0	5.4	0.0	0.0	3.4	0.7	0.3	0.0	0.1	0.0	0.5	2.0	0.0	0.3	2.6	0.1	0.3	0.0	0.0	0.1	0.0	3.3	0.4	0.2	0.0	0.0	0.4	0.5	10.4	0.0	3.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	2.9	0.0	0.0	0.2	0.0	0.0	203.6	0.0	0.0	0.0	311.3	0.0	0.0	0.4	0.0	0.0	195.4	0.3	0.0	0.2	0.6	0.3	6.3	0.2	0.7	0.2	2.6	356.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	1.2	0.9	0.0	3.9	0.0	0.2	0.0	1.8	0.2	0.0	0.0	0.5	0.0	11.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.7	1.2	0.5	0.0	0.0	0.6	18.5	77.3	0.0	0.0	1.1	0.1	0.0	0.0	0.0
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 61.3;Spermatogonia: 143.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HMC-1: 79.6;K-562: 116.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.1	0.2	0.4	0.2	0.5	1.0	0.2	1.2	0.6	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.5	0.2	0.4	0.2	0.4	0.1	0.0	0.2	0.5	0.1	0.2	0.3	0.1	0.2	0.2	0.9	0.1	0.1	0.2	0.5	0.3	0.1	0.0	0.3	0.2	11.0	0.3	0.1	0.4	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.4	0.2	0.1	0.3	0.4	0.2	0.1	0.0	0.4	0.2	0.3	0.7	0.1	0.2	0.2	79.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	116.1	0.6	0.0	0.1	0.3	0.4	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.3	0.3	0.3	0.1	0.2	0.3	0.4	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.3	0.1	2.9	0.3	0.3	0.4	0.5	0.1	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.1	0.9	0.2	0.2	0.2	0.1	0.0	0.4	0.5	1.2	0.6	0.4	0.5	0.1	0.0	0.1	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.0	0.0	6.6	0.1	0.2	61.3	143.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 158.9;Late spermatids: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	11.8	18.5	11.2	6.0	10.9	5.4	14.2	10.6	12.4	14.1	14.5	10.1	7.8	9.8	13.1	18.3	36.9	10.5	10.0	10.8	10.8	21.4	9.0	9.9	9.1	11.5	12.6	15.2	38.7	13.9	14.4	9.6	10.9	10.2	7.9	6.5	11.6	9.5	11.0	18.8	9.6	6.9	12.0	10.8	14.7	51.0	11.2	9.4	19.2	6.9	12.3	10.7	11.5	10.8	12.0	16.6	10.2	20.0	28.5	37.8	12.4	9.9	27.5	16.5	15.8	11.7	14.9	4.9	13.7	27.3	14.3	7.8	13.4	26.1	11.5	7.0	9.1	5.3	13.9	22.0	18.7	15.0	10.5	25.7	26.6	20.9	46.1	42.0	26.0	11.2	4.3	12.0	16.4	20.8	6.6	10.1	16.8	25.3	15.5	3.5	1.5	35.7	44.4	19.0	6.5	21.1	10.9	30.1	23.7	16.8	21.3	16.2	15.9	6.4	9.7	22.6	9.2	37.8	21.9	3.0	24.2	8.3	12.9	12.0	11.1	5.5	13.9	13.7	25.0	23.9	22.4	17.1	11.7	21.1	18.7	12.5	10.9	22.6	12.8	8.1	29.5	12.8	11.2	10.9	10.6	12.4	10.8	10.8	11.5	12.6	10.9	12.0	11.2	10.8	26.8	16.0	12.2	8.5	27.3	25.6	21.6	28.5	22.8	30.2	35.5	40.5	1.2	27.1	20.8	27.6	18.8	28.2	30.0	25.0	37.2	40.7	158.9	61.2	21.5	16.3	19.1	11.1	10.7	39.4	40.0	19.8	28.5	24.6	24.7	32.4	15.0	5.9	19.2	40.4	9.5	22.3	20.3	12.9	24.5	306.6	24.2	16.8	21.4	2.8	23.5	25.8	13.4	6.6	5.5	21.5	21.3	18.4	18.2	10.0	50.4	49.9	75.3	58.4	46.0	19.1	19.0	110.7	33.4	26.5	34.1	18.3	27.1	29.7	30.0	17.3
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 196.9;esophagus: 242.0;skin 1: 301.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 212.9;Muller glia cells: 913.0;Squamous epithelial cells: 736.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;hTCEpi: 23.2;SCLC-21H: 5.9;U-87 MG: 8.4"									"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies, Microtubules"		"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	1.9	56.0	1.6	0.1	1.8	0.8	28.7	1.6	6.6	47.6	1.2	2.9	0.5	0.6	196.9	242.0	80.5	0.6	0.5	1.3	9.3	3.6	0.2	1.6	0.6	1.5	5.3	1.0	22.8	0.0	24.4	0.1	2.4	9.2	0.7	115.6	30.2	1.1	1.0	301.0	1.0	0.5	1.3	0.3	1.5	1.5	4.3	4.8	34.3	0.0	25.0	8.6	108.1	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	0.1	0.2	23.2	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.6	0.0	0.7	1.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.0	1.2	0.8	0.5	0.1	0.6	0.2	0.4	0.2	0.1	0.3	0.4	0.1	0.1	0.5	0.7	0.1	1.2	0.4	0.1	1.6	1.8	1.6	6.6	1.3	9.3	1.5	5.3	2.4	1.3	4.3	1.2	0.6	0.0	0.0	0.0	4.1	106.9	51.8	74.8	212.9	7.2	15.0	19.6	0.1	2.8	29.8	9.2	6.2	6.0	4.9	2.0	3.9	7.6	13.8	5.6	2.2	2.0	3.0	0.0	0.2	6.0	12.8	2.4	0.0	5.4	4.5	148.1	0.7	14.3	14.7	3.3	0.4	2.0	14.2	9.1	9.3	56.1	4.1	5.0	12.4	0.0	5.4	913.0	2.1	1.0	0.1	5.8	7.1	2.2	3.4	11.8	5.9	13.3	4.8	23.8	0.0	1.9	10.9	10.8	4.2	736.5	126.6	4.5	3.1	1.7	2.3	67.4
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 25.7;fallopian tube: 32.6;testis: 51.3"	"Group enriched"	"Detected in some"	13	"Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Plasma membrane"	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.6	0.0	4.3	0.1	5.3	0.3	0.4	2.9	4.7	0.7	25.7	0.2	0.0	0.1	0.3	0.5	32.6	0.3	0.5	4.5	4.5	0.2	0.4	3.0	0.2	7.3	8.8	0.1	0.0	0.2	0.2	0.8	5.5	0.0	0.0	0.7	0.1	0.0	3.6	0.2	0.0	0.1	6.8	0.2	0.1	51.3	5.4	0.4	0.1	0.0	0.2	0.1	0.0	5.4	0.8	0.0	0.1	0.0	0.3	1.2	0.6	0.8	0.4	0.9	0.6	5.4	0.5	0.2	0.0	0.2	8.8	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.7	0.0	1.0	0.7	5.8	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.1	0.3	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.2	0.0	0.5	2.2	0.2	2.0	40.7	0.0	0.0	0.1	0.3	3.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.3	2.9	4.7	4.5	4.5	7.3	8.8	5.5	6.8	5.4	5.4	0.0	0.0	1.1	0.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.7	0.0	11.5	0.0	4.2	0.2	0.0	0.0	0.0	0.2	106.7	11.2	0.0	0.2	0.0	0.0	6.2	0.0	2.8	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	8.2	0.0	0.0	215.3	3.4	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.1	3.0	0.2	2.6	0.0	0.1	0.0	0.1	113.9	0.3	0.0	0.7	2.1	177.1	4.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111754832-111775602	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 738.2;Late spermatids: 718.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	4.6	3.6	0.8	1.3	0.7	2.3	4.3	0.4	0.9	4.2	0.3	3.9	0.5	4.8	0.9	3.3	4.5	1.6	3.6	0.8	0.7	3.0	2.6	3.2	3.0	0.7	0.8	4.3	3.6	2.5	1.9	2.4	0.5	3.0	1.9	0.8	3.3	2.5	8.8	3.6	4.3	2.8	0.5	4.8	3.8	52.8	0.6	3.7	3.2	1.8	4.2	4.0	3.3	1.3	7.0	3.8	7.1	7.3	4.7	5.0	7.0	3.3	9.1	16.3	18.6	5.8	4.5	17.7	5.2	6.4	3.9	5.8	13.5	9.4	18.2	7.3	9.2	7.4	3.2	3.0	4.6	8.4	6.1	3.0	10.4	9.2	12.2	2.4	12.8	7.2	10.8	5.9	12.0	6.5	11.8	0.9	14.1	5.2	8.5	11.3	12.7	5.3	4.8	5.2	11.7	9.5	6.7	7.0	12.7	5.7	7.0	8.5	3.5	7.9	8.2	13.2	8.6	1.2	5.3	12.3	7.5	8.1	18.5	14.9	6.2	6.0	8.2	5.6	10.7	9.3	9.1	8.4	6.8	9.1	10.6	8.6	3.4	9.1	6.6	3.5	10.0	6.9	0.8	0.7	0.4	0.9	0.8	0.7	0.7	0.8	0.5	0.5	0.6	1.3	8.5	12.8	9.4	6.8	13.0	10.8	9.7	6.0	9.6	14.3	6.5	6.6	7.7	5.7	10.0	5.5	2.1	10.2	9.4	2.9	3.9	9.5	738.2	8.1	12.0	9.3	4.2	5.9	7.4	6.9	7.5	6.9	5.1	5.4	7.6	12.3	5.7	5.9	9.3	6.7	7.7	5.8	8.2	7.2	7.0	718.9	16.4	7.3	1.8	3.7	7.5	6.9	6.2	3.0	3.6	6.3	2.3	13.2	9.0	5.2	3.0	7.6	11.8	10.4	6.6	9.7	11.7	121.7	26.3	7.0	7.2	5.1	11.1	14.0	6.6	5.5
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.2;tongue: 122.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Glandular and luminal cells: 66.1;Oligodendrocytes: 123.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 20.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 105.1;RPMI-8226: 193.2;RPTEC TERT1: 149.3;U-698: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria	"Nucleoplasm, Nuclear bodies"	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	14.4	52.8	12.0	3.0	16.7	2.0	20.7	12.6	11.9	39.2	3.8	23.3	16.9	16.5	11.1	15.2	27.1	10.8	5.1	9.7	23.2	40.0	16.3	5.3	10.1	15.8	12.5	24.7	11.9	16.9	11.4	4.9	15.3	12.1	9.9	2.0	106.3	15.6	158.2	6.6	14.5	15.5	14.8	9.5	40.0	2.9	16.3	5.1	98.0	122.3	2.9	5.6	7.0	24.2	0.1	3.5	0.3	1.1	21.0	6.2	0.3	0.1	0.3	0.6	0.5	2.4	0.4	105.1	2.3	1.2	0.3	0.3	5.4	0.2	0.4	2.3	2.7	14.2	0.9	0.6	12.8	3.0	23.7	5.5	9.5	0.8	0.6	0.1	0.0	1.8	0.1	16.9	0.3	7.1	0.1	2.5	1.3	45.5	3.7	0.4	4.9	193.2	149.3	4.1	3.2	0.7	1.7	11.0	3.2	2.8	9.6	0.5	0.0	0.4	0.9	21.4	0.5	45.4	11.4	55.2	6.5	3.9	0.6	0.0	0.9	0.0	0.2	1.7	0.8	0.1	0.4	0.7	20.3	0.1	0.8	0.6	0.3	0.4	0.2	1.0	0.4	1.0	12.0	16.7	12.6	11.9	9.7	23.2	15.8	12.5	15.3	14.8	16.3	24.2	23.1	6.4	9.3	4.9	2.9	5.2	15.4	3.8	27.3	2.1	16.5	10.4	2.4	15.7	8.4	25.8	0.0	0.6	0.8	2.7	86.1	5.7	2.2	19.0	9.7	7.5	16.7	12.4	14.5	11.8	4.1	10.0	29.6	66.1	12.0	5.4	2.5	12.7	3.3	0.0	31.0	7.7	0.0	16.0	39.5	2.2	11.8	14.9	14.2	46.9	1.5	1.2	2.1	9.5	123.9	1.1	36.5	3.4	6.4	7.1	21.0	33.6	1.1	0.7	0.0	8.1	5.7	3.6	3.8	16.5	5.5	0.4	1.3	6.0	16.5	21.9
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8 microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.3;Rod photoreceptor cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076916, HPA079351"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA076916: , HPA079351: "	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	5.2	4.4	5.3	6.1	5.2	7.7	4.8	9.4	5.6	6.8	5.0	7.0	5.0	8.5	3.6	7.1	6.9	4.7	5.2	5.3	4.6	4.7	4.5	5.3	6.3	5.1	5.1	8.4	6.2	6.4	5.2	11.6	5.6	5.5	5.0	6.5	7.2	5.6	14.8	7.5	6.7	6.0	4.7	5.9	6.1	15.2	5.3	9.5	6.0	9.3	5.9	6.8	5.7	6.2	22.7	15.7	20.1	11.9	7.7	12.4	25.5	21.3	12.6	14.1	9.9	17.0	11.3	20.1	11.6	20.0	9.4	21.4	18.4	17.8	12.2	19.7	27.4	21.7	17.4	14.0	20.3	40.7	17.5	10.0	21.6	14.8	10.7	12.9	12.6	12.1	78.7	14.1	16.5	14.6	24.7	12.1	19.4	16.5	11.8	29.0	21.2	6.8	8.5	20.9	22.3	14.3	19.4	11.3	13.0	12.0	10.9	17.2	18.8	20.5	17.1	13.0	21.9	7.8	11.5	19.9	15.3	18.2	20.3	0.0	1.1	0.6	2.0	0.9	1.5	0.7	0.9	2.1	1.3	0.6	0.9	1.2	0.2	1.6	3.6	1.5	1.2	1.5	5.3	5.2	9.4	5.6	5.3	4.6	5.1	5.1	5.6	4.7	5.3	6.2	8.1	6.4	7.9	11.8	6.0	9.6	5.2	6.8	10.2	37.1	9.1	8.0	4.2	11.5	7.3	5.5	39.6	13.6	6.9	9.6	0.0	6.1	61.3	5.5	8.3	10.2	7.3	10.3	12.4	10.2	11.2	7.3	12.8	7.3	3.8	19.2	9.7	14.4	5.3	43.7	12.7	10.3	4.1	8.4	6.5	39.2	18.3	5.0	5.4	6.5	7.2	10.9	11.3	9.5	14.0	10.9	5.8	10.5	9.3	8.6	6.2	3.4	8.1	60.7	6.6	9.7	8.1	25.2	17.5	10.4	9.2	13.5	9.3	15.1	9.7	5.6
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DIPK1B	"C9orf136, FAM69B, MGC20262"	ENSG00000165716	"Divergent protein kinase domain 1B"	Q5VUD6	9	136712572-136724742	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"Adipocytes: 23.1;Cardiomyocytes: 7.3;Endothelial cells: 6.9;Extravillous trophoblasts: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.8"	"Group enriched"	"Detected in many"	9	"B-cells: 2.8;dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 56.4;HEK 293: 58.2;HUVEC TERT2: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054443			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA054443: AB_2682489"	"unprognostic (2.78e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (6.67e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-1)"	17.4	4.8	21.7	3.7	20.3	9.1	14.0	25.7	26.8	14.9	18.7	12.3	5.4	16.8	2.1	4.9	16.7	5.5	35.9	20.1	20.0	17.8	11.4	16.4	5.8	23.5	21.1	11.5	14.3	12.8	25.1	18.7	24.2	13.6	0.8	5.9	9.8	3.1	8.9	11.5	7.7	3.0	17.3	8.6	6.8	15.0	24.2	1.7	16.8	3.8	1.3	8.0	7.7	19.4	3.2	11.3	25.3	21.0	0.0	0.0	19.5	2.9	0.0	0.8	0.9	27.7	6.6	9.2	56.4	0.0	7.9	13.5	11.7	0.3	0.2	8.1	58.2	13.5	4.7	5.9	0.2	7.0	9.0	0.2	0.0	0.3	0.1	10.1	65.2	19.7	14.8	4.2	0.0	14.8	10.8	28.3	36.9	12.6	9.7	49.9	1.9	26.2	1.4	3.7	38.5	38.3	1.8	8.2	27.4	8.7	18.3	21.9	33.3	5.6	18.7	5.3	6.8	12.9	3.3	8.9	3.2	6.7	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	2.8	0.2	0.1	0.0	0.0	0.0	1.0	0.1	0.3	21.7	20.3	25.7	26.8	20.1	20.0	23.5	21.1	24.2	17.3	24.2	19.4	23.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	6.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 160.2"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.4	32.6	22.6	21.4	23.9	32.3	35.1	27.0	31.6	27.3	22.8	24.7	22.6	27.8	38.7	27.4	32.7	19.5	44.6	23.7	24.6	35.9	37.9	20.9	29.2	23.9	23.7	35.0	34.1	38.4	18.6	35.7	25.0	25.0	30.0	30.1	30.5	28.8	100.5	23.7	21.3	34.1	24.5	20.1	24.2	160.2	22.7	40.4	34.5	85.1	38.3	30.8	20.6	26.4	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	22.6	23.9	27.0	31.6	23.7	24.6	23.9	23.7	25.0	24.5	22.7	26.4	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;lymphoid tissue: 11.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 48.3;Horizontal cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 109.1;REH: 45.1;U-698: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: AB_2682769"	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.0	1.7	6.5	5.7	6.8	2.7	6.4	3.2	5.9	2.4	0.2	0.8	1.3	1.5	0.3	0.9	1.8	0.8	1.2	5.2	11.1	3.5	8.9	0.8	11.1	5.2	8.8	0.4	1.6	0.0	3.3	0.3	5.1	0.8	0.1	2.9	2.6	0.3	0.5	1.0	3.5	0.3	3.7	11.8	0.9	1.9	10.5	0.5	2.2	0.1	6.0	0.5	0.6	2.4	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	109.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.3	4.6	0.0	2.0	0.2	0.0	45.1	0.2	2.6	0.0	0.0	2.7	7.1	0.4	0.4	2.5	0.0	0.1	0.2	1.2	0.0	4.0	0.0	0.1	0.5	0.2	110.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	6.8	3.2	5.9	5.2	11.1	5.2	8.8	5.1	3.7	10.5	2.4	0.7	0.0	0.0	48.3	8.8	1.0	0.0	0.0	0.0	4.7	0.2	0.6	0.7	0.0	0.0	1.8	8.4	0.0	0.3	0.1	7.9	2.5	0.7	0.7	17.5	1.7	0.0	0.0	10.6	0.0	0.0	4.5	0.5	0.4	7.0	0.0	0.4	12.4	0.8	171.6	13.8	0.1	0.0	0.3	0.6	1.7	7.8	0.2	3.6	2.8	0.0	11.4	2.1	13.0	1.0	0.2	0.1	7.5	2.5	0.0	0.0	0.2	0.0	2.8	0.0	0.4	1.3	0.8	2.4	0.0	0.4	0.0	2.2	0.8	0.0	0.0
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		890000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	268.6	261.9	912.5	186.7	967.7	126.8	268.0	895.2	1292.9	354.2	894.7	325.8	162.8	319.4	322.3	719.9	544.2	242.7	257.5	975.4	944.7	352.6	238.4	222.6	241.6	896.1	898.5	247.0	225.1	228.2	309.7	259.2	914.2	225.9	327.4	181.3	245.4	264.6	85.6	626.7	206.3	390.1	935.1	185.2	244.5	360.3	909.7	306.5	176.1	163.9	357.8	389.8	474.4	1001.2	721.6	811.4	779.2	600.8	677.1	713.6	250.8	968.0	451.6	785.6	466.7	770.8	472.3	400.6	510.3	945.1	753.0	629.6	949.3	818.3	781.0	528.3	617.9	390.4	532.9	1062.5	676.2	412.8	620.5	436.2	863.0	584.6	477.5	855.7	831.8	421.5	502.0	446.1	1056.8	960.1	541.4	894.8	642.2	917.7	935.7	543.0	403.0	499.2	1143.1	659.8	535.2	392.0	789.3	677.7	926.6	812.6	673.6	595.3	635.2	592.3	502.1	525.6	852.2	264.0	562.8	404.6	656.8	645.1	776.6	516.6	291.9	384.2	200.6	303.3	155.3	310.4	207.2	211.7	281.8	219.0	132.0	165.7	50.1	282.9	334.8	461.6	373.5	353.0	912.5	967.7	895.2	1292.9	975.4	944.7	896.1	898.5	914.2	935.1	909.7	1001.2	810.1	195.5	101.9	79.3	341.4	922.2	359.1	1275.0	356.8	138.4	800.0	949.4	170.8	303.1	764.6	399.1	83.4	524.6	484.1	689.9	1113.2	691.2	1407.2	1842.5	528.5	541.9	480.8	332.9	111.2	538.9	897.4	538.5	240.5	488.1	316.7	611.9	521.9	499.0	732.1	85.8	62.8	801.6	1121.0	329.4	706.1	4098.6	516.6	466.3	595.9	42.2	701.6	164.0	248.2	47.3	156.4	754.9	798.6	701.8	234.9	304.7	533.4	1125.0	2679.6	193.5	368.1	440.7	1016.3	961.5	721.4	1005.4	1610.1	1006.6	396.6	586.3	498.2	389.6
DYNLL2	"Dlc2, DNCL1B, MGC17810, RSPH22"	ENSG00000264364	"Dynein light chain LC8-type 2"	Q96FJ2	17	58083419-58095542	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 455.4;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039954			Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		1000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (7.22e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.12e-12)"	"unprognostic (2.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.02e-2)"	24.5	41.8	76.8	17.7	84.5	17.7	16.9	78.1	77.7	18.2	45.6	26.1	25.0	19.6	22.4	20.3	19.4	13.4	62.8	63.4	80.4	42.1	35.2	17.9	15.5	83.6	90.1	20.4	17.8	47.2	28.7	30.4	83.6	30.3	20.1	41.2	30.8	26.3	113.7	19.1	24.3	18.9	83.4	18.0	21.3	26.2	87.9	22.5	33.0	58.7	18.4	20.7	17.6	72.0	54.1	36.0	72.3	33.1	44.0	24.0	114.6	53.2	21.1	25.2	19.7	80.4	25.4	48.0	58.8	33.1	30.1	28.4	33.8	42.2	43.2	47.8	24.5	52.1	21.9	47.7	34.8	56.2	31.1	24.3	28.2	29.4	23.2	26.4	17.1	39.8	52.7	28.4	24.7	81.5	64.1	23.2	49.9	35.3	36.5	58.3	42.5	19.9	22.0	57.9	49.3	39.4	47.7	19.0	42.0	37.2	56.2	26.1	31.0	49.3	62.2	33.2	39.8	52.6	68.5	57.0	25.5	44.2	35.2	1.0	0.2	0.5	0.6	0.1	0.7	0.4	0.5	0.6	0.1	0.4	0.5	0.8	0.4	0.4	0.9	0.2	0.4	0.2	76.8	84.5	78.1	77.7	63.4	80.4	83.6	90.1	83.6	83.4	87.9	72.0	33.9	12.8	43.8	1.0	28.1	49.1	40.7	13.7	45.5	63.7	55.7	39.8	186.2	44.3	23.8	60.7	39.6	102.1	59.7	56.7	31.3	37.6	455.4	51.5	57.3	32.5	67.2	40.6	1.2	31.2	73.4	30.6	20.9	55.2	22.8	19.1	23.9	104.7	43.0	70.7	2.0	55.7	26.4	28.4	37.4	892.8	29.5	32.8	65.8	1.9	31.9	74.7	19.6	0.5	2.8	38.0	38.6	26.7	19.4	35.3	50.0	78.2	18.4	41.1	26.3	40.1	86.1	46.5	44.8	45.1	46.0	60.1	46.9	29.0	49.7	36.5
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427598-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.1"	"Group enriched"	"Detected in all"	6	"Early spermatids: 268.7;Late spermatids: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 137.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	12.9	9.0	9.2	10.5	8.9	57.1	9.1	7.2	9.4	7.2	7.7	9.0	10.6	7.9	7.6	9.8	7.0	10.4	5.1	10.3	11.1	11.2	19.0	8.3	10.7	9.6	10.3	5.6	9.8	11.8	8.6	10.2	12.3	10.0	9.9	7.7	6.9	6.8	5.3	10.7	10.0	8.3	7.8	9.8	11.4	7.3	10.6	10.6	10.5	5.8	11.1	11.5	5.8	7.9	10.3	16.6	17.1	17.6	9.8	8.3	137.4	14.7	10.5	16.7	16.3	22.7	11.4	28.7	9.3	10.9	10.9	8.6	22.5	13.2	19.2	23.6	16.2	24.8	14.5	20.8	22.1	23.6	19.2	11.0	22.8	24.3	16.2	12.8	16.8	23.1	26.9	20.6	14.1	21.2	23.6	13.2	30.7	19.3	16.9	21.3	14.2	16.0	14.5	17.8	17.6	30.6	18.2	16.7	17.6	21.9	25.2	18.5	16.6	17.5	12.8	15.6	21.8	27.1	58.3	29.7	17.0	27.7	21.1	8.0	7.1	4.6	11.1	5.4	14.3	4.9	9.1	8.7	4.2	3.6	5.4	8.7	6.5	8.1	6.9	9.8	10.9	4.4	9.2	8.9	7.2	9.4	10.3	11.1	9.6	10.3	12.3	7.8	10.6	7.9	11.5	9.6	17.3	6.8	14.2	46.9	9.1	6.0	14.2	8.1	15.8	7.7	4.8	15.7	9.0	12.9	6.2	8.0	29.1	15.5	9.8	8.6	268.7	10.8	16.0	11.8	34.3	7.8	16.4	8.2	14.6	13.9	16.3	14.1	10.2	9.9	12.1	30.4	15.8	21.9	14.0	12.5	12.2	30.7	31.6	389.5	11.5	37.6	23.2	3.7	19.4	5.5	22.6	5.5	10.7	15.6	10.3	12.0	12.2	16.1	16.0	29.7	8.6	6.4	26.3	13.6	11.0	21.5	11.6	17.7	54.3	35.8	22.0	4.3	12.8	19.9
EEFSEC	"EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153481-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	13.5	8.2	0.2	0.2	0.2	0.1	12.5	0.2	0.6	14.2	0.1	11.3	0.0	15.6	0.0	12.3	13.9	0.1	25.5	0.2	0.3	14.3	21.8	9.6	2.2	0.4	0.2	12.3	11.7	3.0	8.8	1.6	0.3	12.1	0.6	0.5	9.7	1.9	24.0	16.5	10.7	0.0	0.2	13.4	11.0	19.3	0.4	0.1	9.9	0.0	1.2	12.7	12.3	0.2	0.5	0.1	4.1	1.7	0.1	0.2	0.5	0.0	0.3	0.2	0.2	0.3	6.9	15.2	0.1	3.8	12.3	1.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.1	5.7	0.3	0.3	0.1	0.1	4.0	0.1	0.2	0.3	0.0	0.1	0.2	3.5	0.2	7.9	0.4	0.4	0.1	0.1	0.3	0.2	1.0	0.0	0.0	0.3	10.4	0.0	17.7	15.4	0.3	9.6	0.7	0.0	0.1	0.0	0.2	0.2	0.4	0.7	0.4	0.1	0.4	0.2	0.4	6.3	6.1	5.0	6.0	3.9	5.4	4.4	4.4	8.7	3.9	4.0	5.0	0.0	7.5	4.8	3.7	5.7	4.3	0.2	0.2	0.2	0.6	0.2	0.3	0.4	0.2	0.3	0.2	0.4	0.2	9.4	0.0	6.0	15.0	17.2	6.4	9.3	9.1	7.4	7.8	6.9	8.6	10.1	8.6	4.4	16.5	2.1	22.3	15.7	6.4	15.6	7.9	27.7	3.1	12.5	8.2	11.4	5.9	25.3	7.1	18.3	10.0	10.2	4.5	28.5	10.0	8.9	14.8	14.6	13.5	36.6	11.7	18.3	7.9	8.2	71.6	13.1	11.4	12.4	28.1	9.8	9.3	17.5	45.8	27.1	5.6	2.7	8.6	17.1	9.4	8.6	25.7	2.7	8.2	26.3	9.0	9.1	27.9	16.9	10.8	9.9	29.7	13.7	11.9	10.6	6.0
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.6;fallopian tube: 19.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.3	0.4	0.8	0.1	1.0	0.8	0.3	1.7	1.1	1.1	12.6	0.1	0.0	0.3	0.8	0.0	19.7	0.2	0.3	1.4	1.5	0.8	1.2	1.7	0.1	4.9	7.0	1.0	0.6	1.7	3.6	0.1	3.2	3.0	0.0	1.6	0.2	0.2	0.0	0.1	0.3	0.0	3.6	0.4	0.7	6.9	2.4	0.2	1.2	0.0	0.2	0.0	0.1	1.0	0.1	0.7	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.7	1.1	1.4	1.5	4.9	7.0	3.2	3.6	2.4	1.0	0.2	3.2	1.7	0.3	0.5	0.5	0.1	0.8	0.0	0.4	0.7	0.4	1.3	1.5	1.8	0.0	2.1	0.0	0.3	0.1	0.0	0.2	29.6	31.9	0.7	0.5	0.0	0.0	2.7	0.2	0.1	0.5	3.1	1.9	0.0	0.1	0.0	1.1	0.1	5.0	0.8	0.3	2.0	0.0	0.0	20.1	0.3	0.3	0.0	0.0	0.1	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	46.0	5.6	0.0	0.5	0.6	6.8	2.7	0.7	0.3	0.0	0.3	0.3	0.0	0.2
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174231-74197122	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 990.0;Late spermatids: 2765.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		750000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	186.9	174.9	151.0	117.8	159.3	283.3	168.3	163.8	157.3	179.8	129.6	208.4	130.2	186.4	76.6	249.3	163.6	100.0	171.0	149.9	151.9	156.6	197.0	158.4	130.3	161.9	156.9	181.2	226.4	160.7	119.9	162.8	162.2	150.3	100.2	149.8	170.1	125.1	399.8	230.9	148.9	119.2	165.2	137.4	192.9	79.9	164.6	150.2	141.2	173.4	137.2	175.3	179.7	187.1	526.3	341.4	251.3	303.1	220.8	231.8	283.4	359.8	276.3	300.3	289.5	423.3	388.6	444.3	96.6	338.8	424.2	266.6	280.5	481.5	286.3	298.0	329.2	247.5	305.2	345.9	253.1	429.0	236.9	273.2	300.8	326.2	460.7	341.5	326.8	260.1	445.8	186.4	305.2	448.2	342.0	516.8	337.6	430.3	328.9	386.9	342.7	401.5	250.9	324.7	252.7	325.4	340.9	420.3	296.0	331.3	476.8	272.4	340.2	411.6	284.6	345.1	474.4	218.8	299.8	771.4	326.3	435.1	441.4	213.7	229.7	245.6	156.9	255.6	164.5	146.4	161.4	158.3	224.2	132.9	183.9	151.7	150.1	193.5	270.2	95.1	194.7	388.0	151.0	159.3	163.8	157.3	149.9	151.9	161.9	156.9	162.2	165.2	164.6	187.1	105.8	83.3	81.2	15.7	97.1	119.2	153.8	101.5	78.0	93.1	103.0	95.5	43.3	68.6	68.7	44.1	25.0	198.8	91.9	98.7	107.6	148.1	990.0	104.8	98.3	103.0	90.4	79.5	25.3	157.7	381.4	101.6	61.2	112.5	122.4	112.1	79.6	95.7	124.2	97.6	24.6	87.2	91.6	101.2	102.7	2765.8	103.8	86.8	72.9	15.9	157.4	134.7	119.4	16.6	44.2	147.0	82.8	110.6	82.7	140.7	84.6	69.0	57.8	72.3	85.5	107.3	117.7	61.2	64.6	90.1	116.1	395.3	92.4	116.9	109.5	140.4
ELL	"C19orf17, ELL1, Men, PPP1R68"	ENSG00000105656	"Elongation factor for RNA polymerase II"	P55199	19	18442663-18522116	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 297.2;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004202, HPA046076"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA004202: , HPA046076: AB_2679526"	"unprognostic (9.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.1	7.7	4.0	9.0	6.2	29.8	11.8	8.4	7.0	11.2	5.0	10.6	6.5	11.0	2.0	10.3	10.6	5.7	10.5	3.6	4.2	12.6	14.1	16.6	7.6	4.7	4.2	13.0	10.0	4.1	11.3	10.0	3.8	9.9	2.3	1.2	8.3	3.6	20.1	15.3	12.8	3.6	4.0	17.3	10.1	38.5	6.1	6.8	8.2	9.9	4.3	10.5	11.0	3.9	12.7	5.7	3.2	6.8	3.4	4.2	22.7	10.0	8.8	7.5	7.1	7.1	9.8	15.6	11.8	6.7	5.2	8.6	4.7	11.1	3.8	13.3	10.9	9.4	5.9	6.3	5.2	10.3	11.8	8.6	9.3	9.8	7.7	5.6	5.4	8.5	13.5	21.8	4.0	10.3	12.5	11.9	10.6	7.8	16.8	10.9	4.8	17.4	5.3	8.8	5.7	6.4	7.4	12.3	11.0	4.1	6.4	12.4	9.0	8.6	6.6	11.6	9.3	34.8	23.4	11.7	11.4	17.6	12.5	0.3	5.9	4.5	4.5	4.1	7.3	2.9	2.6	3.9	5.0	2.1	1.7	2.7	18.1	2.3	2.1	8.6	3.1	4.1	4.0	6.2	8.4	7.0	3.6	4.2	4.7	4.2	3.8	4.0	6.1	3.9	12.3	6.4	6.1	9.1	16.3	28.0	26.4	11.9	23.3	4.5	19.7	10.7	5.1	11.5	7.2	3.7	4.2	47.5	29.5	15.2	11.7	8.7	297.2	22.9	16.0	11.4	19.7	10.3	9.1	8.0	17.6	17.2	12.8	37.7	11.4	5.1	7.5	15.5	19.3	1.7	11.2	10.1	6.1	12.8	21.7	235.9	6.5	20.4	7.2	9.4	13.8	5.3	4.1	7.1	8.0	10.8	3.7	3.0	53.6	14.2	11.8	7.0	8.4	3.4	19.7	13.0	16.7	18.2	24.7	19.4	30.4	68.7	19.2	5.9	7.1	19.9
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920154-13952348	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 140.7;Late spermatids: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB000156: , HPA045828: AB_2679463"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	2.7	3.9	4.7	3.3	5.2	2.5	2.8	6.7	5.4	3.3	4.3	1.9	1.7	3.3	2.8	2.9	3.5	3.0	3.6	4.3	4.9	2.9	3.2	2.7	3.3	5.1	4.8	4.3	2.7	3.9	1.6	2.6	4.9	3.6	2.2	4.1	2.8	2.9	18.5	3.0	1.9	3.6	4.4	3.7	2.6	5.5	5.4	4.2	4.4	3.3	2.9	2.6	1.5	6.8	4.7	5.5	5.3	7.5	8.7	8.1	4.0	6.1	6.4	5.4	6.8	2.1	4.5	7.8	8.6	5.4	4.8	5.8	8.0	4.1	8.3	10.7	4.7	3.8	6.7	5.2	7.9	5.2	4.2	6.1	5.7	7.1	6.0	5.3	7.2	4.6	6.1	8.8	7.6	3.9	7.0	3.4	3.9	2.4	3.1	7.8	10.8	9.7	3.3	3.2	4.3	5.1	7.5	6.0	5.8	4.2	7.5	3.9	7.9	7.8	5.7	7.0	5.4	7.9	9.9	5.2	7.6	6.2	8.1	4.9	2.3	2.3	2.6	2.7	2.9	2.5	2.4	2.0	2.3	3.1	2.4	2.6	2.7	3.6	2.4	3.2	2.5	1.1	4.7	5.2	6.7	5.4	4.3	4.9	5.1	4.8	4.9	4.4	5.4	6.8	14.0	19.2	13.5	16.6	11.3	4.8	6.1	18.3	10.2	0.0	10.0	9.5	8.6	14.3	12.7	5.5	0.0	17.3	9.7	3.3	9.8	11.6	140.7	18.6	19.0	13.5	9.6	12.0	20.4	8.4	6.2	13.0	5.1	7.4	1.3	17.8	17.2	17.7	11.7	0.0	21.2	4.8	10.2	13.6	6.5	117.9	14.9	11.4	10.6	8.4	14.4	0.0	17.5	12.1	20.1	9.9	1.7	21.1	14.4	10.2	4.4	13.3	26.1	0.0	26.3	17.3	12.2	49.4	28.9	9.2	5.5	12.3	11.8	18.0	6.0	4.7
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034546: AB_2674218, HPA063991: AB_2685168"	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	11.3	13.4	22.3	4.2	32.7	1.2	8.6	18.8	23.9	12.6	3.2	8.6	7.3	10.1	6.0	15.1	7.8	6.5	50.7	20.7	25.7	7.2	3.8	7.2	3.1	23.9	25.7	15.0	5.0	13.2	6.1	13.0	23.3	8.0	5.7	14.1	7.7	8.9	11.1	26.5	9.1	10.0	16.4	5.2	6.9	6.9	22.2	4.4	10.2	11.5	6.4	9.7	13.0	40.9	21.7	16.3	14.7	17.8	41.2	16.9	25.3	15.6	21.9	13.2	8.6	22.3	3.3	5.6	9.5	26.2	19.6	35.4	12.4	25.7	18.9	4.2	10.1	16.7	11.0	12.8	22.2	2.4	5.5	14.6	36.6	14.9	23.1	20.6	21.8	8.7	1.8	0.0	17.6	7.5	6.4	2.9	15.3	14.9	9.0	3.4	26.4	2.3	12.7	50.1	7.3	6.3	26.7	8.2	10.9	16.1	5.7	2.3	24.3	15.2	12.8	13.1	9.6	5.5	5.9	0.0	17.7	1.2	12.4	1.3	0.5	0.0	0.7	0.4	0.5	0.7	0.5	0.4	0.4	0.7	0.6	0.9	0.0	0.5	0.6	0.1	0.8	0.4	22.3	32.7	18.8	23.9	20.7	25.7	23.9	25.7	23.3	16.4	22.2	40.9	17.8	0.0	4.1	210.3	4.1	26.1	10.2	9.8	14.8	17.4	5.2	5.2	87.1	12.8	5.1	9.2	25.0	15.1	5.0	10.2	5.9	9.3	62.9	5.6	14.5	14.1	3.0	2.1	351.1	11.5	13.2	12.4	30.5	9.2	8.2	11.6	11.4	5.6	4.6	16.8	393.6	6.0	4.1	12.0	7.1	8.2	8.4	5.0	5.4	286.7	2.0	9.9	1.0	288.5	863.3	11.0	8.6	7.5	3.7	8.1	28.2	5.5	8.4	11.1	0.0	13.5	14.7	12.0	4.9	13.1	37.4	24.6	4.7	5.5	4.5	10.7
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"FA core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 337.5;Proximal tubular cells: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	39.3	57.5	18.1	3.2	18.9	5.6	41.2	20.8	28.0	52.5	20.5	48.5	4.6	50.0	1.3	38.8	37.8	1.5	50.0	14.5	19.6	64.8	52.1	37.9	3.6	24.6	18.9	45.3	38.7	5.1	75.5	3.2	19.6	61.1	1.8	3.7	30.7	7.1	26.4	42.7	31.8	1.8	20.2	45.0	47.3	54.8	26.9	2.9	52.9	4.0	3.1	43.7	40.7	18.9	27.7	4.4	5.8	7.3	3.6	4.7	34.8	30.4	11.0	9.6	12.9	6.7	18.0	31.7	43.7	4.8	9.0	13.5	4.2	4.6	4.9	68.3	61.0	26.5	6.8	14.4	13.5	18.7	24.8	8.1	9.8	5.8	6.3	5.9	11.9	24.6	37.1	7.6	6.7	11.6	27.0	57.6	20.8	5.4	55.6	36.0	18.1	30.7	4.6	4.5	47.4	63.5	19.8	8.6	58.5	5.3	8.5	7.5	25.6	15.1	35.8	18.7	17.4	68.9	39.9	48.2	28.0	11.4	6.4	9.8	16.4	63.4	18.4	16.9	18.1	28.3	16.5	19.8	17.0	25.7	22.2	18.6	20.6	10.8	15.6	42.4	16.2	10.6	18.1	18.9	20.8	28.0	14.5	19.6	24.6	18.9	19.6	20.2	26.9	18.9	71.7	6.4	11.9	0.0	82.3	0.0	97.7	0.0	79.6	29.1	120.9	138.2	22.1	62.9	6.8	97.5	4.2	119.7	83.6	14.5	170.2	128.5	102.7	44.3	77.2	62.1	43.7	36.8	0.0	110.8	144.1	65.3	64.7	49.9	7.6	74.8	84.6	94.5	134.0	15.2	0.0	56.0	0.0	110.8	0.0	337.5	86.0	82.3	0.0	0.0	178.9	84.7	91.6	0.0	0.0	141.1	40.8	82.8	60.9	152.8	56.2	290.1	8.0	29.5	65.7	63.3	68.8	101.5	38.3	88.4	0.0	89.8	62.4	102.5	42.2	113.2
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133577081-133609389	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.1"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 24.8;Inhibitory neurons: 17.8;Late spermatids: 17.3"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"	"Group enriched"	"Detected in many"	6	"amygdala: 26.5;basal ganglia: 44.4;cerebral cortex: 60.1;hippocampal formation: 38.2;white matter: 32.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"SH-SY5Y: 50.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067336	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: AB_2685825"	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	10.0	26.5	0.0	44.4	0.0	0.0	0.0	60.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.1	0.4	5.2	38.2	0.0	0.8	8.7	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.5	0.8	7.3	0.2	0.5	0.2	0.3	0.8	0.0	0.0	0.0	0.0	6.0	0.2	0.4	2.4	0.0	0.2	0.2	0.0	0.0	1.1	0.1	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.7	0.2	0.1	0.0	0.0	2.4	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	44.4	0.0	60.1	38.2	0.0	0.0	0.0	7.3	6.0	0.0	32.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990531-89017059	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 114.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.7;T-cells: 96.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.4;Karpas-707: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	420000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	14.1	26.3	3.6	17.0	3.6	20.8	10.9	2.9	4.7	12.7	2.8	16.4	7.0	12.8	10.3	10.8	14.8	15.7	7.5	3.6	3.7	7.2	23.3	21.7	18.9	4.6	3.1	20.1	3.7	2.7	3.7	10.4	4.0	8.9	23.3	3.3	6.5	9.3	2.3	9.4	9.2	15.0	3.5	11.2	4.4	2.6	3.9	14.4	7.3	2.6	15.6	12.9	10.2	4.3	22.7	8.2	5.4	13.9	37.0	51.3	0.0	51.8	50.2	1.7	9.1	0.1	23.4	4.7	19.0	52.1	9.6	4.0	1.0	44.8	3.2	83.4	8.7	0.4	5.2	14.7	31.6	3.4	1.6	69.2	38.7	31.4	66.0	24.5	4.7	17.8	0.0	109.0	44.0	1.4	6.4	3.4	0.6	0.2	1.8	1.4	0.5	5.0	60.7	7.3	0.4	0.2	7.7	0.0	0.8	7.0	13.9	1.0	9.5	15.8	9.0	15.2	12.3	45.3	5.3	0.4	11.8	10.2	4.5	43.1	9.4	30.9	9.9	12.3	13.8	7.5	27.6	19.6	11.5	4.0	3.1	10.0	114.7	3.1	22.1	0.2	96.2	12.8	3.6	3.6	2.9	4.7	3.6	3.7	4.6	3.1	4.0	3.5	3.9	4.3	10.3	57.7	13.8	40.1	12.8	45.9	109.7	53.1	39.9	0.0	5.5	9.5	3.5	12.8	27.5	9.2	0.0	0.4	16.3	24.9	0.0	6.3	11.3	9.2	22.3	8.9	8.4	9.5	8.8	4.3	0.2	35.4	8.6	15.5	3.8	4.9	2.2	19.3	5.5	1.7	2.8	14.4	8.2	7.0	31.7	4.9	19.0	17.7	12.4	17.8	20.9	14.5	10.3	8.0	0.7	6.5	8.7	13.9	32.2	46.0	15.6	14.4	26.3	0.7	6.6	26.8	29.1	11.3	1.1	28.5	43.9	0.4	48.4	11.8	24.4	30.0
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911931-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	16.0	14.6	22.6	11.7	22.4	12.5	14.2	22.6	28.7	18.6	15.9	19.3	12.9	17.7	4.8	12.8	17.0	13.0	19.0	18.9	20.8	12.8	8.3	14.0	11.3	33.2	23.3	20.6	10.7	14.7	16.4	8.2	30.0	17.2	3.7	13.3	13.7	12.5	32.8	20.4	14.4	7.6	19.2	18.7	13.4	4.0	27.3	9.1	15.5	10.7	6.2	21.8	16.2	23.7	10.0	34.8	7.8	23.2	12.4	12.5	23.6	18.2	14.1	9.0	9.2	5.8	31.8	24.4	47.3	14.0	14.7	20.5	6.5	12.2	1.8	40.8	19.6	8.2	30.9	19.5	27.7	10.9	27.3	11.2	37.9	19.1	13.8	16.7	12.9	16.0	18.6	25.0	7.0	23.8	25.1	13.3	12.7	7.5	23.6	43.5	11.6	44.0	10.6	6.7	16.7	15.5	19.1	20.6	24.1	4.3	16.1	19.6	24.4	15.0	13.6	29.4	12.4	37.1	34.5	22.7	16.4	17.8	17.9	1.2	0.8	0.3	1.3	0.4	2.3	0.9	2.1	2.7	0.8	2.6	1.7	1.5	0.1	0.5	0.4	0.5	1.1	1.1	22.6	22.4	22.6	28.7	18.9	20.8	33.2	23.3	30.0	19.2	27.3	23.7	16.7	0.0	4.2	34.3	10.4	12.4	9.3	9.2	23.3	42.1	8.6	11.3	12.3	8.6	5.1	22.0	35.5	21.2	14.3	6.5	1.9	6.1	0.4	6.0	7.7	13.4	2.4	6.5	26.9	6.5	8.5	13.9	12.2	8.9	0.0	48.3	11.0	6.8	8.5	33.7	29.0	4.9	4.1	9.9	5.1	1.2	11.1	8.9	8.8	13.1	7.9	18.8	9.2	18.6	25.6	7.1	2.9	14.3	10.4	5.3	8.9	6.3	8.3	39.3	0.0	16.6	20.9	0.9	3.2	13.1	13.9	8.8	11.9	5.3	7.4	5.6
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557484-44561262	"Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 53.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.6	1.0	1.4	1.5	0.2	1.3	0.9	1.2	5.9	10.5	1.8	0.9	5.3	1.3	0.9	3.8	1.8	2.8	1.1	1.3	2.8	0.2	2.9	0.8	1.3	1.9	3.3	1.5	2.1	1.1	3.6	2.0	1.7	0.4	0.7	1.0	1.9	0.4	0.6	1.6	1.5	1.3	2.1	1.2	1.5	1.4	0.3	2.4	0.7	0.7	2.0	2.5	1.6	12.9	37.7	38.3	13.8	8.7	6.4	0.4	39.5	30.4	53.4	38.2	28.4	6.2	0.0	8.9	13.9	13.1	5.5	3.6	2.8	30.2	2.9	7.2	1.7	6.6	0.1	7.7	0.2	7.5	10.7	2.8	9.6	8.8	40.8	1.8	4.9	2.5	0.3	20.9	5.9	6.7	3.6	26.8	0.1	6.7	18.1	8.6	1.9	7.7	0.6	3.8	10.9	5.2	1.1	2.3	32.4	14.6	8.4	0.7	24.1	17.5	4.4	22.6	0.8	0.7	3.0	4.0	2.4	11.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	1.0	1.5	0.9	1.2	1.1	1.3	1.3	1.9	2.0	1.3	1.4	1.6	0.5	19.2	0.0	1.6	0.6	0.6	0.3	0.9	0.0	0.0	0.9	2.9	1.9	0.0	0.2	1.8	0.0	1.6	1.8	0.0	0.0	0.3	0.6	1.1	8.4	0.7	1.2	1.3	0.0	1.8	0.5	5.9	0.0	1.5	0.0	1.4	0.7	0.0	4.8	0.0	0.0	0.3	0.0	9.8	6.0	0.4	23.3	5.6	0.0	6.5	6.2	6.0	0.0	0.0	0.2	0.7	0.0	18.0	0.3	0.1	0.0	0.3	0.2	0.4	0.0	0.4	5.3	0.3	1.2	0.3	0.4	2.3	0.2	2.4	0.0	0.0
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566375-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	129.2	166.9	269.1	68.0	278.1	101.6	122.3	297.7	310.8	105.9	237.2	118.5	67.1	101.3	158.1	91.9	106.0	84.1	279.9	259.7	294.9	153.8	113.6	111.3	94.7	280.8	278.4	108.7	81.4	209.5	169.0	113.8	289.2	113.7	81.4	201.4	100.8	102.2	262.9	135.0	90.1	98.6	306.0	112.0	99.7	78.3	282.4	102.1	124.5	186.7	98.9	95.3	104.8	320.2	103.4	85.9	142.7	67.7	217.1	189.9	72.6	118.2	169.9	158.0	176.4	79.8	129.1	148.1	143.0	135.3	95.2	86.6	107.6	110.6	193.9	64.8	208.7	86.9	72.2	119.1	118.2	84.1	151.3	132.0	153.5	133.3	98.6	143.0	130.5	130.5	130.3	58.4	160.2	145.7	125.4	161.0	85.8	114.5	95.8	139.4	69.0	179.6	166.2	66.4	167.7	175.5	184.7	43.7	177.4	113.3	140.1	130.4	119.5	67.9	104.7	100.0	64.5	166.2	172.8	310.6	163.6	80.6	102.6	345.1	148.8	370.8	128.4	140.3	163.0	215.0	135.2	146.8	176.8	199.0	121.4	114.6	502.5	115.3	157.0	274.1	208.1	241.5	269.1	278.1	297.7	310.8	259.7	294.9	280.8	278.4	289.2	306.0	282.4	320.2	341.0	86.6	136.2	30.7	163.9	274.9	278.8	311.4	141.7	247.9	196.5	236.2	361.4	145.8	212.5	174.7	45.9	251.3	188.5	201.5	686.7	183.9	48.2	209.6	112.8	270.1	277.8	457.6	37.0	175.4	120.6	203.5	80.5	162.4	110.1	85.9	239.8	128.5	223.9	307.9	39.6	156.4	297.0	169.6	428.8	59.7	243.5	197.2	257.9	21.5	404.6	491.0	145.2	27.6	63.6	223.6	237.0	261.1	137.5	306.1	195.7	552.4	263.0	208.1	157.8	182.1	187.9	288.1	219.9	136.6	273.9	390.1	159.3	182.5	121.2	328.6
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 4.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.0;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052617, HPA059403"	Uncertain		Approved	"Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Vesicles"	Cytosol	"HPA052617: AB_2681886, HPA059403: "	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.0	0.1	0.1	0.3	0.2	4.4	0.0	0.6	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.9	0.0	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 45.8;Late spermatids: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340"	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	6.1	4.3	6.1	4.5	6.3	10.3	7.9	10.2	7.9	5.9	4.6	6.0	6.7	5.4	7.2	5.7	5.9	4.2	7.7	5.7	3.9	6.1	5.6	4.8	8.8	3.6	2.6	5.9	4.7	3.7	4.6	5.6	3.6	4.8	6.1	4.7	4.3	4.5	12.1	6.3	4.7	7.7	1.1	5.2	5.1	8.3	3.4	9.1	5.5	7.9	7.8	6.2	5.5	6.2	23.6	34.5	33.3	23.7	11.3	12.6	17.0	11.5	9.0	30.3	30.0	30.7	27.9	36.0	23.4	9.8	11.0	17.5	45.6	18.7	31.5	17.6	26.7	21.5	18.1	76.8	23.9	32.6	12.8	7.3	17.6	18.8	27.5	8.7	26.6	31.4	25.2	25.6	17.3	48.9	36.3	31.2	23.6	29.7	38.3	32.8	36.4	22.6	17.5	15.6	32.2	6.2	24.5	17.7	12.4	18.4	41.5	14.0	11.2	12.7	20.0	13.3	18.6	26.8	44.2	54.1	6.6	34.0	19.6	10.8	12.0	9.9	13.5	13.1	9.8	15.3	12.3	13.5	16.2	15.8	13.5	14.4	3.1	11.9	11.5	16.1	11.8	9.2	6.1	6.3	10.2	7.9	5.7	3.9	3.6	2.6	3.6	1.1	3.4	6.2	11.6	6.4	3.7	4.9	10.3	8.5	8.1	20.9	8.0	5.9	7.3	12.1	6.0	5.7	11.4	5.5	10.4	12.9	7.0	2.2	11.7	10.8	45.8	11.2	11.3	10.6	3.6	17.2	7.4	6.4	18.9	12.5	2.6	7.5	5.7	11.7	9.7	6.6	11.4	5.0	6.2	7.1	14.2	10.6	7.3	41.1	9.0	6.3	7.2	4.7	9.4	8.1	9.2	4.0	7.4	6.9	2.5	9.8	9.4	8.0	3.1	14.7	15.5	6.9	6.6	8.3	8.1	25.9	15.4	11.3	8.0	3.8	9.1	11.6	9.3	4.8
GIPC3	"C19orf64, DFNB15, DFNB72, DFNB95"	ENSG00000179855	"GIPC PDZ domain containing family member 3"	Q8TF64	19	3585478-3593541	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.7"	"Group enriched"	"Detected in some"	4	"Adipocytes: 10.4;Endothelial cells: 6.2;Hepatic stellate cells: 12.8;Rod photoreceptor cells: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 19.0;HMC-1: 11.8;THP-1: 23.1;WM-115: 44.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067765			Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA067765: "	"unprognostic (1.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	4.6	2.2	1.4	1.0	1.0	0.3	2.8	1.0	1.1	3.0	0.8	1.9	1.2	2.8	2.9	5.2	2.1	2.1	3.9	1.2	1.2	3.6	1.4	3.8	2.4	1.6	1.2	0.7	0.7	2.7	1.0	1.1	1.6	3.5	1.4	16.7	0.7	2.3	1.7	1.1	4.4	8.3	1.4	3.9	2.0	0.3	1.6	3.1	3.0	1.9	1.6	1.1	1.8	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.9	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4	0.0	1.5	0.0	0.2	6.9	19.0	0.0	0.7	0.0	11.8	0.2	0.0	1.1	0.0	0.0	2.1	0.2	3.2	0.0	0.3	0.0	0.0	1.1	0.7	0.0	1.2	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.5	0.0	4.7	1.1	0.0	23.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.0	1.1	1.2	1.2	1.6	1.2	1.6	1.4	1.6	1.1	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.1	0.3	2.4	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	12.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.8	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.2	1.1	0.0	0.4	0.1	0.3	0.1	0.3	0.1	0.0	0.1
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489026	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	25.2	21.8	62.8	23.5	68.8	28.8	26.0	61.6	90.4	18.6	39.8	35.0	33.5	19.3	14.0	15.8	14.2	16.5	17.2	61.4	75.6	33.6	25.8	24.2	25.3	73.0	64.5	16.1	12.8	20.1	12.3	26.5	71.4	14.8	35.2	18.4	10.7	12.9	7.0	13.7	29.5	18.2	84.0	18.4	19.0	11.1	71.9	16.2	21.9	10.2	24.4	22.3	11.4	85.3	92.7	36.9	71.8	53.2	75.8	94.5	53.9	93.2	67.9	66.2	82.1	42.6	79.4	85.2	42.4	92.0	39.5	33.4	73.7	64.0	104.4	30.9	25.4	42.5	37.4	39.9	64.7	59.9	35.5	72.0	58.8	57.1	56.0	67.9	60.8	38.4	31.4	28.8	106.1	45.7	36.8	22.9	46.4	52.1	38.9	36.9	84.7	24.4	84.4	86.3	42.4	65.5	64.6	54.4	71.4	59.0	59.8	46.4	48.1	94.9	71.9	48.7	58.4	10.4	19.4	52.0	80.0	36.3	61.5	6.8	10.2	9.1	5.0	13.3	7.0	6.6	5.9	5.1	12.6	7.8	6.2	6.6	16.1	8.0	14.0	4.4	8.5	6.2	62.8	68.8	61.6	90.4	61.4	75.6	73.0	64.5	71.4	84.0	71.9	85.3	23.3	25.6	16.2	8.1	39.3	59.9	50.2	33.6	48.9	18.4	28.0	18.0	17.3	20.0	22.6	25.8	4.2	39.3	33.7	61.8	21.5	38.7	27.3	21.5	29.5	22.2	29.9	14.5	16.8	23.3	84.5	35.1	23.9	36.1	21.6	25.4	16.8	24.5	45.4	21.9	13.6	33.6	26.4	34.6	36.4	7.5	20.2	43.0	46.2	8.4	37.8	25.7	25.7	14.1	16.5	37.3	32.1	15.8	16.9	56.0	26.0	60.5	16.4	15.4	13.1	77.0	54.5	16.0	11.4	33.5	43.8	58.3	26.2	18.8	36.2	56.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	47.2	47.1	17.1	42.1	17.0	27.4	68.8	18.4	24.4	38.8	18.7	40.0	38.8	33.8	25.6	65.0	28.2	28.0	29.6	17.9	19.4	33.4	50.3	29.7	51.5	17.9	17.7	35.8	60.7	27.1	35.9	36.4	17.8	46.7	46.0	16.0	46.4	26.3	78.2	39.1	29.6	32.2	16.9	34.0	41.0	26.8	17.9	35.9	28.6	42.9	64.9	92.3	41.3	19.1	110.4	79.1	114.4	125.3	105.6	105.1	178.1	133.0	101.5	135.4	100.6	121.3	80.8	255.4	42.2	100.1	104.6	78.2	189.1	125.1	180.5	156.3	134.6	196.8	139.0	189.3	218.1	283.7	138.0	96.1	216.5	147.8	224.1	90.3	107.8	99.7	214.8	136.2	93.8	77.7	170.6	162.1	195.6	153.4	151.2	99.3	93.0	315.0	108.9	153.9	81.4	105.6	82.1	190.5	193.6	101.7	74.7	155.8	86.6	92.8	100.0	139.2	281.7	147.6	252.0	387.0	96.9	203.5	148.4	1.2	15.2	3.3	19.9	16.7	34.1	28.7	26.8	24.1	26.1	23.9	30.4	29.4	1.8	26.1	12.9	40.7	18.8	20.2	17.1	17.0	18.4	24.4	17.9	19.4	17.9	17.7	17.8	16.9	17.9	19.1	34.6	22.4	48.2	5.2	84.3	163.7	146.0	111.9	77.4	19.0	72.6	46.4	51.3	25.8	144.9	12.9	10.4	73.2	78.5	42.8	41.1	105.1	54.4	44.7	76.5	53.4	47.8	51.5	11.6	104.6	117.5	92.9	47.9	53.0	63.1	47.5	23.2	41.9	40.9	21.9	11.1	71.7	67.1	24.2	77.6	28.2	51.9	43.0	78.2	5.6	59.5	17.7	38.1	7.1	9.4	99.9	34.4	34.3	122.3	126.1	19.1	47.2	56.5	14.8	6.6	106.2	79.1	37.9	74.4	59.4	153.7	90.3	63.0	74.5	85.8	135.7
GTPBP1	"GP-1, HSPC018"	ENSG00000100226	"GTP binding protein 1"	O00178	22	38705742-38738299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003166, HPA064702"	Approved		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		64000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA003166: AB_10601476, HPA064702: AB_2685329"	"unprognostic (1.42e-3)"	"unprognostic (5.82e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (3.17e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.98e-3)"	18.4	19.0	16.5	23.4	19.1	105.4	18.4	20.0	44.3	20.3	20.8	20.5	20.5	20.0	12.1	22.4	22.1	17.7	20.0	18.4	19.3	18.4	17.1	28.9	23.0	19.3	17.0	27.4	22.0	19.2	25.5	16.0	17.0	23.8	17.6	34.7	21.2	15.5	31.7	27.5	22.9	16.6	15.5	28.0	20.4	20.3	16.7	20.0	24.9	19.9	23.0	18.7	19.4	23.9	29.2	10.5	37.4	30.2	12.6	19.7	18.3	27.4	28.7	39.0	33.9	22.0	16.3	27.9	9.8	26.9	17.5	26.6	45.5	28.8	21.6	49.2	32.8	48.7	36.9	16.3	23.9	57.7	24.3	20.3	22.0	31.2	48.7	21.3	24.3	20.2	29.4	56.5	21.8	12.1	32.1	26.1	27.0	16.7	20.8	61.8	38.2	36.7	13.8	23.3	51.0	17.7	33.3	21.0	19.6	16.2	19.0	24.2	26.1	22.3	22.0	16.4	21.2	51.8	18.7	38.5	20.1	29.0	16.9	3.5	3.1	3.9	4.7	4.6	4.2	4.6	3.5	4.9	3.4	3.8	2.5	3.7	7.8	2.3	5.1	1.7	3.3	3.4	16.5	19.1	20.0	44.3	18.4	19.3	19.3	17.0	17.0	15.5	16.7	23.9	17.8	9.6	8.4	7.8	31.8	27.8	36.0	12.7	15.4	32.6	17.5	15.5	11.2	5.7	12.4	12.9	22.9	7.2	35.9	40.3	5.9	13.2	4.5	22.2	14.3	13.1	16.2	35.3	5.5	19.3	7.9	14.5	23.4	26.4	14.0	17.5	13.6	12.4	8.6	20.2	7.9	24.3	16.2	18.4	43.9	5.4	16.1	19.3	10.6	4.7	26.6	13.2	20.6	5.5	15.2	19.9	21.1	19.2	52.8	47.4	29.8	6.1	16.6	41.0	26.3	19.9	14.5	17.2	7.7	19.2	34.2	19.0	31.9	15.5	13.0	51.0
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478227	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 24.3;intestine: 66.1"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.8"	"Region enriched"	"Detected in single"	4	"thalamus: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SH-SY5Y: 119.5;SuSa: 212.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040925, HPA075313"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA040925: AB_10796563, HPA075313: "			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	4.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	3.7	0.0	0.0	0.0	0.0	0.5	24.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	14.3	12.3	0.0	0.0	0.0	0.3	1.5	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	119.5	0.0	0.0	0.0	212.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	15.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0
HGH1	"Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236"	ENSG00000235173	"HGH1 homolog"	Q9BTY7	8	144137774-144140851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 26.4;PC-3: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042470	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA042470: AB_2678013"	"unprognostic (2.13e-2)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (4.62e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.48e-1)"	2.3	3.2	1.8	1.0	1.3	0.6	1.5	1.4	1.8	2.0	1.2	1.9	0.6	2.3	0.1	3.1	1.7	0.5	2.1	1.7	1.1	1.9	3.2	1.3	0.6	2.1	1.2	1.7	3.1	0.8	1.4	0.4	1.4	1.9	0.5	0.1	1.8	0.8	2.7	2.2	1.6	0.7	1.3	2.2	2.9	2.4	1.5	0.6	2.0	1.2	0.6	2.6	1.9	1.6	8.3	2.7	1.9	3.5	2.7	1.7	4.9	13.8	1.1	2.9	1.9	3.6	2.1	23.9	18.7	2.6	1.1	8.6	3.8	1.9	0.9	11.7	14.5	9.1	2.4	1.8	2.6	5.1	5.9	1.2	5.9	3.2	2.0	1.0	1.3	4.9	26.4	0.9	1.8	6.9	17.5	4.7	5.4	3.1	46.6	21.8	1.6	3.7	1.7	1.9	4.1	4.4	6.4	3.4	5.1	0.6	2.9	1.8	4.9	1.7	14.2	5.1	16.5	13.9	9.7	6.1	1.7	8.5	2.8	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.4	0.7	0.2	0.8	0.4	0.3	0.0	0.6	0.2	0.1	0.1	0.1	1.8	1.3	1.4	1.8	1.7	1.1	2.1	1.2	1.4	1.3	1.5	1.6	5.2	0.0	2.4	2.6	5.8	0.0	2.6	0.0	5.2	4.2	6.7	5.7	2.2	2.8	0.6	5.5	0.0	11.1	7.2	1.3	11.7	3.5	11.2	2.8	7.0	3.1	4.9	5.9	1.2	1.8	13.4	4.3	7.1	4.0	0.0	7.9	1.4	9.9	12.2	6.7	1.2	4.0	0.0	4.8	0.0	22.1	7.5	5.6	0.0	1.0	3.5	8.3	14.4	0.0	1.0	2.9	5.6	3.4	4.9	3.2	5.4	10.2	1.5	3.7	6.6	2.6	3.8	15.1	14.8	6.9	0.0	3.1	5.9	11.0	6.5	1.6
HIKESHI	"C11orf73, HSPC138, HSPC179, OPI10"	ENSG00000149196	"Heat shock protein nuclear import factor hikeshi"	Q53FT3	11	86302211-86345943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012708, HPA035063, HPA035064"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441"	"unprognostic (1.10e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.01e-12)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.71e-1)"	34.7	27.0	46.1	17.8	46.7	19.0	31.4	47.8	71.5	33.9	44.5	40.8	10.4	32.3	24.7	33.4	31.0	15.0	57.1	46.1	47.2	17.0	24.7	23.9	26.0	46.6	46.0	37.5	22.8	22.9	31.5	28.3	47.1	24.5	19.1	32.5	19.8	28.6	59.9	29.5	20.8	31.1	49.1	28.5	23.5	19.0	47.1	32.9	17.7	57.8	30.8	32.8	31.8	50.9	28.6	30.5	72.7	40.5	59.9	74.2	38.2	43.2	52.0	44.2	52.6	90.8	77.8	29.0	96.9	57.4	83.9	59.9	54.2	95.1	47.0	62.0	47.6	47.0	47.5	68.2	80.8	58.0	36.8	52.7	94.9	52.8	62.5	56.9	85.9	54.7	51.1	64.6	91.5	78.0	69.6	136.7	59.5	186.3	20.1	53.0	35.7	65.4	77.2	53.2	44.8	38.7	53.8	39.8	31.1	72.7	64.1	38.5	44.2	52.1	36.4	105.8	32.7	27.7	68.3	57.6	26.6	54.4	52.6	47.8	53.4	44.4	48.6	52.5	54.3	61.8	59.1	53.6	68.9	52.9	51.1	52.3	11.2	57.9	53.9	53.7	84.5	43.2	46.1	46.7	47.8	71.5	46.1	47.2	46.6	46.0	47.1	49.1	47.1	50.9	59.9	38.5	32.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	53.4	81.3	0.0	0.0	14.9	27.6	0.0	129.6	28.7	0.0	41.1	76.1	0.0	41.4	60.4	28.7	0.0	0.0	0.0	66.3	146.2	30.2	0.0	36.8	22.7	52.1	0.0	0.0	94.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	50.1	0.0	0.0	0.0	0.0	49.8	0.0	0.0	4.1	0.0	0.0	43.2	27.7	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	77.6	18.1	59.3	0.0	0.0
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890395-29064764	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.0"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764"	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	4.6	6.7	7.6	5.1	11.9	10.8	4.2	10.6	5.7	3.7	1.7	3.8	3.1	4.4	3.0	3.2	3.7	4.2	4.5	5.3	17.9	4.3	4.2	4.6	5.3	15.0	20.0	6.1	3.3	5.0	1.8	6.8	15.6	2.9	3.9	6.2	3.1	2.5	2.8	4.4	4.3	5.2	10.4	5.7	4.3	7.6	11.6	4.9	6.2	3.7	5.9	3.8	2.4	12.9	6.2	6.8	7.1	8.2	6.5	6.7	6.0	2.6	3.5	4.0	4.3	3.1	3.9	15.1	6.3	4.5	6.0	5.3	14.4	5.3	5.6	5.5	2.4	15.6	13.8	4.2	5.3	5.4	10.2	3.3	7.5	5.3	10.1	4.9	9.1	9.0	22.7	14.4	5.7	3.8	9.9	2.7	5.0	6.6	1.6	8.1	7.1	3.4	2.8	11.5	3.0	9.2	5.1	3.9	5.4	5.9	3.9	4.8	13.0	3.6	16.8	3.9	3.8	4.4	4.8	5.9	4.6	6.5	5.4	3.2	2.4	1.1	1.9	2.6	2.7	3.4	1.9	1.8	2.5	2.6	2.4	2.4	1.4	1.2	4.7	1.9	0.8	1.4	7.6	11.9	10.6	5.7	5.3	17.9	15.0	20.0	15.6	10.4	11.6	12.9	25.5	16.0	18.1	125.7	30.3	16.7	15.8	18.1	15.9	24.4	15.3	10.5	23.6	20.0	14.0	29.5	39.6	12.9	18.7	16.2	15.6	8.3	93.0	15.0	21.2	34.2	17.4	19.6	90.1	14.4	14.1	19.2	11.2	29.4	17.1	36.7	68.6	13.7	10.3	30.3	109.8	12.9	22.4	19.8	36.4	31.5	35.8	20.1	16.0	91.8	21.4	28.3	26.8	118.1	111.8	14.1	11.3	31.6	14.4	21.0	20.4	8.8	14.3	31.6	19.7	34.6	17.3	43.6	15.2	10.1	19.7	19.2	22.8	19.5	14.7	22.6
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607232-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 135.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.7"	"Region enriched"	"Detected in some"	7	"spinal cord: 22.2"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	13.2	11.0	0.1	3.9	0.1	0.2	12.4	0.0	0.3	21.8	0.1	16.9	1.1	5.2	135.1	0.4	8.7	0.7	0.3	0.1	0.1	30.4	0.4	2.2	2.7	5.6	0.1	0.5	0.8	5.5	0.1	5.8	1.1	2.4	15.9	0.0	0.2	16.9	1.7	3.3	18.1	6.7	13.3	3.0	5.9	1.9	0.3	0.2	0.4	0.2	0.9	7.7	5.5	7.5	48.1	20.6	0.0	0.5	14.2	21.1	0.0	0.0	0.0	0.2	0.8	31.9	0.9	0.9	81.9	19.9	23.9	6.9	0.1	0.0	0.0	22.3	15.1	7.4	15.4	0.0	11.7	0.0	14.8	13.8	6.3	14.2	0.0	3.5	43.8	14.7	8.0	0.3	46.0	12.5	1.0	0.4	0.0	74.7	0.1	0.0	39.2	5.5	66.5	15.8	0.0	0.1	16.0	0.0	84.3	1.1	3.8	4.7	38.1	0.0	24.8	20.5	36.9	2.6	6.3	0.1	0.4	0.0	58.6	0.0	0.0	0.0	1.5	0.0	0.8	0.7	0.2	0.8	0.0	1.4	0.0	0.5	0.0	1.0	0.0	0.7	2.1	0.2	0.1	0.1	0.0	0.3	0.1	0.1	5.6	0.1	1.1	13.3	0.3	7.5	55.4	0.0	0.0	0.0	2.0	5.5	0.9	0.0	0.6	0.0	0.9	1.0	0.3	0.0	0.0	86.5	0.0	6.8	1.6	131.3	148.7	0.1	0.3	82.9	6.3	20.3	36.5	1.3	0.0	1.3	19.3	6.4	0.0	73.1	5.1	0.0	1.4	0.2	11.5	0.0	0.0	77.6	0.0	10.6	5.4	0.2	0.6	2.8	24.9	0.0	1.7	0.0	2.1	0.0	0.0	0.3	67.8	0.0	5.1	0.6	140.3	31.6	0.0	0.0	0.0	3.5	8.9	1.7	20.9	0.2	2.0	1.8	2.6	0.1	63.1	3.5
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684461	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1209.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2393.2;monocytes: 1987.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1038.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 731.4;HEK 293: 459.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"	Centrosome	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	160.8	175.9	86.6	73.9	88.5	390.3	82.6	83.8	118.2	97.4	68.5	149.9	99.1	69.7	21.0	35.3	108.3	150.8	177.4	89.6	86.8	128.2	562.5	108.1	92.6	80.2	82.9	213.1	60.1	1209.7	65.7	70.3	85.2	125.1	124.7	69.7	114.3	142.4	18.9	69.6	99.4	85.3	81.4	107.4	66.7	13.8	90.1	73.8	223.5	41.2	47.4	110.2	76.2	95.8	2.0	132.4	56.0	68.6	86.8	13.9	208.5	156.6	18.3	68.4	29.1	266.0	7.3	4.1	175.1	262.5	16.9	115.9	36.0	1.0	20.7	731.4	459.5	101.3	81.7	333.9	24.8	76.5	266.3	23.4	3.1	30.5	1.9	19.2	1.4	6.7	6.2	113.9	109.1	45.3	7.8	9.0	102.4	338.5	102.9	9.7	38.4	75.6	71.3	60.5	103.5	146.6	8.4	117.8	12.1	142.0	19.3	44.9	27.5	83.9	14.5	126.5	9.4	8.9	7.9	88.7	106.6	230.2	46.5	110.3	76.0	1038.0	356.7	221.7	214.2	3.6	108.1	251.9	223.8	1.6	133.7	262.1	96.6	880.8	248.9	10.3	9.2	200.1	86.6	88.5	83.8	118.2	89.6	86.8	80.2	82.9	85.2	81.4	90.1	95.8	429.9	141.1	237.9	316.7	41.4	131.3	143.0	494.8	138.9	9.8	231.2	218.4	179.5	316.0	211.2	101.2	16.7	260.3	604.5	337.7	555.7	471.0	12.0	601.1	344.6	281.1	425.9	59.8	23.5	160.3	142.4	276.0	189.1	647.2	973.6	17.1	487.6	554.7	700.3	6.7	13.8	548.0	494.4	415.8	2393.2	21.7	124.2	528.4	282.8	15.9	1987.9	519.9	1070.1	26.7	3.2	69.6	301.9	32.7	86.0	130.1	231.3	264.1	66.7	27.4	19.7	166.6	185.6	2.1	39.9	97.6	104.6	666.0	690.0	16.7	323.1	51.3
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695549	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1492.5;ovary: 1323.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 1104.1;Ionocytes: 980.6;Leydig cells: 1828.2;Peritubular cells: 981.7;Sertoli cells: 1275.3;Skeletal myocytes: 2750.9;Smooth muscle cells: 1376.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 831.3;BJ hTERT+: 2192.6;T-47d: 531.7;U-138 MG: 710.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	110000000	380000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"	"Nuclear bodies"	"HPA059827: AB_2732640, HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	375.1	221.8	35.6	178.2	35.1	0.7	354.6	21.9	30.9	1492.5	46.9	232.3	35.0	837.7	121.3	166.4	953.0	129.3	155.0	50.4	41.8	479.1	34.2	78.2	71.3	36.3	37.9	1323.4	30.7	30.7	272.8	290.7	31.5	241.4	66.2	105.4	111.0	121.8	470.9	129.0	139.3	621.2	28.1	38.7	323.5	28.8	43.8	95.0	326.2	292.9	45.9	259.2	382.9	62.4	0.0	0.0	210.6	0.9	237.1	7.5	0.8	831.3	2192.6	108.8	10.4	0.0	1.0	0.1	3.3	2.3	0.0	0.1	26.2	0.0	5.6	0.1	8.2	218.1	4.4	0.2	103.1	0.1	1.8	33.1	0.0	14.7	0.1	24.8	0.1	0.2	0.7	0.1	0.5	70.9	0.9	1.2	2.3	0.0	3.4	0.3	0.8	1.2	70.3	249.1	14.5	8.5	14.6	100.4	0.0	12.8	531.7	0.1	80.3	710.2	42.2	109.3	41.0	0.7	0.1	0.1	1.4	0.1	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	35.1	21.9	30.9	50.4	41.8	36.3	37.9	31.5	28.1	43.8	62.4	237.3	3.2	4.4	40.1	20.6	102.5	13.5	211.0	25.0	8.7	73.9	199.9	92.0	5.7	251.6	112.2	6.2	3.9	1.7	0.0	5.9	10.3	8.4	140.2	250.7	120.8	0.0	0.0	6.0	0.0	4.5	1104.1	30.5	128.5	2.5	11.4	49.6	1.4	8.7	3.3	13.7	0.0	980.6	0.6	189.7	39.9	1828.2	18.4	101.4	29.0	0.6	674.4	0.0	5.5	0.4	2.2	0.0	981.7	5.5	17.0	0.0	1.1	120.9	18.7	1275.3	2750.9	1376.0	2.2	3.0	17.7	67.9	5.6	18.4	124.7	0.1	16.8
IKZF2	"Helios, ZNFN1A2"	ENSG00000030419	"IKAROS family zinc finger 2"	Q9UKS7	2	212999691-213152427	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.4;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 78.3;Squamous epithelial cells: 47.8;Urothelial cells: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;NK-cells: 5.5;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"JURKAT: 70.5;MOLT-4: 31.1;RT4: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059142	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA059142: AB_2683923"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.93e-3)"	"unprognostic (7.09e-2)"	2.1	2.0	2.6	3.8	5.5	5.5	2.3	3.2	3.2	3.4	0.7	1.8	0.8	1.9	3.2	19.4	2.8	3.1	1.9	2.9	3.8	1.5	1.4	2.9	7.0	5.2	3.5	2.0	2.0	5.2	1.9	2.0	5.3	3.3	1.7	5.5	8.4	4.3	4.1	9.1	1.2	0.8	3.2	5.5	4.4	2.5	3.9	40.3	7.8	1.6	6.8	9.6	8.3	7.4	2.8	1.0	5.3	0.3	17.1	17.2	3.3	3.4	3.9	0.8	1.7	1.4	4.6	3.7	4.4	2.0	0.4	6.5	0.1	1.8	2.7	0.0	0.9	1.9	3.6	0.5	0.1	8.9	0.6	16.9	1.6	0.1	0.5	4.3	0.0	70.5	1.2	3.1	1.6	5.2	31.1	8.9	1.1	2.2	0.8	18.1	3.5	0.0	1.5	28.6	1.6	1.0	0.0	3.6	0.0	4.4	4.8	0.9	9.2	4.9	3.8	2.3	0.7	6.0	2.0	20.6	2.4	0.0	1.1	3.9	0.0	4.8	1.8	0.0	4.9	0.2	0.6	1.4	0.0	1.0	0.3	1.5	0.0	5.5	0.0	0.5	5.8	0.3	2.6	5.5	3.2	3.2	2.9	3.8	5.2	3.5	5.3	3.2	3.9	7.4	2.1	9.6	12.6	77.4	5.2	5.9	23.2	7.9	11.4	4.8	5.1	2.2	7.6	1.5	19.5	7.3	4.2	4.3	27.4	2.8	0.0	2.3	1.3	16.1	1.8	2.4	3.0	9.0	17.7	3.1	1.2	2.7	8.6	18.1	3.8	2.5	2.5	2.2	2.1	0.0	19.9	2.3	4.1	2.4	2.1	0.7	1.8	2.8	1.8	31.9	1.3	3.0	39.1	100.5	78.3	3.6	1.0	2.2	13.9	15.9	1.1	1.0	31.7	7.3	0.0	10.2	4.5	0.8	0.7	47.8	8.7	4.0	22.1	2.0	1.4	51.8
INO80	"hINO80, INO80A, INOC1, KIAA1259"	ENSG00000128908	"INO80 complex ATPase subunit"	Q9ULG1	15	40978880-41116280	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"	"Actin-binding, DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041484, HPA048601"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA041484: AB_2677506, HPA048601: "	"unprognostic (5.39e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.69e-2)"	"prognostic favorable (6.30e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.47e-2)"	9.3	6.5	5.4	7.3	5.7	15.7	8.8	10.1	5.9	8.3	5.3	9.3	7.3	8.9	4.7	9.6	7.7	5.7	6.9	5.3	5.2	7.9	7.8	9.4	9.7	5.9	5.2	9.1	6.9	10.0	5.5	6.8	5.6	7.9	8.6	5.7	7.3	6.6	15.7	10.9	8.7	8.2	5.0	8.9	7.9	7.0	5.8	10.8	8.5	9.6	10.4	9.1	8.5	7.5	13.1	12.9	10.6	10.7	16.5	13.8	11.4	12.2	18.8	17.3	15.0	14.8	10.4	14.0	8.8	17.6	21.6	24.3	19.5	20.7	19.0	17.5	10.0	18.9	17.7	11.8	15.2	17.9	16.2	13.5	18.4	13.8	36.9	11.1	16.8	14.5	20.5	11.6	12.3	10.6	13.2	11.2	11.3	20.6	13.5	19.1	11.2	11.0	12.7	26.1	14.5	9.6	9.6	18.5	7.3	10.4	10.5	19.9	19.2	14.3	11.1	17.3	19.0	12.4	9.6	22.2	16.1	24.7	11.7	0.3	1.0	0.2	0.8	0.5	0.9	1.3	0.8	0.8	0.7	1.1	1.0	1.1	0.3	2.1	0.2	0.6	0.7	0.4	5.4	5.7	10.1	5.9	5.3	5.2	5.9	5.2	5.6	5.0	5.8	7.5	23.7	9.6	25.7	27.4	27.6	8.5	16.2	7.5	23.3	30.4	18.1	15.9	25.1	14.3	16.4	16.5	22.9	13.5	25.4	17.3	7.9	17.6	2.2	17.2	21.5	17.6	13.1	23.8	54.1	13.3	12.0	16.0	32.6	28.9	15.8	18.4	13.2	10.0	9.8	26.9	47.5	11.8	2.0	14.4	6.8	3.3	14.6	18.6	7.2	25.3	20.8	12.9	19.6	43.2	53.3	15.2	16.1	15.8	19.8	21.7	9.5	11.3	16.3	33.0	6.6	28.1	21.3	19.2	24.7	28.2	12.8	19.2	25.8	25.1	13.9	15.1
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455087-74457944	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA070644, HPA078274"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli, Nuclear bodies"	"HPA070644: AB_2732159, HPA078274: "	"prognostic favorable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.56e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	26.3	30.5	18.9	18.0	20.7	20.6	29.1	17.2	27.6	38.1	15.7	24.1	19.4	30.4	17.1	31.1	31.5	15.1	20.1	19.6	17.5	27.4	32.1	25.9	18.9	18.4	17.1	48.1	41.9	19.6	42.0	11.6	19.2	34.7	12.3	18.7	29.9	17.9	30.1	40.8	23.9	14.8	14.2	24.5	32.7	31.0	16.7	12.8	39.3	9.1	20.1	27.1	32.2	20.9	27.8	29.0	11.0	14.2	21.0	29.6	28.2	25.7	23.0	19.4	16.3	19.9	34.4	46.7	32.2	18.8	18.2	29.1	9.1	20.4	15.8	42.5	28.8	35.9	14.5	20.5	22.4	33.9	17.2	29.5	35.0	27.8	31.2	48.4	26.2	27.4	20.7	18.5	16.5	32.7	44.3	47.7	7.7	20.2	39.7	26.3	34.9	47.4	23.5	18.9	16.7	31.8	13.5	37.3	15.4	12.1	16.1	11.6	22.1	17.7	27.9	29.7	20.0	65.8	48.4	16.9	33.3	21.3	18.9	3.2	2.5	1.0	1.2	1.9	1.6	2.6	1.4	0.7	1.6	2.1	1.2	1.1	3.2	2.1	1.7	3.2	2.2	0.9	18.9	20.7	17.2	27.6	19.6	17.5	18.4	17.1	19.2	14.2	16.7	20.9	4.4	0.0	2.2	0.0	5.4	28.0	2.8	8.5	2.2	14.0	11.3	6.0	0.9	4.3	6.8	3.7	12.5	4.3	7.1	5.8	0.0	15.9	3.0	6.5	5.7	5.4	4.8	9.3	0.0	27.0	4.7	3.4	2.6	3.8	5.7	2.4	6.8	10.8	5.6	13.5	0.0	7.9	12.2	9.7	21.0	6.5	3.1	4.3	5.4	0.0	12.5	4.7	9.2	0.0	0.0	17.4	3.3	3.0	5.1	2.2	11.6	6.5	12.3	15.0	0.0	2.1	4.9	5.6	1.9	3.3	31.7	5.3	7.5	2.2	6.7	2.0
INTS13	"ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30"	ENSG00000064102	"Integrator complex subunit 13"	Q9NVM9	12	26905181-26938326	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039543, HPA040109, HPA073020"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA039543: AB_10795150, HPA040109: , HPA073020: "	"unprognostic (2.09e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (1.17e-10)"	"unprognostic (5.22e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.78e-2)"	9.9	21.4	9.3	11.3	13.4	17.2	11.7	13.2	14.3	10.4	8.1	9.7	9.9	10.0	10.3	14.6	8.5	8.2	12.2	9.5	11.6	13.2	15.1	7.9	16.7	15.4	12.0	8.0	11.5	8.0	8.1	10.0	14.8	8.5	10.7	21.8	9.0	7.0	19.0	11.8	8.5	11.9	13.9	12.9	15.4	12.1	12.2	18.6	9.9	18.1	16.8	12.8	10.6	20.0	33.4	38.1	21.5	46.4	30.5	48.9	30.9	44.9	27.4	43.3	48.1	58.4	43.1	82.7	45.0	25.1	40.6	46.2	56.1	43.6	72.8	39.5	37.4	66.7	44.5	44.9	53.9	110.6	38.4	26.3	32.2	69.5	147.0	53.5	56.8	35.6	71.5	31.9	46.7	40.9	57.9	197.8	94.6	45.6	68.9	40.8	62.3	114.0	36.4	31.0	17.8	16.7	39.1	30.6	47.4	72.8	42.6	23.4	36.5	50.1	36.2	85.6	55.1	15.6	19.6	119.4	33.1	75.8	36.2	7.8	8.1	7.8	14.6	5.7	22.1	9.7	18.2	18.2	9.9	11.3	12.7	15.7	2.5	25.9	5.2	6.7	28.1	10.5	9.3	13.4	13.2	14.3	9.5	11.6	15.4	12.0	14.8	13.9	12.2	20.0	7.2	22.4	7.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	7.9	8.3	0.0	0.0	2.5	5.5	0.0	11.8	8.8	0.0	3.9	13.7	0.0	8.7	16.7	3.9	0.0	0.0	0.0	11.9	16.1	8.3	0.0	8.2	7.6	13.9	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	13.7	0.0	0.0	1.6	0.0	0.0	11.6	2.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	13.1	6.5	18.5	0.0	0.0
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520659-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.7;U-937: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	3.4	7.5	3.3	6.3	2.9	13.1	3.8	8.7	3.7	6.7	2.6	7.7	2.6	4.6	2.8	4.7	6.5	3.8	4.4	3.0	3.0	3.8	1.1	4.4	12.6	3.5	3.6	8.2	2.1	1.8	6.7	3.3	3.4	5.0	7.1	5.1	12.0	3.6	1.1	6.1	7.3	3.7	3.3	10.2	3.4	6.3	3.4	8.4	3.3	0.8	11.3	5.7	5.1	3.7	0.1	0.0	7.5	8.9	2.2	2.5	0.0	1.9	4.0	2.2	6.6	0.7	3.2	7.5	6.3	1.6	5.4	5.6	8.4	2.5	1.5	5.8	3.0	6.5	0.7	0.0	1.9	6.8	0.5	3.3	2.4	2.5	2.5	3.8	2.8	4.9	4.3	11.8	1.6	5.5	6.5	20.7	3.5	8.0	3.1	5.3	2.4	6.4	1.8	3.0	1.2	2.7	2.6	2.6	0.2	3.2	2.8	12.5	1.6	5.6	3.2	0.0	2.2	13.5	11.2	11.3	1.9	19.0	1.1	0.0	1.6	1.4	2.9	1.4	3.8	3.3	3.4	3.5	2.3	3.5	5.2	3.4	0.8	1.9	1.8	2.2	2.0	2.5	3.3	2.9	8.7	3.7	3.0	3.0	3.5	3.6	3.4	3.3	3.4	3.7	6.8	12.8	5.8	0.0	7.3	0.0	0.0	0.0	0.0	0.0	7.2	14.0	0.0	0.0	3.7	3.7	0.0	2.1	15.9	0.0	0.0	1.3	0.0	16.0	5.3	3.3	0.0	0.0	0.0	1.6	0.3	3.3	0.0	11.1	25.2	7.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.3	0.0	0.0	1.0	6.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.8	6.9	11.1	0.0	0.0
ITGB1BP1	"ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B"	ENSG00000119185	"Integrin subunit beta 1 binding protein 1"	O14713	2	9403475-9423528	"Predicted intracellular proteins"	"Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067348, HPA071538"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067348: AB_2732765, HPA071538: AB_2686413"	"unprognostic (2.21e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.39e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (4.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (3.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.08e-3)"	113.7	23.2	45.5	19.3	63.1	31.3	60.4	50.3	58.0	43.7	49.3	37.3	13.6	31.0	26.6	20.9	24.3	22.6	37.3	46.4	48.3	50.2	13.3	22.8	22.1	48.2	47.0	22.3	11.8	26.2	19.1	24.2	49.9	18.5	24.2	27.5	15.5	23.7	29.8	29.7	19.1	35.9	41.8	15.2	22.9	9.4	54.3	27.0	22.4	33.5	25.7	30.4	32.5	52.7	53.5	35.4	43.4	51.5	148.9	131.2	23.3	94.9	66.2	83.8	66.1	49.5	33.1	55.6	43.1	135.9	56.1	50.1	66.3	62.7	92.8	158.6	30.2	53.2	43.2	61.1	54.1	42.2	57.4	70.5	49.5	78.4	56.5	75.2	76.6	43.0	29.9	46.1	109.0	44.6	74.7	25.5	35.9	90.3	53.9	39.4	59.1	51.4	88.5	40.6	44.1	45.0	54.8	40.3	71.3	38.9	30.5	32.1	48.6	73.8	54.5	103.3	105.7	46.8	111.0	89.0	106.1	54.8	54.5	86.1	43.1	56.0	54.9	54.0	52.5	40.1	46.6	53.2	56.8	33.0	35.2	45.7	9.3	50.4	41.1	52.8	61.7	53.1	45.5	63.1	50.3	58.0	46.4	48.3	48.2	47.0	49.9	41.8	54.3	52.7	90.0	28.9	18.1	18.3	47.1	61.2	40.6	70.4	40.9	25.2	30.4	41.8	104.3	22.8	35.1	38.6	2.1	45.0	70.7	16.1	391.3	72.0	26.3	31.3	51.9	85.5	33.1	49.4	61.6	72.7	73.9	98.6	25.5	30.9	41.7	44.4	53.6	21.6	91.4	35.3	47.3	30.4	32.6	45.0	88.5	25.7	54.3	51.7	97.8	15.9	95.6	64.2	121.5	25.6	40.1	108.9	27.0	57.2	42.7	35.2	24.7	88.4	35.6	30.6	92.1	49.0	102.4	27.8	19.0	47.5	63.1	31.5	63.0	70.7	35.2	60.4
IVL		ENSG00000163207	Involucrin	P07476	1	152908546-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 162.3;esophagus: 298.3;salivary gland: 94.5;skin 1: 160.9;vagina: 235.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3"					"Not detected"	"Not detected"			"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		4700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	162.3	0.0	0.0	0.0	0.0	18.2	298.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	94.5	0.1	0.4	160.9	0.1	0.0	0.0	0.1	0.2	0.1	0.0	3.5	0.1	0.0	36.9	17.4	235.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	292.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0	86.3	0.0	0.2	3.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.1	3.5	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	0.0	30.8	71.0	0.0	0.1	0.0	0.0	13.3
JRK	"jerky, JH8"	ENSG00000234616	"Jrk helix-turn-helix protein"	O75564	8	142657460-142681968	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052675			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA052675: AB_2681910"	"unprognostic (3.65e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.58e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.69e-2)"	3.7	4.5	5.9	4.1	6.1	2.1	4.0	7.9	7.4	7.4	4.0	5.9	3.0	6.7	3.4	4.9	5.5	2.5	5.9	5.8	4.7	7.9	4.0	3.9	5.4	6.2	5.2	8.5	5.4	4.6	6.4	3.0	5.5	6.2	2.8	3.8	4.7	4.0	7.5	6.0	5.3	3.7	4.3	7.2	5.7	6.6	6.2	5.1	6.9	4.7	5.9	5.7	4.7	6.8	6.5	6.9	8.0	6.4	7.6	10.8	4.8	10.4	4.2	11.9	6.8	6.3	13.1	11.0	4.1	8.2	8.2	8.7	7.0	6.2	6.0	8.5	12.0	11.2	25.3	7.2	3.1	8.6	7.5	7.2	5.4	7.6	4.3	6.0	6.8	13.1	12.0	4.8	10.1	11.1	10.1	4.8	6.8	4.6	9.6	13.1	5.0	6.2	4.1	11.1	14.5	9.6	18.1	7.3	4.3	5.0	7.3	5.2	8.1	9.1	19.5	9.1	5.5	6.3	7.6	6.3	6.9	10.7	9.0	1.0	0.7	0.9	0.9	0.5	0.5	0.4	1.0	0.9	0.7	1.2	1.3	1.0	0.8	0.6	0.2	0.6	0.6	0.4	5.9	6.1	7.9	7.4	5.8	4.7	6.2	5.2	5.5	4.3	6.2	6.8	3.5	6.4	1.1	8.5	4.8	0.0	2.5	0.0	2.2	14.7	4.5	3.3	11.5	4.3	0.6	7.3	20.9	4.4	8.6	3.2	3.9	2.8	1.9	1.4	4.9	6.5	9.1	12.0	11.3	2.5	2.7	3.7	6.6	2.1	1.3	15.5	8.2	2.6	3.0	10.1	11.0	3.1	0.0	6.6	0.0	2.2	11.5	3.4	0.0	8.4	4.5	4.4	12.3	9.5	9.5	5.6	1.4	11.7	4.3	3.7	2.7	2.7	0.7	10.0	0.0	5.8	4.8	9.1	19.4	3.2	0.0	2.2	2.5	6.8	4.2	4.5
KIF3C		ENSG00000084731	"Kinesin family member 3C"	O14782	2	25926598-25982749	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 75.5;retina: 19.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.5;Horizontal cells: 42.1;Inhibitory neurons: 45.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035755			Approved	"Nuclear membrane,Nuclear bodies,Intermediate filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies, Intermediate filaments"	"Nuclear membrane"	"HPA035755: AB_10602242"	"unprognostic (3.95e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.53e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	3.1	6.8	28.4	2.3	40.2	1.5	2.9	6.9	75.5	4.0	0.0	5.4	1.3	3.6	1.7	2.2	2.7	3.6	2.9	46.1	18.6	1.6	0.7	2.0	1.2	37.5	10.9	6.8	1.4	3.7	11.7	2.1	32.7	2.9	1.7	19.6	2.2	3.8	1.8	2.5	2.5	4.2	0.0	1.6	2.3	2.3	13.8	2.6	3.0	2.5	1.1	2.7	3.7	37.8	25.7	38.1	19.9	15.4	11.4	13.1	15.9	13.1	6.4	7.7	8.7	6.8	3.8	0.0	10.6	11.9	24.1	2.7	15.2	7.8	5.2	4.5	7.3	9.3	2.6	14.0	6.7	2.3	7.7	9.6	2.3	24.2	4.8	29.6	25.8	7.3	3.3	3.2	8.3	1.8	6.7	3.2	20.5	0.7	11.1	10.4	9.9	1.7	17.7	6.2	24.2	54.4	5.2	2.2	27.3	16.4	0.8	3.1	20.6	13.4	13.7	6.1	12.9	0.8	4.6	3.1	30.4	12.5	11.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.5	0.2	0.0	0.0	0.4	0.3	28.4	40.2	6.9	75.5	46.1	18.6	37.5	10.9	32.7	0.0	13.8	37.8	1.9	0.0	0.0	9.4	0.2	0.5	1.6	1.5	1.2	16.7	2.0	2.4	3.5	2.8	1.1	0.0	6.2	0.6	2.1	0.1	0.0	8.4	3.4	1.0	2.1	5.6	3.0	0.0	53.5	1.4	4.2	2.6	0.5	1.4	7.0	8.8	7.9	0.1	3.5	42.1	45.9	0.3	2.0	4.6	1.1	4.8	1.8	2.6	3.6	12.2	2.0	7.0	0.0	27.6	13.7	10.1	0.0	4.5	1.5	1.0	0.0	1.2	1.3	9.6	6.6	2.8	3.1	0.3	1.6	1.0	0.3	1.2	1.7	5.1	0.2	1.0
KLHDC2	"HCLP-1, LCP"	ENSG00000165516	"Kelch domain containing 2"	Q9Y2U9	14	49768130-49786385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000628	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nuclear bodies"	"HPA000628: AB_2666051"	"unprognostic (2.65e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.52e-3)"	"unprognostic (4.54e-2)"	"unprognostic (9.72e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-3)"	"unprognostic (6.77e-3)"	"prognostic favorable (2.75e-10)"	"unprognostic (2.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.34e-2)"	21.5	22.3	12.8	8.6	13.3	10.1	19.6	13.7	16.1	18.8	15.0	23.8	18.4	20.7	14.8	15.0	17.0	13.8	38.0	14.4	14.0	34.1	49.1	14.5	10.9	12.4	12.3	25.1	30.3	16.8	17.7	12.7	13.9	18.5	18.0	23.9	20.1	20.1	53.0	18.8	21.6	14.1	13.3	12.3	24.4	23.3	12.6	15.2	28.2	38.2	10.5	22.3	16.2	14.9	14.7	12.2	22.5	11.0	31.7	27.5	23.7	15.0	28.8	18.8	19.0	7.1	19.6	29.1	20.4	27.4	10.8	12.8	13.9	13.9	15.9	20.1	14.7	9.1	8.6	17.0	23.1	19.6	7.8	28.6	23.5	8.6	16.9	23.1	17.4	24.6	11.8	21.5	15.1	17.3	20.1	8.6	16.6	17.0	34.8	15.3	24.0	18.1	8.6	31.2	27.4	22.0	25.1	46.4	17.1	17.2	17.8	7.4	14.9	17.2	13.3	13.7	7.8	29.0	19.7	17.1	9.7	10.0	9.2	12.3	9.1	19.9	11.1	6.1	13.8	18.2	16.8	17.4	9.0	19.0	23.5	15.8	8.4	16.8	5.8	6.8	18.0	12.3	12.8	13.3	13.7	16.1	14.4	14.0	12.4	12.3	13.9	13.3	12.6	14.9	40.6	41.7	52.4	30.3	42.1	48.9	53.5	64.8	53.5	65.1	48.6	40.9	9.3	77.2	53.9	47.8	50.1	102.5	40.7	68.9	107.6	59.8	96.8	44.8	41.9	36.4	57.2	47.8	30.6	85.8	68.6	51.2	67.2	38.7	30.4	62.8	45.3	91.8	33.2	65.6	35.4	75.3	63.1	28.7	33.6	27.1	81.4	26.5	39.2	18.7	36.3	73.9	54.6	28.1	33.1	54.8	78.9	77.5	74.5	53.9	143.9	170.1	27.8	98.1	65.7	46.3	90.5	238.7	93.2	42.7	66.3	82.4	44.9	54.7	78.9	55.5
KREMEN1	"KREMEN, KRM1"	ENSG00000183762	"Kringle containing transmembrane protein 1"	Q96MU8	22	29073035-29168333	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 59.1;Skeletal myocytes: 82.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 34.7;U-2197: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058513			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		1100000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA058513: AB_2683739"																		7.3	13.5	10.3	9.5	22.3	4.1	7.6	7.4	10.8	9.1	5.6	13.1	6.6	6.7	8.7	37.2	10.9	4.0	22.7	12.7	7.6	9.0	2.4	11.9	2.9	8.2	9.8	22.2	4.6	48.2	6.5	6.1	8.0	9.1	11.3	4.0	28.3	9.8	28.7	36.3	11.1	6.2	5.6	9.1	9.4	12.5	12.9	22.4	9.5	42.6	16.4	9.2	13.7	8.3	5.2	3.6	11.8	6.2	3.9	11.9	9.9	1.4	12.0	3.8	5.7	16.5	2.4	0.1	4.5	5.6	9.6	24.7	24.6	9.9	4.1	6.2	15.5	1.4	1.7	15.6	4.1	0.1	1.3	11.4	19.7	4.3	2.4	1.6	0.6	10.1	5.4	0.3	4.8	4.4	0.1	1.7	0.5	34.0	2.5	0.8	34.7	0.3	4.1	9.7	23.6	13.1	14.2	5.0	18.3	3.9	18.5	0.9	0.4	15.7	4.8	59.3	1.7	1.2	0.4	0.2	10.0	2.2	18.5	1.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	4.6	0.3	0.2	0.6	0.1	0.1	10.3	22.3	7.4	10.8	12.7	7.6	8.2	9.8	8.0	5.6	12.9	8.3	2.0	16.0	18.4	59.1	0.3	15.3	14.0	14.1	7.4	4.4	5.7	6.1	23.9	14.3	18.3	7.3	0.0	15.5	0.3	3.9	1.9	5.4	3.2	6.2	19.7	3.9	0.0	17.2	10.3	4.2	1.8	24.4	8.6	8.0	19.0	5.9	5.3	2.6	2.6	0.0	2.7	19.4	4.1	24.1	6.8	10.8	17.7	2.5	0.0	15.9	2.7	22.2	2.1	10.6	6.3	3.0	9.5	10.5	0.1	10.9	2.2	4.7	18.4	3.4	13.1	82.2	7.9	8.1	6.0	26.3	19.5	5.3	2.3	33.5	10.2	10.5
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL histone methyl-lysine binding protein 1"	Q9Y468	20	43489442-43550954	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 5.1"									HPA059648			Supported	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	2.7	4.8	8.6	0.8	8.5	0.8	3.9	6.4	10.2	6.4	6.1	6.1	1.1	5.0	2.0	4.2	6.9	0.6	3.9	8.0	9.4	5.9	2.0	3.0	0.8	8.0	8.8	7.5	3.3	1.1	16.7	0.6	8.7	6.4	0.7	3.4	4.6	1.7	5.1	3.9	4.8	0.8	6.1	5.5	3.9	10.1	10.8	0.8	6.9	1.1	0.5	4.8	6.4	7.6	0.1	0.1	1.6	0.9	0.1	0.0	2.6	0.2	0.3	0.5	0.4	0.2	1.7	0.9	0.4	0.9	0.5	1.1	0.0	0.4	0.3	0.0	1.1	0.3	1.4	2.1	0.3	0.0	0.3	0.3	0.6	0.1	0.0	2.9	0.3	0.9	0.6	0.2	0.1	0.3	0.4	1.2	1.0	0.7	1.4	0.6	0.2	0.5	1.2	0.4	0.4	1.3	0.5	0.5	0.1	5.1	0.6	1.7	0.6	0.2	1.1	0.0	0.4	1.0	0.4	0.3	1.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	8.6	8.5	6.4	10.2	8.0	9.4	8.0	8.8	8.7	6.1	10.8	7.6	1.2	3.2	3.2	16.0	3.3	0.9	2.0	1.9	8.0	17.2	2.7	2.8	1.9	1.5	4.2	5.5	14.6	2.1	5.2	0.9	1.9	1.3	2.0	2.4	2.6	2.2	1.2	1.7	12.4	0.2	3.3	1.9	2.0	1.8	5.1	8.3	1.8	0.6	1.4	6.7	24.4	2.1	4.1	1.6	1.8	2.8	5.0	2.0	3.6	4.7	1.0	4.7	4.1	31.2	25.4	0.8	1.9	6.0	1.7	2.5	3.1	0.7	6.6	10.8	0.0	4.2	2.8	13.9	12.3	1.5	1.1	1.9	2.3	4.6	1.8	1.4
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LHFPL2	KIAA0206	ENSG00000145685	"LHFPL tetraspan subfamily member 2"	Q6ZUX7	5	78485215-78770021	"Predicted membrane proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 121.9;Microglial cells: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.9;plasmacytoid DC: 6.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.3;granulocytes: 7.9;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042402, HPA076743"	Uncertain		Approved	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA042402: AB_10794276, HPA076743: "	"unprognostic (2.19e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (3.40e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.85e-2)"	18.2	18.8	10.9	19.6	11.5	18.4	20.5	12.0	13.4	14.0	15.3	17.7	23.8	18.0	18.9	6.3	9.1	22.6	12.2	10.1	11.1	3.1	6.4	19.7	15.2	17.2	13.7	18.5	11.4	10.4	5.7	14.8	14.9	11.4	17.5	5.5	19.3	24.7	2.7	5.7	21.2	22.0	14.6	4.3	14.8	9.1	18.5	14.8	9.1	4.1	14.4	36.3	10.3	18.7	9.8	36.1	10.6	14.1	63.0	18.0	32.7	11.0	28.0	18.7	32.5	12.8	28.4	24.4	4.8	21.7	116.4	16.6	10.2	11.8	30.6	0.2	9.1	24.3	7.2	21.6	46.5	0.1	0.2	20.7	46.6	57.3	88.4	29.6	44.8	0.9	0.2	17.8	42.9	5.2	0.1	1.4	11.8	7.9	10.3	4.7	15.0	6.8	7.1	42.6	2.0	14.4	17.9	6.6	62.5	22.3	3.9	3.0	29.8	21.7	11.8	60.1	33.2	0.7	0.1	34.1	57.5	0.2	39.7	7.9	3.9	4.0	0.0	1.4	0.1	0.6	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	0.5	6.3	0.1	1.3	10.9	11.5	12.0	13.4	10.1	11.1	17.2	13.7	14.9	14.6	18.5	18.7	13.5	3.2	3.4	20.2	5.7	8.7	7.3	5.2	0.6	6.6	18.2	15.6	3.7	1.5	7.6	7.3	0.0	4.0	20.3	34.8	0.0	9.1	1.5	7.5	26.3	21.4	2.4	10.7	15.8	12.9	2.6	38.1	10.7	14.6	0.0	121.9	35.3	1.4	60.1	3.3	7.9	16.3	6.1	40.4	14.7	1.7	19.3	36.3	10.6	209.9	5.5	5.4	0.0	55.3	4.6	17.0	16.1	33.4	3.3	10.4	29.8	0.7	3.9	2.2	6.6	19.1	13.1	0.7	1.7	1.4	4.8	7.3	1.3	22.1	10.0	12.4
LHX5		ENSG00000089116	"LIM homeobox 5"	Q9H2C1	12	113462033-113472280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.0"	"Cell type enhanced"	"Detected in single"		"Basal respiratory cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053908			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA053908: AB_2682304"		"unprognostic (5.20e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.06e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.56e-1)"			"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.54e-3)"	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.0	1.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	0.1	0.0	1.9	5.0	1.5	1.7	1.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;ovary: 3.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Fibroblasts: 4.2;Leydig cells: 20.2;Oligodendrocyte precursor cells: 3.5;Skeletal myocytes: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;NTERA-2: 15.2;RH-30: 6.4;U-937: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	0.5	0.0	1.8	0.4	1.3	0.3	0.8	1.1	1.7	0.6	1.1	0.3	0.0	1.1	0.3	0.6	0.3	0.8	0.7	3.0	1.2	0.1	0.1	0.1	0.0	1.8	1.7	3.6	0.4	0.0	0.1	0.0	1.3	0.2	0.4	0.1	0.3	0.1	0.0	0.5	0.3	0.5	2.6	0.1	0.4	0.3	1.1	0.7	0.1	0.3	0.4	0.3	0.2	3.8	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.2	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	2.1	0.0	0.4	1.7	15.2	0.0	0.2	0.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	2.6	0.0	0.0	0.2	0.0	0.6	1.2	0.0	0.7	0.7	3.7	1.5	6.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.3	1.1	1.7	3.0	1.2	1.8	1.7	1.3	2.6	1.1	3.8	1.2	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.5	20.2	0.1	1.8	1.0	0.6	1.0	0.0	3.5	0.1	0.0	0.0	2.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.3	1.5	0.4	0.0	0.4	0.2	0.0	0.2
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515385-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 45.3;skeletal muscle: 165.0;tongue: 94.1"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 198.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	2.4	0.7	1.5	0.7	3.6	0.8	1.9	1.1	2.8	3.5	0.2	1.9	0.7	4.8	2.4	1.4	2.4	3.0	45.3	2.7	0.1	4.5	5.6	1.2	0.5	0.4	0.4	5.2	1.1	0.9	1.2	0.9	0.3	2.1	1.6	0.3	2.2	0.3	165.0	1.9	0.8	4.0	0.2	2.8	1.8	0.8	0.1	3.2	22.1	94.1	0.7	2.3	2.0	1.4	0.1	0.0	0.1	0.1	0.6	1.4	0.1	0.5	1.0	0.3	0.5	0.0	0.1	0.2	0.1	7.2	0.0	0.1	2.5	0.0	0.9	0.3	0.0	4.2	0.3	0.0	0.1	0.1	0.0	0.1	0.0	2.8	0.0	2.3	0.1	0.5	0.0	0.2	4.1	0.0	0.5	0.1	1.0	0.3	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.8	0.5	0.1	1.0	0.7	0.1	0.5	3.2	0.1	0.3	1.6	1.1	0.2	0.2	1.9	0.1	0.1	0.9	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.5	0.1	1.5	3.6	1.1	2.8	2.7	0.1	0.4	0.4	0.3	0.2	0.1	1.4	1.6	9.6	1.1	2.0	0.2	1.9	1.1	0.6	0.6	0.1	0.8	1.3	198.4	7.2	0.0	1.8	0.0	0.1	0.0	0.2	9.8	0.6	2.3	0.3	1.6	4.0	3.0	0.0	12.5	1.0	0.0	11.9	3.1	0.4	10.2	2.5	5.0	10.2	2.0	0.0	11.2	1.8	0.0	0.8	5.7	2.9	0.6	0.6	10.6	3.7	0.0	0.4	0.0	3.5	0.7	1.0	0.4	0.0	3.0	0.6	0.0	0.8	0.7	0.2	0.0	32.7	2.6	0.6	0.7	0.0	2.4	0.1	2.1	7.9	1.9	0.4
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640791-194672463	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	14.9	12.8	13.2	15.8	13.8	28.1	15.8	13.9	15.9	12.8	14.0	15.1	17.2	15.2	19.8	15.9	14.5	12.6	14.0	13.1	14.5	16.6	21.7	12.8	18.7	14.7	16.4	14.2	15.5	16.8	11.1	17.2	15.8	14.6	18.1	14.0	13.8	13.9	23.0	19.3	14.9	14.5	14.0	15.4	13.6	14.4	14.4	17.2	15.5	18.9	21.3	18.2	14.3	15.4	55.6	36.0	21.2	35.3	32.3	17.8	43.1	31.0	30.1	42.9	37.6	47.9	25.1	43.1	93.5	29.4	75.5	39.5	68.2	35.0	52.1	56.3	32.5	46.8	38.4	27.6	22.9	51.1	42.4	17.3	31.5	44.4	41.7	16.0	47.1	29.4	39.5	46.2	36.0	76.6	46.3	30.8	57.7	73.5	65.6	56.2	35.0	49.3	23.7	46.9	40.5	27.9	39.9	38.2	40.0	39.7	90.3	32.9	36.5	32.4	37.3	46.2	66.6	50.6	71.1	97.7	26.2	64.7	52.4	3.5	10.1	13.6	15.3	13.2	17.1	16.6	12.5	13.9	17.2	14.3	14.4	12.9	1.3	21.0	8.9	9.0	15.4	10.6	13.2	13.8	13.9	15.9	13.1	14.5	14.7	16.4	15.8	14.0	14.4	15.4	25.0	19.2	29.6	10.4	22.5	16.2	13.4	8.9	25.0	18.3	12.1	11.9	17.2	18.6	27.9	9.2	12.5	25.1	21.2	14.0	5.9	23.3	12.0	22.1	24.5	23.7	7.8	16.2	10.5	22.4	19.4	17.7	21.9	24.0	53.7	21.9	11.7	14.0	13.0	15.2	8.3	14.2	12.2	4.4	10.2	8.9	15.5	15.5	12.4	8.4	14.0	18.2	12.3	12.5	12.2	19.7	8.0	14.7	23.8	11.5	10.8	9.7	34.3	18.6	19.7	22.1	14.6	26.4	35.7	30.5	16.1	28.5	24.0	23.2	17.6	9.0
MAGEA11	"CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511"	ENSG00000185247	"MAGE family member A11"	P43364	X	149688228-149717268	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 21.0"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 29.4;Spermatogonia: 30.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-2 OS: 23.8"									HPA052687			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA052687: AB_2681915"	"unprognostic (4.06e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-2)"		"unprognostic (9.64e-2)"		"unprognostic (1.32e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.16e-1)"				"unprognostic (6.67e-4)"	"unprognostic (1.14e-1)"		"unprognostic (1.33e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	23.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	30.9	0.0	0.0	5.9	0.0	0.0	0.0	0.0
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343195	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	10.9	2.7	5.8	6.3	5.5	3.1	14.2	17.2	3.9	10.6	6.9	6.1	3.0	5.4	1.8	5.5	8.0	7.7	4.4	7.1	10.6	9.9	2.4	9.8	8.7	9.0	9.0	7.9	5.9	5.9	4.0	12.2	7.4	7.4	6.2	6.8	11.0	5.7	2.0	7.9	4.8	6.5	7.0	10.3	4.8	2.3	7.5	13.7	6.5	4.8	7.0	8.8	6.5	6.6	10.7	2.0	17.8	4.7	18.1	20.7	3.8	12.1	17.9	7.8	8.1	1.3	22.1	2.3	27.7	28.1	4.1	9.6	3.6	11.7	10.7	52.8	1.3	1.4	3.7	4.1	10.5	0.1	0.0	30.4	1.1	13.9	8.2	14.3	4.5	0.3	6.1	3.2	14.0	0.9	0.2	2.9	1.9	5.5	3.3	3.7	3.4	12.3	11.6	14.8	0.1	1.6	4.5	1.9	5.0	5.7	1.7	0.5	19.7	13.6	3.2	4.7	7.7	2.2	0.4	3.3	6.5	2.0	25.6	0.1	0.6	0.0	0.8	0.3	1.3	0.9	1.6	2.1	0.6	1.2	3.2	2.2	2.6	2.4	0.4	0.5	0.6	1.2	5.8	5.5	17.2	3.9	7.1	10.6	9.0	9.0	7.4	7.0	7.5	6.6	43.5	16.0	8.6	690.5	35.4	19.5	21.5	12.6	19.9	44.1	28.6	43.1	5.3	18.6	16.6	12.9	91.8	15.4	21.8	31.0	11.7	19.3	1.4	61.6	49.4	24.0	6.7	2.7	81.6	0.4	26.0	41.6	20.9	52.3	1.3	44.0	9.3	0.4	18.6	0.0	36.8	7.6	4.1	19.2	21.2	3.0	8.7	29.3	12.4	579.9	26.0	21.9	16.5	1300.8	311.4	15.0	16.8	8.6	18.1	19.1	9.4	17.1	24.2	25.9	32.9	3.6	51.5	0.6	0.8	19.4	13.5	13.0	38.1	9.0	14.3	19.2
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MESD	"BOCA, KIAA0081, MESDC2"	ENSG00000117899	"Mesoderm development LRP chaperone"	Q14696	15	80946289-80989828	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	Chaperone	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039414, HPA041721"	Approved		Supported	"Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	"Nuclear bodies, Cytosol"	"HPA039414: AB_10674981, HPA041721: AB_2756310"	"unprognostic (9.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.93e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.09e-3)"	"unprognostic (4.04e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.88e-1)"	14.4	17.4	11.9	13.7	13.6	5.4	13.9	13.7	13.0	17.8	14.6	14.6	12.8	11.3	42.7	14.6	12.4	11.5	12.8	11.7	14.2	14.4	20.6	14.1	14.0	13.4	13.1	17.4	19.2	14.0	17.8	26.9	13.8	18.2	14.5	10.4	18.4	14.3	7.7	10.9	12.7	11.1	13.4	13.8	15.3	9.8	13.8	14.2	33.7	10.6	13.2	15.4	14.4	15.0	26.8	40.2	34.6	22.3	57.1	32.4	54.0	40.0	47.4	42.7	51.6	36.0	72.9	22.4	45.4	32.3	45.1	43.8	54.1	41.1	40.3	50.2	35.5	28.3	33.0	61.9	43.7	33.8	30.0	33.9	46.6	36.1	42.4	35.7	41.1	27.0	34.7	55.5	36.7	34.0	20.9	28.3	41.9	39.3	16.4	31.7	21.3	59.7	35.6	36.3	29.9	17.6	43.9	29.3	70.0	62.4	34.0	26.8	32.4	40.9	39.1	22.1	52.2	35.0	48.0	30.2	38.5	59.7	43.8	39.4	26.1	19.1	35.6	24.9	41.8	34.5	37.2	35.4	27.2	35.4	34.6	34.7	8.1	44.8	22.5	45.2	42.5	31.1	11.9	13.6	13.7	13.0	11.7	14.2	13.4	13.1	13.8	13.4	13.8	15.0	59.7	80.1	59.6	0.0	20.6	0.0	0.0	0.0	0.0	0.0	51.0	44.2	0.0	0.0	27.9	58.8	0.0	341.4	41.6	0.0	13.7	100.9	0.0	41.4	79.4	36.9	0.0	0.0	0.0	111.9	279.3	48.4	0.0	69.8	36.6	56.4	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	86.3	0.0	0.0	0.0	0.0	82.5	0.0	0.0	18.8	0.0	0.0	48.8	43.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	436.0	25.8	63.6	0.0	0.0
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Oligodendrocytes: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	18.6	9.5	29.3	10.7	46.9	18.7	10.3	49.4	33.3	11.2	24.8	9.9	12.8	9.4	9.4	20.9	7.5	9.6	12.7	28.0	36.3	30.6	24.2	13.6	12.0	57.6	48.5	11.5	12.4	21.3	1.9	25.9	56.5	11.0	10.3	12.1	14.9	11.4	29.4	11.2	11.6	10.0	45.3	15.1	13.0	8.5	40.8	16.7	14.2	24.0	10.6	10.1	5.4	63.3	8.1	9.0	8.2	5.2	17.7	9.6	7.2	11.9	23.9	9.4	9.4	5.9	3.5	3.9	15.5	15.5	9.1	11.5	6.5	7.0	8.9	12.5	2.1	5.5	6.2	10.4	10.3	8.9	12.2	13.2	5.4	6.1	6.7	10.8	23.7	10.9	4.9	9.2	8.9	2.3	9.3	5.6	4.7	9.7	4.3	6.7	6.7	19.5	35.6	12.7	3.0	7.8	5.4	6.3	2.4	10.4	4.2	16.4	10.9	10.6	8.0	5.6	6.8	9.4	7.8	9.0	6.7	4.7	13.4	3.7	3.2	3.1	0.7	4.0	0.8	1.9	0.8	0.6	3.1	2.8	1.2	1.2	13.5	1.4	7.4	3.7	1.2	1.7	29.3	46.9	49.4	33.3	28.0	36.3	57.6	48.5	56.5	45.3	40.8	63.3	15.8	25.6	15.2	86.2	11.3	8.9	4.3	3.3	8.0	0.0	6.7	4.6	24.1	10.0	7.0	33.1	0.0	19.3	12.9	12.7	1.9	3.4	13.6	10.1	9.6	16.8	6.0	5.2	15.4	3.8	3.1	8.6	13.3	19.7	17.1	9.4	11.4	33.9	11.8	0.0	13.6	7.7	2.0	24.9	16.2	24.9	10.5	19.0	8.8	55.3	13.8	0.0	3.1	25.6	149.3	5.6	9.2	7.5	8.0	6.7	14.4	18.6	4.7	0.0	0.0	10.6	8.9	11.1	8.9	33.6	11.1	38.4	6.8	6.7	8.2	8.7
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1 autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 276.9;Late spermatids: 909.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	45.7	52.3	48.4	39.4	54.5	20.1	55.9	52.1	48.2	52.0	51.2	66.2	70.1	48.9	39.9	40.3	53.4	44.5	67.3	43.7	49.9	84.7	91.3	47.3	41.0	52.2	50.4	69.7	43.9	97.1	28.8	60.1	52.9	64.7	70.4	80.1	49.4	52.0	112.2	42.9	73.8	49.3	52.1	53.0	52.6	141.0	51.6	59.0	68.2	116.0	45.4	47.3	34.5	65.2	42.3	49.8	42.6	44.6	93.5	95.2	41.0	77.1	147.2	60.5	50.4	26.6	65.1	22.7	77.8	105.1	62.6	46.1	48.5	97.4	90.3	70.0	51.2	27.1	62.0	60.0	89.4	23.2	40.1	108.4	111.6	67.2	133.7	127.3	96.0	50.8	58.1	58.7	83.7	23.9	48.9	17.7	13.6	50.0	32.8	16.5	65.6	73.3	81.6	48.0	25.9	45.8	53.1	26.1	79.8	70.7	70.7	38.0	82.2	89.9	34.1	42.7	31.5	69.9	61.8	29.1	61.8	31.5	63.6	41.6	25.7	40.1	20.3	23.3	20.7	13.7	18.1	19.6	19.3	9.4	17.0	16.6	34.4	24.3	36.4	12.0	26.4	25.0	48.4	54.5	52.1	48.2	43.7	49.9	52.2	50.4	52.9	52.1	51.6	65.2	36.9	41.7	44.1	24.5	21.9	23.8	29.2	28.1	54.1	37.3	33.8	27.4	86.4	35.8	40.4	36.8	39.6	28.0	34.6	94.2	19.6	25.4	276.9	40.5	30.4	39.0	40.2	53.2	24.7	21.9	19.4	37.6	31.1	33.0	25.9	53.1	45.3	67.8	22.0	20.2	28.2	56.4	20.3	62.9	19.9	909.9	58.7	35.7	26.6	29.0	35.6	49.3	44.3	33.2	41.4	25.8	64.5	44.4	26.1	41.1	100.3	57.4	63.4	56.9	39.5	33.9	36.2	49.6	30.9	26.7	27.3	15.7	31.9	68.6	52.4	38.7
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49852821	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		830000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	16.5	13.8	9.5	18.0	13.0	42.1	14.7	18.1	14.7	16.2	5.9	13.6	10.0	16.2	13.5	22.5	12.2	13.2	17.7	7.9	10.6	14.9	11.9	13.8	17.9	11.8	11.6	15.2	15.2	24.8	10.3	18.2	11.9	16.0	14.5	14.7	14.6	15.8	23.0	14.3	13.6	15.7	10.9	15.5	14.1	10.7	10.7	16.3	18.5	21.5	17.9	18.0	11.6	18.4	34.3	39.2	35.9	24.1	37.3	31.0	32.1	42.0	28.3	27.6	27.3	23.2	35.3	13.3	32.0	35.7	21.2	47.5	34.1	26.7	42.2	38.9	22.7	38.7	40.3	29.1	23.8	50.7	33.4	26.8	19.6	29.9	27.2	36.3	39.8	23.8	47.3	36.2	37.7	30.6	31.2	17.9	21.9	28.6	36.8	32.6	35.5	20.8	33.7	44.8	23.6	22.2	41.6	40.4	39.2	37.2	37.6	31.1	47.2	39.2	34.4	26.6	28.9	24.5	47.6	40.9	14.7	23.9	35.5	76.4	38.9	45.8	45.7	36.9	44.8	83.7	47.1	44.4	33.9	86.7	55.6	59.1	61.3	47.8	54.4	79.7	46.1	20.3	9.5	13.0	18.1	14.7	7.9	10.6	11.8	11.6	11.9	10.9	10.7	18.4	66.2	41.7	76.7	65.3	81.1	34.4	67.4	81.6	29.6	92.1	31.7	43.1	97.2	34.3	74.4	44.1	100.1	85.8	78.4	51.8	37.2	57.0	13.9	52.2	60.1	65.2	54.0	57.0	75.7	39.1	58.1	53.0	41.8	60.7	89.3	68.0	49.6	28.1	58.9	131.2	80.7	48.9	71.2	48.7	57.0	13.1	65.9	57.9	24.9	62.8	79.4	54.8	82.4	56.8	99.5	46.4	68.5	67.4	50.0	66.1	59.4	29.9	82.4	90.0	72.3	65.7	70.7	83.0	58.3	32.5	34.1	108.4	66.9	64.1	54.6	88.6
NFKBID	"IkappaBNS, IkBNS, TA-NFKBH"	ENSG00000167604	"NFKB inhibitor delta"	Q8NI38	19	35887653-35902303	"Predicted intracellular proteins, Transcription factors"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 152.7;granulocytes: 90.3;Langerhans cells: 418.5;Macrophages: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054778			Uncertain	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Nuclear bodies, Plasma membrane"	"HPA054778: "	"prognostic favorable (6.01e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.34e-6)"	4.0	1.8	0.7	4.4	0.6	15.9	2.5	2.7	1.6	1.9	2.1	2.3	1.1	1.8	0.0	2.1	3.0	2.4	1.5	0.8	1.4	2.5	1.5	5.6	4.8	1.4	0.9	3.3	2.1	0.9	4.2	0.8	1.2	2.2	0.8	0.7	1.6	0.5	0.4	2.2	4.0	0.5	1.0	5.4	2.0	0.4	1.3	5.2	3.9	0.2	3.1	2.2	2.0	1.7	3.3	3.0	0.6	2.0	0.3	0.5	1.4	2.0	2.4	2.1	1.5	0.7	2.6	4.0	1.5	2.1	1.9	1.7	2.1	1.6	0.9	2.3	0.4	2.4	4.9	0.7	0.5	2.1	7.0	0.7	1.0	3.9	0.9	0.5	0.8	1.8	0.5	2.4	0.4	2.6	1.7	2.5	0.8	0.6	0.6	0.9	0.4	0.8	1.8	1.4	1.0	0.8	2.7	2.1	0.2	0.5	0.9	2.1	0.8	3.3	3.0	1.5	1.4	1.7	0.6	4.6	1.8	4.9	0.5	0.0	0.9	1.7	1.4	0.6	1.1	3.3	0.6	1.1	0.9	5.5	1.0	0.6	3.2	1.5	1.1	1.2	1.5	0.5	0.7	0.6	2.7	1.6	0.8	1.4	1.4	0.9	1.2	1.0	1.3	1.7	11.7	0.0	11.3	2.9	152.7	29.7	14.3	12.9	34.7	8.0	10.9	7.5	1.1	5.7	5.6	1.8	20.9	1.3	58.9	5.7	0.0	2.5	0.1	27.8	6.8	21.5	3.0	1.7	4.9	1.0	2.8	11.3	2.0	80.8	90.3	3.8	9.3	0.3	39.2	0.0	3.4	5.7	2.0	31.0	418.5	0.4	1.2	89.4	19.6	2.8	40.0	1.0	13.4	1.5	0.5	2.8	2.1	1.9	38.1	13.8	9.2	1.7	3.9	9.2	0.0	3.3	6.7	0.4	1.0	20.7	33.4	1.0	45.3	2.4	6.2	10.0
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOVA2	"ANOVA, NOVA-2, NOVA3"	ENSG00000104967	"NOVA alternative splicing regulator 2"	Q9UNW9	19	45933734-45974044	"Human disease related genes, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045607	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"HPA045607: AB_10962628"	"unprognostic (9.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.42e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.31e-2)"	6.7	1.9	12.4	0.7	15.1	0.0	5.7	0.5	16.7	3.2	0.0	1.8	0.6	3.4	0.6	1.4	2.9	1.4	6.7	16.0	5.8	4.7	1.0	9.3	0.5	4.6	3.0	1.2	1.1	1.0	6.2	3.9	3.6	2.3	0.5	5.6	1.1	0.8	2.3	1.1	1.7	2.0	0.6	1.5	1.5	2.0	4.6	0.4	4.5	2.5	0.2	2.5	2.0	9.8	0.0	0.1	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	1.3	0.0	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	15.1	0.5	16.7	16.0	5.8	4.6	3.0	3.6	0.6	4.6	9.8	39.4	0.0	0.0	5.9	0.1	0.6	0.2	0.0	0.6	56.7	0.1	0.5	3.4	1.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.1	32.0	0.0	0.0	21.8	0.2	0.0	1.2	0.0	0.1	0.0	0.1	42.5	0.5	0.1	21.9	20.9	0.0	0.0	1.6	1.5	3.5	0.0	0.1	0.0	9.4	0.0	1.3	0.0	11.6	9.5	0.2	0.0	0.4	1.2	0.3	0.0	0.0	0.0	3.3	0.0	0.6	0.6	2.4	2.3	0.3	0.1	0.0	0.5	0.4	0.0	0.3
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	3.9	7.7	3.6	12.4	4.0	5.1	23.4	10.2	7.0	4.8	5.3	2.4	7.4	7.2	2.4	4.8	5.9	5.2	5.8	10.6	12.0	1.6	1.8	4.1	12.4	10.0	8.4	3.0	0.6	2.8	2.6	12.9	4.1	3.0	3.9	3.6	4.9	4.9	2.6	4.7	4.9	8.1	9.1	3.6	2.1	12.0	3.0	5.5	7.5	2.6	4.3	4.7	13.3	0.4	0.9	1.5	0.8	0.0	0.0	1.8	1.1	0.0	0.0	0.0	2.3	1.1	1.2	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.9	1.3	2.0	2.9	0.2	0.0	2.4	1.4	0.0	0.0	0.0	0.0	2.2	0.0	1.3	1.1	2.7	0.0	1.0	1.5	1.2	1.5	0.9	0.4	0.9	1.6	0.7	0.0	1.5	1.1	1.7	0.8	1.2	0.3	2.7	0.8	0.4	1.2	0.6	0.7	0.9	1.6	0.4	0.1	1.8	1.5	1.1	0.8	3.7	0.3	0.1	0.5	0.2	0.3	0.7	0.4	0.5	0.2	0.6	0.8	0.3	0.1	0.4	0.1	0.3	0.1	0.1	7.7	12.4	23.4	10.2	5.8	10.6	12.4	10.0	12.9	8.1	12.0	13.3	0.6	0.0	1.1	0.0	0.2	0.1	0.5	0.0	0.0	5.0	0.1	0.9	1.3	0.0	0.0	1.8	6.2	0.3	0.3	0.0	0.0	0.0	1.6	0.2	0.9	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.4	0.0	0.1	3.3	3.3	0.0	0.0	0.6	0.3	1.8	0.3	0.5	0.0	2.8	0.0	0.6	3.1	0.5	4.9	0.0	0.0	5.3	0.0	0.3	0.0	0.2	0.0	8.8	26.3	0.5	23.1	0.1	0.3	0.1	0.1	0.0	1.1	0.4	0.0	0.1
NUFIP2	"182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1"	ENSG00000108256	"Nuclear FMR1 interacting protein 2"	Q7Z417	17	29255839-29294148	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 79.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067443			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067443: AB_2685841"	"unprognostic (6.51e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.04e-3)"	15.3	14.9	4.4	22.7	3.6	79.9	12.5	10.3	20.4	12.7	11.7	14.9	16.2	11.5	11.9	17.2	10.9	14.0	13.6	5.1	19.9	13.0	24.0	21.0	19.8	12.1	14.7	12.0	14.7	18.4	11.0	29.6	11.0	12.1	13.0	23.1	15.5	9.8	15.9	12.1	13.2	10.3	2.1	20.7	18.7	14.2	10.8	18.0	13.5	17.6	17.5	16.4	14.2	14.1	42.5	67.1	38.9	27.2	32.8	38.0	65.1	41.3	24.8	31.1	28.4	75.0	22.5	68.5	60.1	28.5	27.7	58.6	31.4	28.9	39.3	74.0	55.9	51.8	64.7	19.8	30.3	66.6	53.8	33.1	34.5	34.4	36.7	35.9	23.2	24.8	86.2	49.5	32.1	34.8	70.6	30.1	40.2	32.2	24.9	57.2	66.8	29.4	26.1	68.4	37.1	23.5	73.6	136.6	44.6	51.5	47.3	44.2	38.5	59.1	59.1	35.0	71.3	68.4	68.9	79.3	39.0	34.9	51.6	13.6	6.1	8.5	5.6	5.9	4.3	8.5	5.5	6.2	5.2	7.6	7.0	5.9	25.4	5.1	9.6	12.1	3.2	2.3	4.4	3.6	10.3	20.4	5.1	19.9	12.1	14.7	11.0	2.1	10.8	14.1	139.7	80.1	67.0	58.1	76.8	99.5	78.2	40.0	118.4	55.3	105.0	124.8	81.7	38.6	69.3	31.3	95.9	69.2	124.3	72.6	15.6	33.9	35.2	108.2	139.0	85.9	48.3	55.6	47.4	27.9	31.3	86.4	82.6	154.2	46.2	41.2	55.0	54.6	44.6	57.2	47.1	62.5	20.3	74.7	108.8	24.9	35.4	122.9	40.9	41.2	50.0	35.2	37.0	44.7	85.9	37.4	43.1	35.0	65.2	91.8	26.5	27.6	88.8	60.6	19.7	171.7	78.5	36.6	29.8	120.8	97.7	182.0	93.8	51.8	57.1	111.9
OBI1	"C13orf7, FLJ13449, RNF219"	ENSG00000152193	"ORC ubiquitin ligase 1"	Q5W0B1	13	78614289-78659155	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	5.8	4.8	5.4	6.1	5.8	2.4	6.7	6.6	6.7	5.9	3.0	4.8	4.8	7.1	4.5	5.0	5.6	4.5	7.1	5.6	6.1	4.6	4.4	5.2	9.9	5.5	5.9	7.6	4.1	4.1	2.9	7.4	5.0	5.5	5.3	9.6	4.2	6.1	4.8	5.5	4.7	6.5	6.1	7.3	4.5	14.8	7.2	13.3	5.9	6.4	11.3	6.0	4.5	5.9	23.7	9.1	39.1	23.1	13.5	12.9	17.8	19.3	14.5	18.7	23.3	18.3	17.3	39.8	9.2	12.4	12.2	23.0	31.2	15.3	32.6	24.9	22.8	61.0	11.4	16.1	11.3	59.6	18.2	12.4	16.7	15.7	16.8	10.6	15.6	19.9	16.1	5.3	24.6	6.6	36.5	20.2	0.0	25.1	10.0	42.0	32.2	15.4	12.7	12.5	28.4	15.9	13.4	16.9	14.8	22.2	8.6	47.3	12.9	16.2	14.7	10.7	16.3	5.5	6.6	37.9	25.9	35.6	17.8	4.9	5.4	7.5	7.9	8.8	9.5	8.8	8.8	9.8	6.3	8.9	10.8	9.8	1.8	11.1	10.3	5.3	9.6	6.6	5.4	5.8	6.6	6.7	5.6	6.1	5.5	5.9	5.0	6.1	7.2	5.9	14.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	15.8	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	12.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.1	1.1	0.0	0.0	0.0
OTP		ENSG00000171540	"Orthopedia homeobox"	Q5XKR4	5	77628712-77638713	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"brain: 28.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Sertoli cells: 6.6;Spermatocytes: 2.2;Spermatogonia: 1.5"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"hypothalamus: 20.0"	"Region enhanced"	"Detected in some"		"hypothalamus: 15.5"	HPA059342	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies"	"HPA059342: AB_2732635"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-2)"		"unprognostic (6.25e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.16e-1)"		"unprognostic (7.77e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.39e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.76e-14)"	"unprognostic (3.38e-2)"	"unprognostic (1.84e-1)"		"unprognostic (9.49e-3)"	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.1	0.0	9.2	1.7	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	28.7	9.2	1.7	6.6	0.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439075-23442377	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	13.0	11.7	8.0	10.2	8.4	60.4	10.3	9.5	10.2	8.4	8.4	8.7	6.8	10.2	6.8	7.8	11.2	9.7	43.4	8.7	9.0	19.7	7.6	19.7	14.4	8.3	8.0	13.6	6.9	19.4	8.0	12.1	7.6	8.8	7.6	5.9	6.7	7.6	29.4	20.9	8.2	9.4	8.4	13.7	22.9	7.5	9.2	6.8	13.3	22.6	12.5	11.9	7.6	9.2	4.8	2.3	2.4	1.1	9.3	4.6	3.2	1.9	4.2	4.4	4.0	0.9	38.1	2.2	4.1	2.4	1.5	36.5	2.5	4.5	2.9	17.4	7.1	0.1	5.7	1.5	8.0	0.4	3.2	4.8	19.4	1.3	6.1	3.9	1.5	2.2	0.5	15.1	2.5	2.3	1.5	1.4	1.9	2.7	1.3	2.4	10.8	2.2	5.8	4.0	1.1	2.6	23.4	4.1	11.3	6.3	1.7	3.3	2.7	2.5	3.7	7.0	0.8	7.6	15.0	1.1	3.8	1.5	1.0	2.5	0.5	1.0	0.3	0.6	0.3	0.7	0.5	0.3	0.3	1.2	0.4	0.6	1.3	0.0	1.9	0.2	1.3	0.2	8.0	8.4	9.5	10.2	8.7	9.0	8.3	8.0	7.6	8.4	9.2	9.2	17.3	67.3	11.5	3.3	55.9	32.0	7.1	5.0	13.6	20.1	12.3	9.1	149.0	7.2	4.9	5.5	2.1	3.3	9.6	47.2	11.7	6.0	8.0	35.0	44.5	25.6	6.0	13.5	4.3	7.1	3.2	20.8	47.4	33.8	5.7	10.4	16.4	10.1	51.0	53.8	4.8	77.9	10.2	68.2	219.1	7.6	6.5	105.7	33.8	8.4	9.3	33.8	10.3	4.0	6.5	10.1	16.3	13.2	50.0	7.7	8.0	25.1	9.8	26.2	6.6	82.2	19.4	7.2	4.7	15.1	30.5	7.9	16.5	7.5	24.3	10.9
PALM2AKAP2	PALM2-AKAP2	ENSG00000157654	"PALM2 and AKAP2 fusion"	"Q8IXS6, Q9Y2D5"	9	109498325-110172512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.6;naive B-cell: 10.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	97.0	13.5	21.8	37.3	21.1	9.9	17.5	6.9	22.7	28.5	0.0	17.4	14.8	28.8	8.5	26.5	14.7	37.4	93.8	15.7	18.5	30.8	38.2	69.1	32.2	18.1	26.6	9.3	13.1	14.0	0.1	97.9	20.3	14.9	18.1	3.3	38.0	25.1	17.0	10.1	13.3	48.5	10.5	38.4	18.5	4.6	38.8	45.4	25.6	24.3	31.7	43.0	0.4	26.3	20.6	7.7	112.5	0.1	110.8	93.0	33.4	116.0	141.3	101.6	93.4	134.6	17.9	92.1	30.6	129.6	146.2	28.9	9.5	98.8	185.4	68.9	12.5	9.2	30.4	11.0	75.9	12.4	256.2	109.8	24.7	183.3	280.4	62.5	150.9	14.5	0.3	76.2	204.7	1.2	61.9	31.1	47.2	9.1	62.6	5.5	98.2	25.3	72.4	2.8	25.2	1.5	10.3	9.5	26.4	87.8	4.1	22.2	240.0	94.0	77.9	137.5	108.8	52.5	89.1	52.5	81.4	51.3	73.9	2.9	0.1	1.3	1.0	0.2	0.2	10.6	1.2	1.4	1.2	10.3	0.7	0.8	0.5	2.2	0.0	2.4	3.9	1.4	21.8	21.1	6.9	22.7	15.7	18.5	18.1	26.6	20.3	10.5	38.8	26.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PALM3		ENSG00000187867	"Paralemmin 3"	A6NDB9	19	14053363-14062076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 46.9;liver: 55.7;stomach 1: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 40.9;Cholangiocytes: 22.8;Collecting duct cells: 38.6;Exocrine glandular cells: 27.9;Hepatocytes: 40.5;Spermatogonia: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AN3-CA: 17.6;CACO-2: 20.2;GAMG: 5.5;HAP1: 15.8;NTERA-2: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052794, HPA056119"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA052794: AB_2681952, HPA056119: AB_2683042"	"unprognostic (3.67e-2)"	"unprognostic (9.08e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.72e-3)"	0.1	0.2	1.3	0.1	1.4	0.0	0.6	1.3	1.5	2.0	1.0	0.8	1.6	1.0	6.7	0.3	1.8	1.0	0.4	1.3	1.8	46.9	55.7	4.3	0.0	2.9	1.7	0.2	24.5	6.5	0.4	0.4	2.6	4.0	0.2	0.5	3.7	4.5	0.1	0.5	1.1	0.0	1.7	0.1	30.5	15.2	1.8	0.0	12.7	0.0	0.0	4.7	1.6	1.7	1.4	1.3	2.9	17.6	0.3	0.0	3.3	0.3	0.0	0.7	0.5	20.2	0.3	0.0	0.2	0.4	5.5	0.0	15.8	0.0	0.3	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.5	0.0	0.0	3.4	0.0	0.0	3.2	0.2	0.0	10.3	1.6	0.8	0.0	0.0	0.0	0.0	1.7	1.9	2.3	0.1	0.0	0.0	3.2	1.3	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	1.3	1.5	1.3	1.8	2.9	1.7	2.6	1.7	1.8	1.7	0.1	57.7	40.9	0.3	0.5	0.0	0.6	0.1	0.0	0.7	1.0	1.4	0.3	22.8	10.1	38.6	0.0	0.3	0.0	0.7	1.9	9.4	0.0	3.2	1.0	0.2	1.2	0.0	0.3	27.9	3.1	1.7	7.1	6.3	1.3	0.1	1.8	40.5	0.1	0.0	0.5	3.0	0.0	1.3	0.3	0.5	0.9	0.2	1.8	0.0	1.0	0.8	0.0	0.0	0.1	5.5	1.3	2.6	0.0	1.0	3.2	9.5	2.1	0.6	0.0	0.1	0.2	0.0	18.8	0.0	0.0	2.2	0.3	0.0	1.0	1.0
PARP11	"ARTD11, C12orf6"	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	3.4	5.0	2.7	5.0	2.9	3.2	5.3	2.0	2.9	4.2	2.0	3.6	3.7	6.5	5.4	3.1	4.1	4.0	2.3	2.5	3.4	3.9	4.5	3.8	10.2	3.4	3.2	8.2	2.5	7.8	1.8	3.2	3.3	8.6	4.1	3.3	4.0	4.2	1.8	2.2	3.7	5.2	2.8	6.2	3.3	9.4	3.5	10.4	9.1	2.9	9.4	5.0	1.9	3.5	2.7	2.3	14.0	2.3	4.4	7.2	4.1	3.3	5.5	5.6	5.7	8.7	2.2	8.0	2.0	6.4	6.6	2.2	4.8	4.8	9.0	16.1	4.9	12.0	0.0	6.5	5.1	8.1	4.4	5.9	3.8	4.4	12.4	0.0	4.4	15.3	3.1	6.5	8.1	4.0	4.2	3.1	5.2	2.9	0.3	8.3	9.8	1.8	2.6	6.3	0.9	2.9	3.1	2.8	4.2	15.1	0.5	7.1	8.5	4.9	4.8	7.3	4.4	3.1	7.3	11.7	4.6	4.4	1.2	20.3	8.9	9.2	7.4	7.4	10.0	10.0	8.3	5.5	8.9	8.8	9.2	7.5	8.5	7.7	6.1	7.8	3.7	6.2	2.7	2.9	2.0	2.9	2.5	3.4	3.4	3.2	3.3	2.8	3.5	3.5	8.6	9.6	9.5	16.0	18.3	1.9	4.4	6.7	7.4	10.6	5.7	4.1	3.8	2.8	4.5	1.8	2.1	4.2	17.7	2.6	0.0	3.4	61.5	2.1	9.6	5.3	3.6	12.0	30.8	3.1	1.6	8.4	1.1	1.9	14.7	72.0	6.8	4.1	7.1	3.3	30.8	4.7	2.0	9.8	5.8	45.1	10.5	9.7	1.8	18.7	10.3	5.4	17.5	32.6	18.8	3.3	7.6	8.6	3.7	6.6	2.6	4.1	6.0	6.4	6.6	7.0	9.8	9.9	10.9	3.6	1.8	2.6	15.0	8.9	5.0	3.4
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	24.3	32.1	16.5	11.8	22.3	3.1	36.1	10.7	18.0	88.3	1.9	52.3	22.4	136.8	21.6	30.1	74.6	37.6	24.0	15.3	14.1	29.4	7.7	20.7	4.5	8.8	32.7	52.1	48.1	29.5	14.3	19.5	6.7	38.0	19.8	17.1	43.8	53.8	36.3	10.2	19.9	125.2	13.7	10.2	21.9	6.8	12.6	10.9	35.1	26.5	8.1	40.2	41.5	12.1	2.9	74.4	82.4	19.1	50.8	23.3	3.4	25.2	20.9	8.4	6.1	14.2	11.8	0.0	5.5	47.8	4.3	22.8	31.7	8.1	3.6	3.1	31.3	93.0	56.5	0.3	34.7	0.0	22.2	24.4	0.0	5.4	2.1	19.2	0.3	0.0	0.2	0.0	2.2	47.1	0.2	0.6	111.5	3.8	4.5	0.0	21.6	27.0	6.3	44.1	2.5	39.6	27.8	186.1	0.1	71.4	73.2	0.0	0.5	3.7	8.6	24.2	8.1	8.5	61.2	0.1	0.4	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	16.5	22.3	10.7	18.0	15.3	14.1	8.8	32.7	6.7	13.7	12.6	12.1	28.6	22.4	18.6	382.3	2.8	22.8	115.0	39.8	70.6	39.9	129.9	87.8	50.0	98.7	25.3	33.1	110.5	101.3	1.5	29.2	33.2	47.9	91.3	47.7	144.3	47.0	90.9	30.3	475.9	68.7	7.3	126.7	32.1	38.5	71.7	57.6	68.9	18.7	9.7	5.0	405.0	38.2	50.8	1.9	17.5	124.4	63.6	12.1	16.0	125.5	1.6	33.5	1.0	327.2	227.4	31.7	72.5	103.8	2.8	41.5	40.4	57.9	37.3	30.6	39.5	142.0	70.9	2.3	17.5	83.6	28.1	104.7	7.6	168.0	43.7	75.9
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 153.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.9	56.0	10.4	12.9	14.6	6.9	10.0	17.4	13.2	27.2	7.0	47.9	6.8	9.8	20.0	11.8	14.2	22.5	38.0	7.2	15.0	7.1	18.1	13.0	8.0	19.7	21.0	58.2	18.8	153.1	12.6	6.7	19.4	30.9	13.7	28.0	11.8	28.0	8.5	19.4	14.3	22.6	18.8	12.8	21.5	8.2	15.3	16.7	35.1	5.7	6.9	20.7	21.9	21.7	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	10.4	14.6	17.4	13.2	7.2	15.0	19.7	21.0	19.4	18.8	15.3	21.7	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	107.3	51.9	23.8	38.1	25.6	41.7	76.6	25.8	29.8	58.4	34.1	68.1	127.3	52.3	51.3	57.5	44.2	53.4	50.7	25.0	30.2	96.0	173.8	42.7	30.6	25.6	29.6	57.9	74.2	80.5	49.0	85.3	27.7	53.0	65.2	55.1	55.3	73.2	54.4	98.2	121.9	67.4	26.6	32.5	95.8	39.5	28.5	28.0	65.6	44.0	40.8	56.3	51.0	29.8	123.3	44.4	80.3	64.9	339.8	177.6	80.5	164.6	182.7	119.4	158.3	46.4	123.6	86.3	187.8	213.4	138.8	70.1	74.3	81.6	149.3	49.7	42.7	58.0	111.3	88.3	429.1	84.7	41.7	140.9	161.3	100.3	123.3	277.0	109.1	55.0	98.2	105.6	173.7	38.2	78.9	39.2	63.1	148.5	39.7	62.5	64.2	59.8	176.8	42.9	63.3	59.7	92.4	103.1	97.3	131.2	79.7	38.0	203.5	100.0	81.4	103.8	77.3	121.0	106.0	91.3	109.9	74.4	70.1	2.2	1.0	2.0	1.5	0.9	0.7	1.2	1.8	1.5	0.6	0.9	1.6	1.5	0.9	1.1	0.7	2.4	2.0	0.6	23.8	25.6	25.8	29.8	25.0	30.2	25.6	29.6	27.7	26.6	28.5	29.8	95.9	54.5	41.0	16.6	27.0	100.1	49.7	27.8	54.1	22.4	49.2	32.8	60.7	58.6	35.9	44.1	10.4	85.4	41.2	68.2	29.4	57.3	80.9	42.2	59.1	50.0	35.5	104.2	20.4	74.2	146.6	69.9	53.0	64.2	12.0	31.0	47.2	125.1	35.3	11.8	19.1	67.8	40.7	15.7	39.5	49.5	46.3	22.1	67.6	13.1	19.0	98.6	21.6	13.6	25.0	69.7	50.6	37.6	48.9	58.0	177.3	111.0	27.4	41.1	13.1	63.3	53.1	33.3	27.3	51.9	111.8	274.9	32.4	39.4	58.8	34.4
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 252.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;RH-30: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	37.7	74.8	4.1	18.5	5.2	21.7	29.6	1.9	7.0	31.4	5.8	28.8	9.6	29.5	9.0	32.9	20.8	26.9	26.4	3.8	2.9	17.0	3.6	26.7	12.1	3.6	4.1	36.5	27.7	9.5	81.6	252.3	3.9	26.0	21.3	1.6	30.1	12.1	12.2	61.9	20.6	19.7	3.2	15.6	26.9	8.7	6.0	6.6	13.8	22.3	12.1	39.6	34.4	4.0	0.2	5.0	99.0	0.1	39.4	78.0	0.3	32.9	21.6	16.1	33.5	0.3	6.0	2.7	16.0	30.4	4.0	0.0	0.8	12.0	32.2	3.1	4.4	45.2	58.7	0.9	13.9	40.9	8.9	60.5	4.6	15.8	13.8	23.4	33.5	16.1	4.4	0.8	18.0	6.2	16.9	19.8	17.2	0.0	3.7	20.7	94.1	0.1	33.1	1.1	8.7	10.3	51.0	0.1	0.1	29.6	0.1	50.1	19.8	0.2	35.2	77.7	36.4	9.1	9.0	0.6	25.3	16.6	2.0	4.9	12.0	25.1	1.4	9.1	1.4	3.7	1.3	1.9	14.9	5.8	0.9	1.5	21.7	2.2	2.9	6.7	2.0	3.8	4.1	5.2	1.9	7.0	3.8	2.9	3.6	4.1	3.9	3.2	6.0	4.0	19.5	51.3	51.0	28.4	15.2	21.7	14.6	5.3	34.1	2.1	16.8	14.0	8.4	5.7	12.6	5.5	0.0	4.6	19.0	16.1	7.9	11.8	1.8	8.6	91.9	23.8	16.7	19.3	60.3	11.3	15.0	143.6	11.7	13.0	18.4	38.7	8.6	0.2	20.3	8.4	76.6	33.6	18.3	26.8	27.8	5.5	138.5	26.8	8.8	49.6	37.6	0.9	2.1	10.6	5.5	13.0	22.5	97.0	5.7	52.0	4.3	15.3	4.4	0.4	13.1	61.7	31.1	0.9	1.0	24.1	43.3	9.9	10.0	205.8	28.5	19.7
PLEKHA2	TAPP2	ENSG00000169499	"Pleckstrin homology domain containing A2"		8	38901235-38973912	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.1;dendritic cells: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 164.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004706	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA004706: AB_1079633"	"unprognostic (2.78e-1)"	"unprognostic (8.80e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.61e-2)"	"unprognostic (9.07e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.60e-3)"	17.5	15.7	13.6	35.3	11.1	39.7	10.6	6.1	18.3	16.9	13.1	16.9	10.1	15.0	10.6	14.0	15.8	17.7	42.8	25.3	10.2	17.1	9.4	20.1	78.7	10.7	6.9	19.1	6.6	21.2	8.7	17.8	11.8	10.2	12.4	5.4	7.4	18.8	4.5	8.4	16.0	18.9	10.1	43.0	12.6	5.9	10.1	17.9	19.3	8.0	66.1	17.3	10.3	16.3	30.0	6.5	4.1	10.0	10.2	20.1	4.6	35.7	27.2	25.9	21.5	3.7	19.4	164.7	41.3	31.9	22.9	17.9	10.8	21.6	38.4	42.8	1.0	84.7	54.4	4.0	36.9	28.0	32.9	46.3	14.7	13.2	23.6	60.1	4.4	26.3	8.7	45.0	24.1	3.7	56.0	12.8	3.9	23.2	10.2	14.1	22.4	34.6	31.3	24.9	0.5	6.5	41.9	7.4	27.9	6.1	16.9	13.0	6.5	18.5	14.5	3.2	28.5	14.7	14.8	76.3	29.3	28.7	4.2	6.9	1.5	8.1	1.9	2.0	2.0	10.0	2.2	2.3	1.8	12.7	1.4	2.6	3.3	3.9	2.2	5.4	1.9	1.0	13.6	11.1	6.1	18.3	25.3	10.2	10.7	6.9	11.8	10.1	10.1	16.3	8.8	3.2	17.9	15.0	94.1	8.8	15.7	17.1	6.8	1.8	7.2	5.2	40.7	12.8	17.3	40.5	0.0	7.7	132.0	9.0	1.9	7.4	1.0	17.8	28.7	10.9	13.1	12.2	21.2	5.5	17.7	22.2	9.2	25.4	36.8	21.3	19.6	10.2	48.8	58.9	7.7	11.8	6.1	79.6	55.3	2.5	22.7	49.7	16.0	35.6	48.4	12.1	64.9	52.3	4.7	24.5	4.7	25.2	56.4	9.9	15.9	16.3	23.5	1.4	13.1	35.8	24.8	0.7	7.9	5.1	6.7	4.5	53.9	4.4	12.8	35.7
PNMA8A	"FLJ10781, KIAA1183L, PNMAL1"	ENSG00000182013	"PNMA family member 8A"	Q86V59	19	46466491-46471563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 8.4;Granulosa cells: 13.5;Respiratory ciliated cells: 10.9;Theca cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 32.9;K-562: 36.3;LHCN-M2: 35.9;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"							"HPA012956, HPA077702"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA012956: AB_1844328, HPA077702: "	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.76e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.48e-3)"	1.1	22.8	45.8	0.9	44.8	0.7	4.7	16.2	54.3	5.8	13.9	3.6	0.7	12.5	16.2	1.2	22.1	5.2	15.0	45.4	53.9	8.7	0.4	1.7	0.3	27.0	30.1	17.2	6.3	15.8	36.7	2.6	35.3	8.8	0.7	35.6	6.0	9.6	1.6	1.2	1.3	7.2	23.3	0.6	1.8	22.5	39.8	30.1	15.4	1.1	0.6	3.1	1.6	34.6	0.0	13.9	19.7	19.6	5.6	12.7	3.5	1.3	0.2	2.4	1.2	0.2	1.6	0.1	18.1	0.9	6.8	0.2	32.9	5.3	1.6	0.1	12.2	0.0	0.5	0.5	9.4	0.2	0.2	3.3	6.5	8.2	0.0	1.8	2.0	11.9	36.3	0.2	35.9	0.1	0.2	0.2	16.5	0.0	0.0	0.0	21.5	0.0	8.2	0.1	16.0	31.3	0.1	0.3	0.0	18.0	0.2	0.3	1.2	0.0	0.2	0.2	6.8	0.1	0.1	0.2	0.3	0.1	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.0	0.0	45.8	44.8	16.2	54.3	45.4	53.9	27.0	30.1	35.3	23.3	39.8	34.6	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.9	0.0	0.0	1.8	11.0	0.0	1.9	0.0	0.0	3.9	0.9	0.0	8.4	2.3	0.3	0.0	0.0	0.0	0.0	0.5	2.8	0.0	1.3	0.0	13.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	10.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.0
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 21.0;Spermatogonia: 24.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	0.9	0.9	0.5	5.1	0.3	18.2	3.0	0.5	0.6	2.1	0.0	3.8	2.5	2.5	0.7	3.7	1.0	0.9	0.6	0.2	0.2	0.7	3.1	1.2	5.1	0.2	0.4	1.0	0.8	0.7	0.5	3.0	0.2	1.4	4.5	3.0	1.0	0.7	0.5	3.5	3.6	2.3	0.3	1.5	2.1	4.1	0.2	5.5	0.9	0.9	6.2	1.4	1.9	0.6	37.2	18.6	34.3	16.3	1.7	9.9	18.2	20.4	10.4	31.9	36.7	19.3	27.5	23.6	11.6	11.6	17.5	22.3	35.3	12.8	36.9	27.4	19.6	35.4	20.6	23.9	0.8	41.2	14.6	2.8	0.8	18.5	2.9	4.1	19.0	30.5	30.9	14.3	31.6	32.7	43.6	28.4	20.2	30.9	42.6	35.9	31.7	21.0	11.6	20.6	24.8	14.3	20.5	11.9	6.7	16.5	24.5	15.8	6.7	5.3	38.5	21.4	16.9	10.7	22.7	52.7	9.8	30.1	20.9	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.0	0.2	0.0	0.9	0.0	0.2	0.7	0.1	0.5	0.3	0.5	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	2.0	3.2	0.5	4.2	2.4	4.8	2.1	1.9	2.2	0.8	1.5	1.1	1.2	1.5	1.3	0.0	0.0	9.1	1.0	2.2	0.0	1.3	1.2	0.8	2.6	1.5	1.2	21.0	9.5	1.5	10.6	2.7	1.1	1.5	0.0	4.3	5.0	5.5	5.5	0.0	11.9	2.8	0.0	1.9	1.6	0.8	1.5	1.1	1.8	7.5	1.0	2.0	4.1	12.1	11.5	0.8	0.5	3.0	5.7	1.9	1.1	1.2	0.9	3.1	0.0	2.1	7.4	5.3	24.4	6.0	3.7	3.4	1.7	1.8	4.7	1.5
POLR3G	"C31, RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514557	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 84.5"									"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	1.8	0.6	3.5	2.4	4.5	3.0	2.0	6.3	5.9	1.3	0.7	1.6	1.8	1.5	4.7	4.3	1.2	1.3	1.8	3.6	6.0	0.9	2.2	1.6	4.7	5.7	4.4	1.9	2.4	2.0	0.9	1.8	6.8	1.7	1.5	3.3	2.3	0.5	3.0	4.3	1.4	0.8	1.9	1.8	1.2	4.5	4.2	0.8	3.2	0.8	1.9	2.0	1.7	6.3	24.1	13.0	18.8	5.3	5.9	8.2	7.7	11.9	4.3	19.8	16.8	9.0	18.8	63.7	4.2	5.3	20.0	11.6	20.8	23.2	69.2	29.6	19.6	26.2	8.1	15.1	9.5	19.4	6.2	6.7	8.1	32.7	25.8	4.6	27.2	26.5	35.8	6.4	8.3	13.2	19.1	14.1	78.1	4.0	63.2	16.5	7.4	40.2	5.9	3.2	22.0	6.4	3.7	9.6	35.1	7.7	5.4	6.2	29.1	10.3	21.2	13.2	48.3	13.5	36.7	50.0	22.1	23.7	84.5	3.3	0.2	0.2	1.5	0.4	0.7	1.7	0.5	0.9	0.4	0.9	1.1	1.2	0.7	2.9	1.5	1.0	0.2	0.3	3.5	4.5	6.3	5.9	3.6	6.0	5.7	4.4	6.8	1.9	4.2	6.3	3.2	6.4	2.2	11.8	2.8	3.6	1.6	1.5	1.8	3.0	2.8	3.7	5.2	0.0	0.7	1.8	8.4	0.8	0.7	0.9	3.9	2.4	4.5	1.6	2.3	2.0	6.7	8.8	24.8	4.4	5.4	3.8	0.5	1.2	7.0	1.6	4.6	2.6	1.7	3.3	21.2	1.4	0.0	0.3	0.3	1.0	0.3	1.2	1.8	5.6	0.0	1.1	1.0	14.6	70.8	4.1	3.0	1.2	5.4	6.1	0.4	1.5	3.0	0.8	0.0	1.1	1.8	7.2	26.6	6.3	8.5	0.8	1.7	6.5	2.0	0.8
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"eosinophil: 7.5;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	3.0	4.0	1.8	1.6	2.0	3.5	3.0	3.2	2.0	5.2	4.2	3.2	1.3	6.0	2.8	2.2	4.6	2.4	3.0	1.6	3.2	1.9	0.4	4.2	0.9	4.1	4.0	10.3	4.8	8.6	3.9	3.5	4.0	4.1	2.9	4.7	1.8	4.3	1.6	1.5	1.8	4.4	4.7	2.4	2.1	3.6	2.9	1.4	5.8	3.0	0.8	2.9	3.3	4.4	2.2	3.4	7.8	0.1	4.5	9.3	9.2	4.7	9.9	4.7	4.2	4.4	1.2	0.4	1.2	6.2	4.5	0.1	0.0	1.0	6.0	0.0	1.4	2.9	3.1	0.3	4.9	10.0	0.1	6.6	2.9	3.3	4.1	4.3	3.4	1.2	0.0	14.2	5.7	0.4	1.5	0.1	5.7	0.8	2.7	0.0	9.3	6.1	1.6	0.0	1.4	6.2	0.0	0.1	0.9	4.0	6.4	4.1	1.4	0.2	2.7	4.8	4.6	13.0	19.7	0.1	3.6	0.1	3.6	0.1	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	1.8	2.0	3.2	2.0	1.6	3.2	4.1	4.0	4.0	4.7	2.9	4.4	7.1	12.8	5.6	51.2	0.5	1.7	2.7	2.4	9.1	9.1	1.1	2.4	8.2	2.8	3.8	1.8	8.4	1.0	0.2	1.5	1.9	2.3	75.6	1.4	9.4	6.3	3.6	0.0	25.0	2.5	2.6	9.6	2.6	1.4	2.5	15.5	3.6	0.0	0.8	0.0	31.9	3.6	4.1	0.3	0.7	31.0	8.7	0.6	1.8	23.4	0.2	7.6	0.0	52.8	8.0	1.5	0.8	9.4	0.7	2.6	0.1	0.2	1.8	7.5	6.6	10.1	6.6	8.2	3.5	4.6	1.7	0.5	1.2	14.9	3.0	0.7
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86047109-86088621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 2.4"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 2.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 9.4"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome 20S subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033765, HPA037646, HPA043891, CAB079995"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA		20000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies, Centrosome"	"CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavorable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	87.2	85.5	55.1	94.9	57.8	135.8	96.2	55.4	68.2	76.8	58.7	92.5	96.4	80.7	108.0	94.7	79.4	79.6	140.5	59.4	64.4	98.4	139.2	77.5	114.9	55.8	56.6	79.4	54.6	78.5	50.4	113.0	58.8	81.7	101.9	63.2	74.4	85.8	168.7	80.5	86.1	96.1	56.6	75.6	75.7	56.2	60.2	122.2	88.4	152.6	109.9	111.2	56.0	58.6	408.8	279.8	227.8	275.7	223.7	225.5	193.3	232.9	305.2	348.3	283.9	244.2	500.1	349.5	262.1	248.6	315.4	303.1	259.3	290.1	328.3	344.0	389.6	220.4	190.5	326.1	291.0	355.3	277.5	217.8	171.6	188.9	390.7	252.7	347.0	271.6	398.9	283.4	315.2	277.8	334.0	319.5	191.6	340.5	414.1	223.3	336.1	217.5	313.0	304.7	188.2	119.3	246.6	273.9	229.0	233.8	164.4	222.9	272.0	226.2	222.9	402.7	295.4	123.3	366.1	319.9	334.8	291.1	296.6	115.5	191.2	47.5	97.7	139.8	128.0	104.1	110.8	109.7	243.3	95.3	98.5	94.4	36.3	145.1	137.5	138.7	154.9	235.8	55.1	57.8	55.4	68.2	59.4	64.4	55.8	56.6	58.8	56.6	60.2	58.6	119.0	83.3	90.2	64.3	101.7	142.9	231.2	365.7	76.2	50.3	105.7	125.9	0.0	82.9	176.1	88.3	18.8	469.5	135.3	49.2	256.3	228.5	75.5	84.0	94.0	135.5	40.1	163.9	56.8	233.1	370.6	128.5	66.8	79.8	78.2	134.7	95.3	127.9	292.9	57.2	66.3	63.6	231.9	161.8	170.5	36.3	116.5	153.6	144.1	122.7	263.7	111.6	168.9	64.8	35.3	223.2	88.6	127.5	112.1	209.1	135.0	257.1	115.1	54.8	85.5	99.2	129.8	174.9	80.1	114.3	151.9	627.3	130.7	137.2	97.1	248.1
PSMB7	Z	ENSG00000136930	"Proteasome 20S subunit beta 7"	Q99436	9	124353465-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	115.7	180.4	129.4	103.9	136.9	189.7	122.6	132.7	144.8	99.8	119.6	103.5	98.7	102.9	147.0	139.1	94.6	87.2	212.0	135.8	137.0	150.9	222.9	91.4	112.7	138.2	139.5	101.6	142.2	143.4	74.7	120.2	138.2	94.8	107.8	81.0	114.3	75.0	277.8	166.2	98.3	92.7	131.5	91.7	115.3	155.2	137.8	147.6	91.3	205.3	124.6	110.5	104.2	135.0	344.4	411.7	275.8	336.4	190.4	224.8	396.1	325.3	447.6	461.7	315.1	546.3	327.1	389.2	256.8	307.4	457.2	480.2	346.7	345.4	420.0	375.0	299.3	245.3	673.3	460.0	428.5	491.6	234.3	270.8	299.6	483.7	478.5	355.1	394.3	345.5	507.9	269.8	362.4	600.0	355.9	329.5	409.7	519.6	581.5	309.8	411.4	457.2	331.5	221.9	323.7	263.6	310.4	394.0	498.4	268.7	454.8	212.7	315.9	297.5	240.7	384.9	499.0	289.9	873.7	394.9	498.1	297.8	429.1	162.7	201.5	154.5	128.3	211.4	138.9	177.8	145.7	142.5	221.1	159.7	138.2	135.9	87.0	185.3	206.8	187.5	226.0	264.8	129.4	136.9	132.7	144.8	135.8	137.0	138.2	139.5	138.2	131.5	137.8	135.0	73.1	76.9	77.6	26.1	88.0	194.1	184.4	309.1	39.9	41.5	113.9	97.5	147.3	134.4	150.0	69.9	22.9	441.4	83.0	146.9	330.6	351.3	404.6	105.7	93.8	123.8	141.2	93.8	38.4	392.7	356.7	112.3	52.5	90.3	104.6	130.8	107.1	277.3	237.2	33.7	31.9	162.5	160.7	122.1	148.4	472.8	139.1	92.5	199.3	33.7	168.5	119.7	113.3	30.7	44.8	393.6	143.7	125.3	69.9	158.0	173.6	484.7	135.7	61.6	85.5	133.8	221.2	330.6	190.4	60.4	218.9	488.7	81.4	135.8	181.2	201.3
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
PSTK	"C10orf89, MGC35392"	ENSG00000179988	"Phosphoseryl-tRNA kinase"	Q8IV42	10	122954381-122997513	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.3;Spermatocytes: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037780, HPA037781"	Approved		Approved	"Nucleoli,Nuclear bodies,Actin filaments"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"	"Nucleoli, Nuclear bodies"	"HPA037780: AB_2675662, HPA037781: AB_10670530"	"unprognostic (8.95e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-4)"	"unprognostic (5.21e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (5.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.55e-4)"	0.9	2.2	1.3	0.6	1.5	6.1	2.9	1.5	2.2	1.9	0.3	1.6	1.9	1.9	3.5	1.5	1.9	0.7	1.7	1.5	1.6	2.0	4.1	1.0	0.9	1.6	1.5	1.3	2.1	1.1	2.6	1.3	2.5	2.0	1.5	0.5	1.9	1.1	3.5	1.6	1.0	1.9	1.3	1.1	1.3	3.2	1.4	1.8	2.4	0.9	1.2	1.3	1.3	2.8	4.1	3.4	1.7	0.8	1.6	3.2	2.1	2.0	3.5	3.0	3.7	4.6	3.4	4.4	3.9	2.5	2.0	2.3	0.7	3.1	3.4	2.4	8.7	2.7	1.2	4.0	4.3	6.7	3.6	3.3	5.2	2.9	5.2	2.7	2.3	3.9	4.3	6.0	4.3	6.6	2.0	3.9	3.3	1.6	4.3	4.5	3.0	4.4	4.3	2.6	1.6	2.1	3.9	3.8	5.3	1.4	1.8	0.4	3.1	2.8	2.6	1.2	4.5	2.6	1.6	5.8	2.4	4.3	0.9	0.0	5.0	6.0	7.4	3.1	8.8	6.2	5.7	7.0	6.7	5.9	7.5	7.7	0.6	6.8	3.6	6.7	3.8	5.3	1.3	1.5	1.5	2.2	1.5	1.6	1.6	1.5	2.5	1.3	1.4	2.8	3.0	9.6	7.3	14.4	4.6	4.5	5.0	11.0	5.2	8.3	7.1	11.7	5.9	10.0	7.5	5.5	8.4	7.7	8.0	1.6	9.8	4.6	31.3	5.7	5.2	3.2	4.2	3.4	18.8	6.3	3.1	6.0	1.5	11.6	2.5	8.1	3.6	6.3	4.8	5.0	20.3	2.6	14.2	2.1	4.3	5.4	5.3	3.0	5.4	4.7	6.1	8.8	5.2	12.5	29.4	3.7	3.8	5.7	3.3	3.5	3.0	7.7	8.3	11.4	0.0	5.6	8.6	37.5	20.6	5.5	4.7	9.6	6.9	10.8	4.3	3.5
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridine synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: AB_2680824"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	3.6	3.7	2.7	4.1	2.7	5.1	5.4	2.9	3.4	3.0	3.2	3.6	7.5	3.3	6.4	2.7	3.7	4.1	3.7	2.7	2.5	4.8	15.0	4.9	6.8	2.7	2.6	4.8	4.0	3.9	2.9	3.2	3.0	4.8	4.4	3.9	3.8	2.6	3.1	4.9	9.3	2.7	2.9	4.8	3.4	4.5	2.9	4.5	6.9	1.8	6.8	2.6	1.6	3.6	3.2	1.7	4.9	8.4	4.1	4.6	5.3	6.1	5.5	6.0	5.6	4.8	4.4	12.8	6.3	3.4	5.4	4.2	5.7	4.9	7.4	10.0	2.9	9.0	2.5	15.9	7.6	10.6	5.8	5.3	6.0	4.2	9.4	7.7	7.9	9.1	9.2	6.4	4.6	2.7	8.0	8.7	4.4	3.0	3.5	7.7	6.6	4.7	4.3	6.3	2.8	3.9	5.0	9.7	9.9	3.5	3.4	6.3	5.9	5.7	4.6	3.9	4.7	8.1	3.8	23.6	5.0	6.8	6.5	9.1	1.2	1.1	2.3	1.3	2.5	3.0	1.4	1.6	0.9	1.7	1.7	1.9	2.3	3.1	4.8	3.0	1.0	1.1	2.7	2.7	2.9	3.4	2.7	2.5	2.7	2.6	3.0	2.9	2.9	3.6	6.6	0.0	14.3	20.5	6.8	2.4	3.5	3.3	1.8	6.6	5.9	2.8	5.1	1.5	4.3	3.7	0.0	7.0	8.1	11.9	7.9	3.7	1.6	6.2	4.3	5.8	1.2	5.9	28.3	5.1	4.7	3.1	5.1	8.5	0.0	9.9	4.6	16.3	5.8	1.7	21.7	2.5	4.1	5.7	2.1	1.8	3.1	4.6	1.8	14.0	9.0	7.0	7.2	19.1	24.4	3.5	3.0	1.5	4.6	3.8	26.7	6.3	7.7	7.1	6.6	3.1	3.0	13.9	13.4	3.9	2.3	12.4	6.6	8.2	4.5	10.6
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535335	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Hepatic stellate cells: 103.5;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		69000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nuclear bodies, Plasma membrane"	Cytosol	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.1	6.5	1.5	5.2	4.6	3.1	13.3	1.3	7.9	9.4	0.3	7.0	7.8	5.6	4.6	8.8	5.1	8.9	5.9	5.0	8.5	7.2	61.6	14.3	3.7	2.4	7.0	2.0	6.4	5.6	3.6	13.0	4.1	6.6	7.3	7.3	8.6	4.3	6.6	8.9	7.9	7.8	0.1	16.9	8.8	9.4	2.7	2.6	30.0	6.2	4.9	7.7	6.6	2.2	11.1	7.5	15.6	9.0	12.0	15.4	14.7	15.1	11.0	15.3	19.1	35.0	11.4	0.0	3.7	23.1	11.2	5.8	8.2	12.9	31.7	2.2	4.6	0.0	17.9	6.2	30.0	0.1	0.2	21.5	10.7	28.1	29.4	16.8	24.2	1.7	0.8	8.2	31.0	6.2	0.1	0.0	9.2	5.7	10.0	0.2	22.0	6.9	11.2	34.9	5.5	7.5	10.3	9.8	12.5	20.4	5.5	0.5	29.0	37.5	12.5	18.2	16.1	3.8	7.7	0.1	30.9	0.2	8.4	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	1.5	4.6	1.3	7.9	5.0	8.5	2.4	7.0	4.1	0.1	2.7	2.2	36.3	16.0	8.4	12.7	1.2	49.1	20.7	10.3	16.5	11.3	21.6	9.4	1.1	15.7	9.7	14.7	14.6	8.9	0.8	32.9	7.9	6.3	14.4	24.4	17.7	29.0	2.4	3.2	84.0	9.3	7.6	23.4	47.9	65.7	1.3	6.2	103.5	79.6	18.1	10.1	56.7	8.6	4.1	17.8	51.1	4.9	4.7	28.8	12.4	92.8	3.3	18.6	0.0	41.2	9.1	20.5	21.3	4.9	0.1	19.0	22.4	2.8	5.2	4.4	19.7	26.8	33.4	29.3	19.6	26.9	40.9	10.9	2.8	0.9	13.3	28.4
RIF1	"FLJ10599, FLJ12870"	ENSG00000080345	"Replication timing regulatory factor 1"	Q5UIP0	2	151409883-151508013	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036887, HPA036888"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies, Plasma membrane"		"HPA036887: AB_2675361, HPA036888: AB_2675362"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.41e-2)"	6.1	5.0	4.4	7.4	8.4	21.7	10.0	13.8	7.0	6.5	2.6	5.6	4.3	8.2	4.0	5.6	5.6	5.6	3.5	4.6	5.1	5.5	6.7	5.1	8.5	4.4	5.1	11.2	7.0	6.8	3.5	8.0	5.4	6.0	6.1	8.2	7.7	5.0	7.5	7.2	4.6	6.2	4.9	6.5	6.1	11.0	4.5	10.7	9.1	9.5	7.9	7.3	4.6	13.8	20.8	17.4	26.8	20.5	10.7	13.8	25.9	24.8	18.0	21.6	25.5	28.9	16.4	39.2	21.7	17.3	17.9	21.3	41.2	17.1	36.1	27.8	19.8	63.4	21.4	21.0	11.2	64.7	20.2	10.3	11.3	38.8	28.7	12.3	21.3	23.5	52.2	32.6	22.1	13.8	38.3	22.9	43.2	11.2	22.9	38.4	42.1	26.1	11.6	24.9	24.2	18.8	32.0	14.6	16.5	18.8	12.9	23.1	27.0	32.9	22.8	20.3	26.7	16.0	29.6	55.4	15.3	25.5	22.5	6.3	2.5	3.0	4.3	1.7	4.9	4.0	3.6	3.2	1.8	3.1	4.8	3.7	2.8	7.7	3.5	1.6	2.8	1.7	4.4	8.4	13.8	7.0	4.6	5.1	4.4	5.1	5.4	4.9	4.5	13.8	53.1	96.1	49.7	41.1	43.5	49.3	47.5	21.9	33.0	48.2	30.4	29.8	38.2	28.6	38.0	14.7	31.3	39.2	40.3	19.6	1.9	38.5	22.6	38.0	61.7	48.0	25.0	84.3	68.5	21.9	35.9	51.3	34.7	65.0	34.1	88.6	27.1	19.7	23.0	47.1	72.4	30.9	14.2	26.4	27.0	14.0	43.8	37.6	30.2	48.7	44.1	35.8	32.0	73.9	126.3	29.9	23.5	34.3	45.1	53.2	14.9	12.9	21.3	42.8	85.5	106.5	51.2	122.8	113.1	28.9	41.6	40.9	45.3	58.9	34.6	45.4
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202179-56221933	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	32.2	24.6	22.5	18.0	23.3	19.6	21.4	15.7	23.8	21.2	13.0	23.8	12.4	22.3	13.2	23.1	24.3	25.5	32.7	24.6	24.8	19.7	15.1	23.8	23.4	16.8	19.1	22.9	23.0	27.4	22.8	21.3	21.2	33.9	19.0	23.8	15.0	20.7	34.0	15.0	16.1	28.5	15.3	20.6	17.0	15.9	23.5	26.5	28.6	40.8	25.1	28.2	17.0	19.2	21.6	32.6	34.7	55.2	71.0	51.3	25.8	70.8	69.5	62.2	50.2	40.0	27.6	41.6	36.7	60.2	20.6	24.3	47.4	34.1	44.9	43.8	25.7	55.8	22.3	23.2	148.3	61.6	58.3	66.0	78.6	52.0	91.0	81.7	61.3	34.5	40.4	41.3	35.1	34.9	35.6	27.6	41.9	21.6	37.8	38.2	24.9	25.3	33.3	31.3	62.9	38.1	61.9	35.0	55.4	34.3	49.2	71.3	37.3	31.3	32.9	40.6	27.8	29.6	36.6	37.5	37.2	36.4	38.0	59.1	27.2	99.9	27.6	26.7	24.9	50.3	23.0	24.3	30.6	55.1	23.4	24.0	36.2	33.1	28.3	23.7	29.4	31.0	22.5	23.3	15.7	23.8	24.6	24.8	16.8	19.1	21.2	15.3	23.5	19.2	18.9	44.8	22.6	11.1	42.2	12.0	19.9	8.6	19.9	30.7	22.2	21.1	24.6	24.3	18.8	16.5	22.9	15.2	17.0	10.2	17.6	15.3	92.8	13.9	14.2	20.7	20.4	11.1	15.0	21.3	18.5	22.7	9.7	14.2	25.9	16.8	30.0	16.7	19.3	28.6	15.7	13.9	8.2	34.9	22.7	58.0	23.0	25.0	7.2	9.4	33.5	26.2	15.5	14.6	12.3	20.8	20.3	25.9	14.6	33.5	12.3	19.6	18.0	18.3	26.3	23.2	27.4	10.4	14.2	14.4	16.6	16.8	16.6	17.1	14.3	23.1
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2 activator of ARL3 GTPase"	O75695	X	46837043-46882358	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 62.8;Langerhans cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: AB_2666140"	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	10.9	8.9	1.9	15.6	2.3	49.5	7.2	2.6	2.3	7.9	3.6	10.1	10.6	6.9	4.0	12.9	6.8	12.7	4.8	1.7	2.7	6.7	13.2	11.8	12.9	3.3	2.8	6.5	4.6	7.4	1.7	25.2	3.5	6.7	10.5	4.2	4.4	5.3	2.0	5.3	11.0	9.0	3.5	13.2	8.1	4.0	2.3	9.8	6.1	3.6	11.2	10.4	4.2	4.6	21.8	10.3	20.4	11.0	15.7	19.4	48.0	27.4	21.5	23.8	23.9	44.6	18.2	25.8	10.7	29.3	20.1	14.0	19.8	20.0	32.1	11.5	11.5	13.9	11.7	10.7	17.9	29.2	46.4	15.1	13.0	18.8	10.1	13.3	30.5	11.4	6.2	13.1	27.0	1.9	18.1	26.8	12.5	14.8	19.5	22.9	27.9	13.8	15.3	22.0	7.4	10.0	24.4	14.9	12.4	36.2	16.8	27.1	27.1	18.3	13.6	29.1	9.8	4.9	6.8	15.4	9.5	20.4	19.5	62.6	22.6	35.5	6.1	30.8	5.0	10.3	4.9	5.3	22.6	9.6	6.0	5.7	43.5	7.6	36.3	7.6	6.1	12.2	1.9	2.3	2.6	2.3	1.7	2.7	3.3	2.8	3.5	3.5	2.3	4.6	9.6	9.6	7.4	3.9	18.9	15.8	3.2	6.1	15.4	3.1	7.8	6.1	1.7	7.2	5.1	9.2	2.1	23.2	12.0	28.6	0.0	4.7	2.8	15.8	14.5	8.6	3.6	10.3	3.1	5.3	6.4	10.3	12.8	14.9	12.0	4.0	12.5	20.1	24.3	0.0	4.0	9.4	2.0	62.8	72.9	1.7	5.6	44.7	21.4	6.5	36.6	3.6	6.2	12.1	5.9	11.6	13.4	5.7	13.2	8.2	9.8	3.6	14.5	5.5	6.6	7.7	10.5	7.8	4.6	36.4	14.9	38.2	11.4	4.7	10.5	13.6
RSBN1	"FLJ11220, ROSBIN"	ENSG00000081019	"Round spermatid basic protein 1"	Q5VWQ0	1	113761832-113812476	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042124, HPA049484"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA042124: AB_10794644, HPA049484: AB_2680787"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-3)"	6.4	6.0	4.6	7.7	4.7	34.4	8.2	12.7	6.1	7.9	2.8	8.4	6.2	10.3	6.5	7.3	7.9	6.4	5.2	4.2	5.3	8.0	6.4	7.5	10.6	3.1	3.7	14.2	11.0	11.0	5.1	6.6	3.2	7.9	8.6	13.7	6.8	6.9	8.0	7.5	7.5	7.0	3.9	9.2	6.8	10.7	4.3	12.3	9.0	7.9	10.5	6.4	5.5	5.2	14.6	4.1	13.7	8.2	8.0	9.2	6.6	5.1	10.9	10.1	10.5	4.9	4.3	12.7	7.9	6.3	4.6	6.2	9.8	6.2	16.4	12.3	7.1	9.6	4.4	5.6	6.0	18.1	9.9	7.0	6.7	8.6	8.2	8.6	8.1	14.0	14.7	7.7	7.5	14.9	14.7	10.8	11.6	4.6	6.9	26.3	13.4	6.6	6.0	6.2	13.8	11.0	9.7	9.4	8.7	6.8	4.5	12.1	9.7	9.0	9.7	13.5	8.3	10.3	8.2	15.9	9.3	10.9	15.4	53.3	14.5	25.6	29.1	11.7	29.3	32.2	31.2	27.2	12.8	33.1	31.9	26.2	29.0	25.4	13.4	27.3	30.6	12.6	4.6	4.7	12.7	6.1	4.2	5.3	3.1	3.7	3.2	3.9	4.3	5.2	37.4	35.3	20.1	16.0	52.7	74.7	39.2	26.9	45.5	90.0	35.0	46.7	21.5	24.3	29.6	25.8	66.7	26.3	68.0	55.5	19.6	22.3	25.6	26.2	39.4	38.9	49.4	37.5	34.3	26.0	24.1	41.5	17.9	28.8	36.1	23.4	32.5	18.7	19.2	97.6	34.2	58.5	28.5	26.3	37.7	9.0	50.4	25.7	40.9	30.9	35.0	56.7	62.8	33.7	34.6	21.2	54.0	49.7	34.7	44.3	40.2	17.2	27.8	106.5	39.5	43.8	54.9	96.8	37.0	34.3	65.1	31.5	84.8	24.2	52.7	37.8
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA		48000	"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	26.8	35.8	23.3	22.4	23.8	35.2	25.8	28.0	30.3	48.4	21.0	35.3	22.2	38.2	21.0	23.1	44.0	15.6	30.8	21.7	29.6	40.6	30.7	27.8	24.4	24.2	23.9	56.2	30.5	18.0	48.6	14.2	23.1	43.0	16.1	34.7	27.6	18.6	41.5	25.8	34.3	19.3	17.5	39.9	27.8	32.5	23.9	22.3	38.9	20.4	21.2	31.5	35.0	27.5	44.9	54.8	38.8	30.4	36.7	23.7	47.6	40.9	21.3	24.4	23.3	69.9	31.4	84.9	36.9	19.9	19.6	39.9	47.2	24.9	39.2	59.8	53.5	64.4	59.5	54.6	21.2	53.0	58.2	23.5	25.4	35.2	26.9	23.9	24.6	29.3	63.6	40.6	28.7	48.9	65.7	53.1	69.9	33.1	59.9	82.2	34.2	47.6	27.7	70.5	37.6	35.3	54.7	25.3	35.3	24.4	36.5	33.0	40.5	30.7	32.7	39.3	57.6	55.2	52.2	58.6	31.2	47.1	52.2	42.8	12.6	22.0	14.6	10.8	16.8	13.9	13.2	11.7	11.3	14.9	14.5	11.7	23.4	9.4	12.3	12.5	13.4	7.9	23.3	23.8	28.0	30.3	21.7	29.6	24.2	23.9	23.1	17.5	23.9	27.5	40.6	41.7	45.1	79.7	69.7	46.7	58.1	41.4	47.3	70.2	39.1	30.6	28.7	20.0	39.3	33.1	75.0	46.8	63.0	46.4	23.5	49.7	7.6	44.5	92.6	49.0	43.0	45.8	36.2	44.4	44.7	47.3	44.4	58.3	42.3	45.4	26.7	23.3	30.6	43.7	42.7	46.5	57.0	27.6	49.5	13.3	72.4	46.6	26.6	32.8	52.2	77.5	52.5	29.7	34.6	42.2	48.6	65.8	70.0	50.3	54.1	61.5	55.3	78.4	46.0	75.4	47.9	68.3	78.8	37.3	41.9	32.3	79.1	59.7	44.8	54.2
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	125.7	164.3	140.9	122.9	152.2	242.3	121.6	149.6	198.9	120.4	137.8	141.8	137.4	123.8	97.5	159.2	112.9	82.4	195.8	147.4	160.7	190.4	171.1	106.5	118.0	154.7	153.8	109.5	134.6	114.2	129.6	111.7	157.7	109.7	58.5	89.5	126.3	73.0	297.9	119.5	127.5	51.7	164.1	107.6	119.5	194.3	155.7	115.5	110.7	156.3	64.8	131.7	118.5	170.7	182.1	99.3	159.5	173.1	169.0	140.5	246.9	227.1	167.2	205.5	151.3	181.1	342.4	187.3	272.0	189.1	223.4	186.5	198.1	142.4	231.5	288.0	100.4	267.6	121.2	305.9	191.8	367.1	207.5	143.0	159.7	157.5	187.1	158.4	157.3	223.1	128.8	103.6	188.2	231.0	417.0	599.0	200.7	501.5	109.7	261.1	251.4	187.1	295.7	160.7	185.0	161.1	145.7	213.8	296.5	176.5	206.8	528.0	192.6	126.0	141.9	230.1	268.9	159.6	243.6	536.7	122.5	214.9	236.4	433.0	431.5	540.0	344.1	485.0	349.3	493.7	418.2	410.9	427.8	443.6	405.9	402.9	430.5	395.3	547.4	568.8	517.5	909.3	140.9	152.2	149.6	198.9	147.4	160.7	154.7	153.8	157.7	164.1	155.7	170.7	638.0	134.6	143.5	15.0	291.7	458.6	336.3	640.9	310.7	101.5	298.9	594.9	592.9	194.5	383.8	233.6	41.7	566.2	397.4	353.6	759.2	396.5	1259.5	334.1	231.1	273.1	234.5	214.4	20.8	365.6	528.0	374.0	170.2	256.2	258.6	176.6	180.2	242.0	396.0	119.5	23.4	364.5	468.0	189.5	440.9	206.0	342.3	260.4	407.4	17.8	385.0	370.8	233.8	19.6	26.2	401.9	417.6	303.6	182.3	325.9	475.0	1100.6	446.8	132.3	203.8	362.5	438.3	547.7	319.9	271.7	422.2	908.3	338.8	254.2	344.7	419.9
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779949-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 108.1;intestine: 36.5;lymphoid tissue: 120.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA		14000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	8.6	5.6	5.2	61.8	5.6	108.1	4.3	5.4	7.4	3.2	5.1	9.4	11.6	3.1	1.8	3.6	4.9	10.2	2.7	4.8	6.4	3.7	5.9	21.3	120.6	9.6	7.0	1.8	2.5	1.5	2.2	7.5	8.4	4.2	9.9	0.2	7.9	2.2	1.3	2.1	36.5	7.5	7.5	100.3	13.6	1.3	8.4	120.7	3.9	1.7	108.2	15.4	3.0	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	58.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	119.4	0.2	13.6	0.0	0.0	120.6	89.1	0.0	0.0	0.0	88.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	24.0	0.3	0.0	0.3	0.1	0.1	0.1	35.0	150.2	0.0	117.2	0.0	41.6	135.4	245.5	192.2	195.3	159.1	79.1	108.2	178.9	121.5	90.8	76.9	120.9	128.0	153.3	209.9	55.1	145.6	343.7	5.2	5.6	5.4	7.4	4.8	6.4	9.6	7.0	8.4	7.5	8.4	10.2	0.8	0.0	3.6	0.0	69.5	0.5	0.1	0.0	0.0	0.0	0.5	1.1	1.0	1.5	0.0	0.0	0.0	0.5	66.3	0.1	0.0	0.1	0.1	0.2	0.2	1.2	0.0	13.5	0.2	0.0	0.6	0.9	2.6	0.3	22.2	0.0	3.3	0.9	51.3	0.0	0.2	0.1	0.0	58.9	19.1	0.0	0.3	40.0	0.0	7.5	45.3	0.0	101.0	0.0	0.1	0.0	0.0	0.0	39.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.1	1.3	0.5	60.6	0.0	0.1	0.0
SCARF2	"HUMZD58C02, SREC-II, SREC2"	ENSG00000244486	"Scavenger receptor class F member 2"	Q96GP6	22	20424584-20437826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 44.8;Fibroblasts: 21.2;Leydig cells: 13.4;Peritubular cells: 17.7;Sertoli cells: 13.1;Smooth muscle cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 25.5;SH-SY5Y: 28.5;SK-MEL-30: 31.7;U-138 MG: 38.7;U-2 OS: 40.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035079	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035079: AB_10670287"	"unprognostic (2.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.38e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (4.28e-4)"	15.1	5.4	2.4	1.9	2.6	0.4	10.7	0.5	3.3	19.1	4.1	10.0	1.3	22.4	0.5	3.6	15.5	3.6	10.3	2.1	3.9	10.6	3.6	23.2	1.3	5.1	3.2	20.2	4.0	0.4	5.4	3.7	2.2	15.5	0.3	0.1	4.6	4.5	3.1	10.1	6.0	2.2	2.0	9.4	7.8	2.7	4.7	0.2	11.8	0.4	0.2	13.3	13.2	1.3	0.7	0.4	5.8	10.1	3.4	4.8	2.3	25.5	10.8	6.2	3.3	0.1	0.1	0.4	14.6	12.7	0.4	0.2	3.4	0.1	0.7	0.9	21.6	2.1	0.5	4.9	21.3	0.0	1.1	8.2	0.1	3.0	1.5	3.0	3.0	0.1	0.2	0.2	2.2	1.1	0.0	0.5	7.8	0.0	3.3	0.6	16.1	0.0	0.1	0.1	2.5	28.5	0.1	0.0	31.7	1.1	0.9	0.1	3.7	38.7	40.7	1.0	5.9	1.2	0.5	0.4	0.1	0.5	19.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	2.6	0.5	3.3	2.1	3.9	5.1	3.2	2.2	2.0	4.7	1.3	3.6	0.0	0.0	1.6	0.1	2.8	1.6	0.7	0.0	2.9	0.3	0.9	44.8	0.0	0.3	0.0	2.1	0.4	0.3	0.1	0.0	0.0	0.3	2.6	8.9	10.5	0.0	0.0	1.9	0.0	1.6	21.2	1.5	1.0	0.0	0.6	3.9	0.7	0.7	0.0	5.2	0.2	0.0	0.8	2.4	0.5	13.4	0.4	3.6	6.5	0.0	0.3	1.0	3.0	1.1	0.0	0.1	17.7	0.2	7.1	0.0	0.2	4.2	0.8	13.1	1.4	19.5	1.1	0.7	0.3	2.7	0.4	1.2	2.1	0.2	0.6
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: AB_2797246"	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (5.80e-4)"	22.0	24.0	15.2	11.3	15.9	17.8	23.2	16.5	18.1	32.0	18.6	54.6	12.7	35.4	20.5	14.0	33.1	15.8	39.3	16.1	16.9	29.8	19.7	20.6	10.4	13.6	14.7	36.3	40.1	34.7	27.6	11.0	13.1	40.4	17.0	21.0	27.5	30.7	44.9	13.3	23.4	24.6	12.2	15.5	32.5	32.8	16.7	16.6	24.1	34.2	10.5	38.9	21.3	14.1	19.5	12.8	29.9	27.5	13.4	25.4	0.1	15.4	26.7	25.2	26.0	12.3	24.6	35.4	11.4	28.1	21.1	4.8	23.3	20.6	21.6	24.7	17.8	16.6	17.7	31.2	58.2	35.7	26.2	27.7	20.5	16.7	40.2	30.5	25.7	43.3	15.7	26.8	25.0	10.6	36.0	30.8	27.7	16.4	13.5	39.3	31.3	21.0	20.4	24.1	21.0	22.5	26.7	21.1	22.1	20.2	18.8	90.7	19.0	26.3	20.4	16.4	28.5	27.1	16.2	38.6	16.5	31.5	24.4	0.6	0.6	1.2	1.6	1.1	2.0	2.4	1.9	1.5	1.9	1.1	1.3	1.1	0.0	1.6	0.2	3.9	1.4	0.9	15.2	15.9	16.5	18.1	16.1	16.9	13.6	14.7	13.1	12.2	16.7	14.1	7.1	9.6	10.8	125.4	9.4	6.6	25.8	11.5	26.7	17.0	16.4	17.0	14.9	18.6	7.4	12.9	16.7	7.3	10.8	7.2	1.9	11.4	9.4	7.2	13.8	9.6	8.4	16.0	161.3	21.3	3.3	11.4	15.3	13.1	5.1	11.9	8.9	7.3	6.2	8.4	213.0	7.4	8.2	3.3	6.5	12.4	16.4	3.2	8.8	102.1	2.7	6.9	2.1	154.3	77.9	12.4	6.2	18.0	20.2	23.3	10.4	18.1	5.8	14.2	19.7	11.9	10.3	54.3	26.1	6.1	3.7	4.8	7.4	3.5	12.4	14.5
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443555-116574823	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 60.1;brain: 75.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		620000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	13.4	60.1	24.1	4.9	48.6	3.5	13.1	39.9	31.9	10.0	0.3	20.6	19.9	6.0	2.8	4.4	8.2	12.9	7.1	24.5	40.3	8.6	5.6	17.9	4.5	51.9	41.0	18.1	11.2	2.0	5.8	31.9	50.0	6.0	17.5	10.4	16.6	2.5	8.2	6.9	25.5	5.8	32.9	11.2	7.0	7.5	44.1	3.6	9.1	6.5	2.2	5.6	8.1	75.2	0.3	0.1	36.9	44.3	0.2	0.0	38.2	0.7	0.4	0.2	0.2	2.2	1.5	1.6	1.7	0.6	0.7	0.4	52.0	0.0	0.1	1.6	7.7	0.7	0.7	13.1	0.5	0.5	2.6	0.7	0.0	0.0	0.0	0.5	0.2	0.3	0.3	0.4	0.2	0.8	0.7	3.9	115.2	0.2	0.3	6.9	24.2	1.8	19.0	33.7	10.3	3.7	0.2	0.7	19.7	221.1	14.4	2.6	0.9	3.6	3.1	0.4	1.5	0.6	0.7	0.8	0.6	1.8	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	48.6	39.9	31.9	24.5	40.3	51.9	41.0	50.0	32.9	44.1	75.2	64.7	0.0	0.6	71.8	1.1	6.5	0.7	13.1	34.7	17.9	17.0	8.3	8.6	61.5	3.1	14.7	2.1	128.9	0.3	73.3	0.0	42.9	13.6	12.2	4.8	60.9	28.1	2.7	26.9	1.3	8.1	15.4	1.1	10.6	0.0	9.7	145.6	0.9	12.5	138.0	62.2	30.7	0.0	14.8	4.6	2.4	6.5	1.1	24.9	54.4	0.1	5.8	0.0	138.7	311.3	2.0	46.7	1.9	2.6	1.5	40.7	4.4	0.6	3.5	0.0	36.1	8.1	0.9	1.5	11.3	4.1	348.1	0.8	3.5	40.3	2.2
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342576	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	40.8	43.9	55.0	35.6	61.7	35.8	45.9	62.3	76.2	35.4	54.0	52.1	39.2	26.5	68.2	36.6	33.8	34.4	30.5	54.5	59.0	51.0	24.5	37.0	50.9	64.0	59.0	31.9	51.1	36.1	17.3	48.9	65.3	47.5	50.1	12.9	70.7	28.0	22.2	24.7	39.0	24.8	62.9	41.9	50.7	26.9	57.2	41.7	46.3	27.5	47.9	40.4	29.4	72.4	47.1	39.9	41.9	86.3	76.1	65.9	56.4	70.7	69.6	56.8	85.5	80.2	103.3	43.9	55.7	68.8	90.2	59.7	62.5	67.0	88.3	58.8	88.4	53.0	35.4	133.4	65.9	134.9	106.5	61.1	78.9	65.5	58.3	81.8	31.3	73.1	96.1	46.8	90.3	68.5	42.1	241.5	40.2	154.5	36.2	28.6	45.0	105.4	141.6	46.1	8.0	34.3	45.6	87.8	73.0	48.1	46.4	252.3	28.6	33.4	60.4	87.4	79.7	40.7	32.3	50.6	70.4	84.8	85.5	141.1	90.7	126.3	62.1	98.6	38.7	88.1	47.3	52.3	103.4	72.5	50.3	51.7	166.0	58.9	107.3	204.9	79.4	92.7	55.0	61.7	62.3	76.2	54.5	59.0	64.0	59.0	65.3	62.9	57.2	72.4	45.6	41.7	66.5	25.1	103.4	86.5	127.8	262.4	59.2	10.0	136.0	103.6	25.0	51.5	143.9	108.5	0.0	153.0	154.2	109.3	90.1	154.5	70.3	52.0	49.9	55.8	28.8	63.3	15.6	126.8	259.4	81.5	61.2	73.9	149.0	31.3	65.3	30.6	211.6	15.2	13.6	162.5	168.9	178.5	178.4	25.2	85.1	143.5	99.6	21.5	198.3	31.7	111.2	16.6	71.5	155.4	146.5	47.4	108.5	239.2	115.5	140.4	96.0	9.1	85.5	69.5	64.0	159.0	93.4	72.9	102.9	131.2	74.9	63.2	131.4	194.0
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26052016	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.4;skeletal muscle: 14.2;thyroid gland: 21.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.1;Basal prostatic cells: 14.6;Breast glandular cells: 24.1;Oligodendrocytes: 10.9;Urothelial cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.7;JURKAT: 20.8;LHCN-M2: 18.7;NTERA-2: 15.5;RH-30: 46.3;U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.5	0.0	1.1	0.2	2.3	0.1	12.4	1.5	2.0	1.7	0.9	0.1	0.7	0.1	7.8	0.2	0.2	0.5	0.2	2.0	1.5	4.7	0.0	4.3	0.5	1.9	1.5	0.3	0.3	0.1	1.6	0.0	1.6	0.5	0.1	0.0	2.7	0.3	14.2	1.1	0.7	0.1	2.2	0.2	2.1	1.2	1.6	2.5	21.0	1.2	0.7	0.7	0.0	5.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.4	4.2	1.4	0.0	0.0	1.7	26.7	1.0	20.8	0.0	0.0	18.7	1.2	2.3	0.5	15.5	8.4	8.2	0.0	46.3	0.3	1.7	6.5	0.4	0.0	0.4	0.0	5.4	2.6	0.7	0.2	1.6	0.1	0.7	30.4	7.0	0.0	0.0	0.0	0.0	0.0	4.1	0.8	0.1	0.5	0.1	0.2	0.2	0.1	0.4	0.1	0.0	0.2	1.0	1.6	0.4	0.2	0.3	0.1	0.2	0.1	1.1	2.3	1.5	2.0	2.0	1.5	1.9	1.5	1.6	2.2	1.6	5.4	4.7	0.0	13.1	0.0	0.4	5.4	14.6	2.3	0.6	0.0	24.1	6.2	0.5	0.0	1.5	3.7	0.0	0.3	0.3	0.1	0.0	6.0	2.6	1.0	0.5	5.1	0.0	0.0	0.0	0.2	0.3	2.8	3.1	2.5	0.0	2.4	1.1	0.0	0.8	0.0	1.0	0.1	8.2	0.3	2.3	1.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.5	10.9	1.2	0.0	0.4	0.2	3.9	0.0	0.3	1.1	0.0	0.0	7.6	1.6	0.7	5.1	0.4	1.7	0.1	1.1	0.7	0.0	19.6
SKIDA1	"C10orf140, FLJ45187"	ENSG00000180592	"SKI/DACH domain containing 1"	Q1XH10	10	21513475-21526368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.1;Early spermatids: 17.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.1;AN3-CA: 6.7;BEWO: 12.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039208, HPA040439"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA039208: AB_10795034, HPA040439: AB_10796122"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.45e-4)"	"unprognostic (9.97e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.38e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.20e-2)"	"unprognostic (8.52e-3)"	0.3	0.6	0.4	0.1	0.6	0.6	0.2	0.4	2.3	0.5	0.0	0.6	0.1	0.2	0.2	0.2	0.5	0.1	1.2	0.5	0.0	1.3	1.4	0.3	0.1	0.1	0.0	1.3	0.5	1.1	0.5	0.8	0.0	0.3	0.2	1.5	0.5	0.6	0.2	1.0	0.2	0.3	0.0	0.1	0.2	1.7	0.0	0.2	1.2	0.2	0.1	0.3	0.3	0.9	0.5	1.1	26.1	6.7	0.5	0.3	12.1	0.5	0.4	0.0	0.1	2.5	0.2	0.2	1.0	0.4	0.2	1.6	2.4	0.5	0.0	0.0	2.9	0.1	1.3	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.4	0.2	0.2	0.1	1.1	0.9	0.1	1.6	0.0	0.0	0.4	0.8	0.0	0.5	0.7	2.9	6.0	0.9	4.5	0.1	2.1	0.4	5.4	0.4	0.2	0.8	0.2	0.6	0.1	0.0	0.3	1.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	2.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	1.5	5.2	0.2	1.5	1.0	0.6	6.8	19.1	1.8	2.2	6.9	4.3	1.4	1.8	0.0	5.3	0.0	0.1	7.9	0.1	17.9	0.4	1.3	4.3	0.0	0.0	2.8	0.6	3.4	2.1	0.0	0.3	1.3	3.3	4.6	10.3	3.2	1.7	2.2	0.0	0.0	2.2	0.3	10.2	1.5	0.6	0.0	1.0	0.0	6.1	0.0	3.5	2.1	0.3	0.0	2.2	0.1	0.7	0.0	8.5	0.6	4.7	6.6	1.5	1.2	6.5	5.1	4.2	1.8	3.4	0.1	5.2	0.0	0.2
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"RT4: 3.6;SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.1	0.7	1.1	0.5	3.0	0.0	0.1	0.0	10.3	0.7	1.0	2.6	0.7	0.1	0.1	0.3	0.1	0.1	0.3	0.2	5.3	0.3	0.0	0.2	0.0	20.2	21.2	0.2	0.1	0.0	0.0	0.0	32.9	0.3	0.7	0.9	0.3	1.1	0.0	0.0	0.8	0.7	2.8	0.0	0.5	0.1	1.6	0.0	1.2	0.1	0.0	1.3	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.0	0.0	10.3	0.2	5.3	20.2	21.2	32.9	2.8	1.6	7.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702236-66782849	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.1;lung: 27.9"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA061917: AB_2684637"	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (5.45e-5)"	9.5	2.6	5.2	1.6	4.9	0.1	7.6	4.9	4.3	6.8	8.6	3.7	1.9	6.2	0.6	2.1	5.4	1.4	30.1	3.4	4.1	8.9	6.7	27.9	0.5	7.6	5.4	5.9	2.7	1.1	3.4	7.4	5.8	7.0	1.1	0.9	2.1	3.5	1.6	2.4	3.9	0.9	4.4	2.6	5.5	1.8	6.8	0.4	15.5	1.5	0.2	8.0	5.7	4.6	1.3	10.2	1.6	3.5	6.0	1.6	9.4	7.2	0.1	1.1	0.1	2.0	4.6	0.7	29.8	6.1	0.9	18.2	2.2	0.0	0.2	2.3	8.4	16.1	28.6	1.7	0.7	0.1	1.2	2.0	0.0	0.1	0.0	3.4	1.3	5.1	1.4	1.0	0.5	2.0	0.1	4.4	3.0	10.5	3.8	0.0	1.8	2.2	3.4	8.1	3.6	1.6	3.9	4.3	0.8	5.9	1.4	2.9	6.2	4.3	5.5	17.6	1.4	0.5	1.8	0.3	3.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.9	4.9	4.3	3.4	4.1	7.6	5.4	5.8	4.4	6.8	4.6	19.8	12.8	6.0	5.2	0.9	0.8	1.2	2.1	0.6	0.6	0.9	1.1	4.9	4.3	3.0	1.8	2.1	0.8	0.1	4.3	3.9	4.7	3.4	8.3	5.5	25.1	0.0	0.0	0.3	5.8	0.9	4.9	5.1	6.5	4.5	5.9	91.4	4.0	1.7	0.0	0.3	2.1	0.0	10.0	0.3	1.4	2.8	1.2	0.0	57.1	0.7	10.2	0.0	0.5	0.4	8.4	1.5	8.2	0.0	1.3	2.1	1.9	0.1	0.6	0.0	0.9	1.5	0.2	3.2	0.4	0.1	0.8	0.4	0.1	5.5	0.4
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920338-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: AB_2680910, HPA077597: AB_2732354"	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	21.2	21.6	15.4	10.4	17.7	16.7	19.6	14.7	21.4	37.1	11.0	36.1	9.7	50.7	5.7	14.3	35.0	8.3	16.6	17.1	16.0	17.2	11.9	17.1	9.1	15.6	15.2	20.7	17.8	10.1	25.5	6.5	16.4	27.0	3.8	1.8	16.6	17.2	9.0	20.5	15.2	12.4	13.8	21.4	18.7	32.6	16.3	7.6	13.1	9.7	4.9	31.7	25.1	15.3	20.6	22.9	10.8	42.0	14.7	31.1	10.0	21.4	22.6	20.5	18.5	10.6	17.4	17.6	25.8	25.0	16.4	24.7	7.7	15.9	5.9	22.7	19.7	24.5	9.6	15.4	26.6	15.4	38.7	25.5	24.0	24.3	14.9	16.6	23.5	18.1	24.5	28.3	12.7	18.1	19.9	43.6	13.9	10.4	51.8	23.4	10.7	17.6	19.1	7.1	12.7	28.7	11.0	11.8	48.6	4.8	19.2	16.6	30.9	68.8	24.5	65.2	26.8	27.4	48.1	10.8	43.1	31.6	22.2	7.0	23.8	23.5	19.0	30.8	19.2	15.7	16.1	16.5	30.1	14.5	16.6	16.9	3.5	27.7	33.4	19.9	24.0	16.4	15.4	17.7	14.7	21.4	17.1	16.0	15.6	15.2	16.4	13.8	16.3	15.3	19.8	3.2	3.7	3.3	15.4	24.3	20.0	25.1	35.9	8.6	25.8	26.2	3.2	7.2	10.7	11.0	0.0	12.2	22.9	9.8	17.6	21.2	1.9	10.7	25.0	20.7	12.0	20.2	4.1	24.5	24.2	18.5	8.6	15.0	18.4	15.4	12.5	5.2	28.6	23.5	2.6	11.9	14.2	19.6	28.0	6.0	13.7	19.2	19.6	1.0	31.3	6.0	13.4	2.0	3.0	28.9	6.6	14.3	8.4	28.5	16.7	16.1	3.0	6.1	13.1	7.3	30.1	9.5	38.6	19.0	24.3	9.9	18.4	29.2	15.5	24.1
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.7;Late spermatids: 270.7;Spermatocytes: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: AB_2682055, HPA066031: AB_2685600"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	4.1	6.6	5.5	4.0	5.2	1.7	3.8	10.4	7.6	6.5	4.9	5.8	4.2	5.9	5.4	5.5	5.1	3.8	7.0	7.7	5.5	4.6	3.4	4.3	4.4	5.4	5.5	7.1	4.3	4.9	5.1	6.2	6.2	4.8	5.1	11.3	4.5	3.7	7.9	5.0	5.3	4.5	4.5	4.9	4.8	5.5	6.4	3.5	4.4	6.2	3.9	5.1	5.9	8.0	4.7	5.9	12.3	4.7	9.6	10.0	7.2	7.2	3.1	4.2	4.9	2.8	2.0	3.3	2.7	4.6	5.9	2.8	6.6	3.4	5.1	15.5	7.7	11.9	13.4	4.0	4.8	2.7	8.9	6.5	6.6	2.9	3.3	17.7	7.8	7.7	3.4	5.3	9.7	1.4	3.2	8.5	3.9	3.5	15.4	6.6	1.5	1.8	7.3	2.8	13.1	9.2	2.5	2.2	1.7	10.7	5.3	5.5	6.5	7.0	2.7	3.0	9.3	6.9	9.0	4.2	4.4	3.5	3.3	4.9	14.2	7.8	7.6	24.6	7.6	15.2	7.6	7.0	11.2	16.5	10.9	10.5	1.7	7.8	32.2	9.2	12.2	8.9	5.5	5.2	10.4	7.6	7.7	5.5	5.4	5.5	6.2	4.5	6.4	8.0	13.8	19.2	11.9	31.6	21.1	9.6	14.1	18.1	8.6	19.7	9.7	6.9	39.5	7.2	16.8	20.2	31.3	12.4	14.5	21.3	13.7	17.6	121.7	15.2	14.8	18.7	15.0	19.4	56.0	9.2	17.3	15.3	11.2	14.7	17.2	22.2	20.3	14.8	16.1	35.3	63.9	15.7	38.7	25.0	10.7	270.7	33.8	16.3	19.6	26.2	21.5	13.8	18.6	46.8	46.3	12.4	27.9	30.5	18.0	9.8	36.4	28.4	23.9	19.0	13.1	11.6	32.0	113.3	27.1	9.1	11.9	9.7	13.4	34.6	17.7	11.7
SNRPA1	"Lea1, U2A'"	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA		48000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	19.0	18.2	11.0	35.5	11.4	68.1	20.8	13.2	15.4	14.7	14.7	30.6	24.3	15.5	33.0	33.8	18.6	12.7	25.8	12.0	11.6	25.2	25.5	19.5	43.3	11.5	11.3	13.6	22.2	18.3	13.9	30.4	11.7	16.3	30.8	15.5	23.1	12.6	19.7	18.5	30.1	19.3	10.9	25.2	23.2	37.8	12.4	37.4	18.3	12.4	51.9	26.3	18.2	12.6	175.5	119.5	112.7	57.4	31.3	25.6	111.3	158.2	72.8	139.2	105.1	255.8	150.7	192.9	89.2	107.8	109.0	101.7	170.2	113.1	148.1	98.0	262.5	151.4	196.7	137.3	24.0	175.1	103.7	21.0	83.0	89.0	111.3	30.9	90.9	147.1	216.1	175.8	86.5	194.6	177.6	185.7	144.5	232.0	100.1	174.5	121.7	194.8	103.3	450.2	88.6	92.7	97.2	109.0	125.1	117.1	105.2	136.4	66.2	74.1	141.0	86.8	160.3	143.5	464.8	378.9	59.9	162.9	89.3	3.8	36.6	21.5	55.7	47.2	55.3	53.0	57.7	56.1	58.0	47.4	46.6	59.0	6.8	48.5	44.0	54.7	68.9	39.0	11.0	11.4	13.2	15.4	12.0	11.6	11.5	11.3	11.7	10.9	12.4	12.6	41.5	19.2	54.6	16.3	71.6	65.6	73.4	141.6	70.6	37.8	41.8	52.6	30.5	18.6	80.3	36.8	12.5	124.3	69.6	37.4	68.4	94.6	96.2	52.7	42.5	47.2	27.0	61.4	30.9	109.0	154.1	51.5	27.0	55.6	65.8	37.7	21.4	35.5	67.0	37.0	29.2	44.2	126.1	24.1	39.2	22.4	34.8	36.4	42.7	13.1	76.4	39.6	47.4	16.6	28.6	95.3	41.8	28.6	76.1	142.3	78.7	87.1	89.2	34.9	13.1	37.9	67.1	192.9	65.9	68.3	50.6	112.3	68.1	42.3	52.4	101.6
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555958-24582052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	30.5	31.1	24.7	35.2	25.7	39.2	37.5	29.6	34.8	31.8	25.7	50.5	33.2	35.5	35.5	43.5	36.7	20.2	35.3	25.0	25.8	48.0	64.9	26.9	47.7	23.7	23.9	34.3	23.7	51.2	27.0	24.7	25.5	33.8	40.7	54.1	29.7	31.9	103.7	28.8	35.7	29.5	23.6	34.3	36.5	24.7	25.0	74.4	38.9	86.2	53.3	39.5	32.3	30.7	182.5	45.7	188.6	58.5	70.1	57.7	56.1	173.1	74.8	166.1	148.1	61.4	65.8	158.7	70.1	109.2	83.0	130.7	252.1	219.3	175.5	107.9	188.8	152.4	95.4	113.9	66.2	408.0	95.7	66.5	93.8	186.3	86.6	81.8	120.6	139.8	116.2	60.5	61.5	56.8	187.0	82.6	98.9	237.8	61.9	179.5	190.7	66.6	154.5	130.0	82.2	95.6	83.4	62.7	87.7	162.7	102.3	97.5	135.5	127.0	126.3	74.3	126.2	74.3	168.2	283.7	70.1	127.1	91.4	18.5	42.9	53.9	35.6	50.2	37.6	60.5	38.4	39.2	54.2	50.7	36.6	41.3	18.6	51.1	51.1	49.7	41.1	47.4	24.7	25.7	29.6	34.8	25.0	25.8	23.7	23.9	25.5	23.6	25.0	30.7	120.0	96.1	81.8	7.5	118.2	108.6	115.3	293.1	133.1	61.1	94.2	138.8	95.9	101.5	162.9	130.6	35.5	239.5	123.1	112.6	291.6	161.9	91.0	176.6	157.7	96.8	111.0	139.4	8.1	114.8	228.8	121.0	92.2	147.9	86.2	145.3	66.0	203.3	176.4	38.7	8.7	134.2	168.9	74.5	84.8	85.1	116.2	98.1	67.6	10.3	151.0	134.3	86.5	8.0	13.4	129.4	118.2	118.5	120.7	96.8	191.7	310.5	135.2	68.9	65.7	102.8	209.6	111.1	131.4	164.9	113.7	180.3	111.9	176.2	139.0	113.3
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599025	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;kidney: 37.8;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 11.7;T-reg: 4.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.7;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.2	3.3	7.8	7.8	7.6	37.9	2.4	5.8	9.1	2.6	3.4	8.3	7.9	1.9	2.4	8.3	1.7	1.8	1.4	7.6	7.7	37.8	14.8	3.4	14.5	6.7	6.8	2.7	1.5	1.1	4.3	5.7	6.7	2.2	10.7	10.8	2.4	0.8	1.0	5.5	9.1	3.4	5.0	7.4	3.6	74.0	7.7	22.4	8.7	0.7	17.3	2.6	3.6	7.5	84.7	87.7	103.3	78.4	5.2	8.6	42.4	65.9	42.4	98.1	78.3	69.2	25.5	59.8	34.2	46.8	91.7	70.2	114.5	42.7	103.8	108.6	72.9	62.9	87.9	80.2	0.6	83.1	76.1	2.9	3.8	78.6	40.4	14.5	52.1	90.6	69.7	101.5	80.7	52.6	109.4	92.9	54.2	68.3	44.5	72.1	144.4	70.9	29.0	43.0	78.6	45.8	96.4	114.9	31.6	84.9	82.2	70.6	25.7	56.4	91.3	46.6	114.6	46.7	72.9	87.3	37.8	60.6	91.8	11.7	0.0	0.0	0.4	0.4	0.7	0.6	1.2	0.9	0.1	1.4	1.1	0.9	0.2	0.8	0.3	0.3	4.9	0.9	7.8	7.6	5.8	9.1	7.6	7.7	6.7	6.8	6.7	5.0	7.7	7.5	0.5	3.2	1.7	0.7	3.3	2.0	0.9	1.3	1.2	5.0	1.1	1.0	0.7	0.0	1.9	0.0	0.0	9.0	1.3	4.7	1.9	0.5	126.0	6.0	1.1	1.5	13.1	37.2	5.2	0.4	12.2	2.6	5.1	1.8	1.3	12.6	3.3	6.3	6.5	3.3	6.0	4.6	4.1	2.7	4.0	25.2	0.9	6.1	0.0	1.9	0.9	0.7	0.0	2.0	1.7	0.4	4.7	0.0	13.1	0.8	8.1	12.5	7.7	3.9	6.6	2.0	2.2	72.6	21.0	5.2	1.0	3.8	2.8	0.9	5.1	1.1
SRCAP	"DOMO1, EAF1, KIAA0309, SWR1"	ENSG00000080603	"Snf2 related CREBBP activator protein"	Q6ZRS2	16	30698209-30741409	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 186.4;Club cells: 145.6;Ionocytes: 179.0;Respiratory ciliated cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028929	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA028929: AB_10601265"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.11e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.07e-1)"	15.4	11.9	3.6	18.9	4.8	30.1	10.1	7.1	4.2	12.8	1.7	13.2	15.7	15.5	6.4	13.5	14.2	10.9	12.1	2.9	3.4	9.6	7.1	11.6	15.3	5.9	4.3	16.9	19.4	20.2	9.5	12.6	3.5	12.6	11.2	12.5	18.0	13.1	24.5	16.2	16.1	15.0	0.8	18.7	16.0	20.6	7.7	20.2	14.0	19.4	13.6	11.3	9.9	6.8	29.5	60.1	36.9	35.9	28.3	19.5	37.7	24.0	21.1	26.2	20.7	27.8	21.9	65.9	29.7	30.5	16.9	27.8	37.7	27.5	21.9	42.2	88.1	42.5	56.2	24.3	11.4	49.8	48.0	20.8	13.2	40.3	29.0	12.8	27.8	21.7	65.4	36.5	19.7	34.5	42.2	17.4	37.6	10.8	27.7	57.7	28.7	36.4	7.5	34.2	34.5	36.5	26.6	31.0	8.4	12.2	35.4	26.0	44.1	37.0	26.5	21.0	31.6	39.8	36.7	45.9	29.7	23.2	28.9	0.3	0.7	2.9	0.8	1.2	0.6	0.7	0.4	0.9	0.5	1.0	0.5	0.4	2.2	0.6	0.3	0.9	0.9	0.7	3.6	4.8	7.1	4.2	2.9	3.4	5.9	4.3	3.5	0.8	7.7	6.8	3.0	3.2	3.7	8.8	9.8	24.6	1.9	186.4	13.1	7.5	3.3	1.8	2.4	4.3	145.6	1.8	8.4	2.3	5.3	54.3	0.0	1.4	1.2	4.6	3.0	3.4	11.3	7.6	8.6	3.1	1.4	4.2	19.9	4.7	2.5	3.0	2.2	3.0	2.3	8.4	8.6	17.7	179.0	1.9	14.3	0.9	2.8	3.4	10.6	8.4	3.0	1.7	6.2	4.5	10.6	1.9	39.1	1.2	11.1	3.1	3.1	0.6	118.3	5.8	0.0	5.0	14.3	5.6	6.0	7.8	58.2	2.5	8.9	2.0	25.6	3.1
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051480-5500994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	3.5	0.3	2.3	1.2	7.8	1.5	4.3	1.9	2.3	3.3	1.5	1.1	0.5	3.5	0.3	1.2	1.3	1.4	0.4	2.1	4.5	15.0	0.1	0.9	1.8	3.7	3.9	0.6	1.8	0.3	0.4	3.2	3.7	0.6	1.1	0.8	1.0	0.9	1.3	2.4	1.1	2.5	3.6	0.2	6.0	4.5	3.5	19.5	1.7	1.7	1.0	3.1	1.5	3.6	0.0	14.0	0.8	0.0	0.6	1.0	0.0	9.7	1.1	6.3	0.2	0.1	0.0	0.0	2.1	19.7	27.5	0.1	1.5	0.0	2.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.2	27.5	1.4	0.0	0.1	3.4	0.0	0.0	2.0	4.1	0.0	0.0	25.2	0.1	0.0	6.2	0.0	0.4	0.0	0.0	0.1	8.5	0.6	0.0	0.0	7.1	0.2	2.8	43.8	0.0	0.9	0.1	0.0	0.1	0.0	112.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	7.8	1.9	2.3	2.1	4.5	3.7	3.9	3.7	3.6	3.5	3.6	3.6	0.0	1.1	1.6	0.0	2.3	0.2	0.0	0.0	0.0	4.2	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	17.6	1.1	108.2	0.2	0.1	3.2	0.0	0.0	3.7	0.0	0.1	5.5	4.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	14.4	0.0	0.0	0.0	1.2	39.3	1.5	1.1	5.4	27.2	0.5	0.0	0.0	169.4	1.3	0.4	0.0	1.2	0.0	0.1	0.0	18.9	0.0	0.0	0.0	0.6	0.4	1.2	5.5	0.0	1.0	0.0	0.2	0.4	0.0	0.1
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817397	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.0;Erythroid cells: 135.4;Spermatocytes: 158.0;Spermatogonia: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	34.7	15.1	36.4	13.7	37.7	43.1	29.9	39.1	49.9	30.9	33.6	29.3	11.6	24.9	26.2	17.7	27.2	15.2	24.7	37.1	38.4	25.6	19.1	17.4	23.0	38.2	37.3	36.3	12.1	22.1	30.6	20.6	37.5	20.3	15.7	22.6	15.9	15.4	28.0	17.7	19.9	19.2	38.2	22.1	19.0	52.9	37.1	48.3	19.0	23.5	23.5	23.9	24.8	40.3	25.9	12.9	75.2	26.9	30.9	48.3	37.2	21.5	18.1	28.8	29.7	22.8	20.2	29.1	23.5	28.6	22.6	18.3	14.3	23.7	35.2	53.6	23.7	54.5	12.1	43.9	25.6	41.3	35.2	31.2	37.4	16.2	15.4	29.7	29.1	56.0	46.2	14.3	35.3	12.0	41.5	50.8	40.8	23.7	14.5	30.9	55.8	19.2	29.9	25.3	45.5	40.4	26.8	14.9	31.7	76.9	11.3	120.1	22.7	25.4	28.1	19.6	35.6	14.9	19.1	20.7	16.1	27.5	24.4	60.5	40.2	76.5	26.8	40.8	23.5	56.4	46.5	32.3	39.2	59.8	42.8	37.2	70.3	37.3	43.8	33.0	115.7	24.7	36.4	37.7	39.1	49.9	37.1	38.4	38.2	37.3	37.5	38.2	37.1	40.3	46.2	9.6	6.3	0.0	25.0	0.0	33.0	0.0	23.9	6.2	33.1	53.1	0.0	28.6	9.3	20.2	2.1	53.8	20.0	19.5	54.8	51.7	149.0	32.2	34.6	32.3	18.2	135.4	0.0	24.5	66.0	36.6	14.3	18.2	11.4	22.8	42.8	45.6	70.4	6.7	0.0	19.6	0.0	51.8	0.0	61.6	42.9	48.4	0.0	0.0	70.2	33.1	29.9	0.0	0.0	43.1	21.7	53.8	16.9	21.9	20.5	43.2	7.3	15.5	59.2	28.1	28.4	158.0	153.8	21.4	0.0	61.6	21.4	24.1	23.6	31.1
TCAF1	"FAM115A, KIAA0738"	ENSG00000198420	"TRPM8 channel associated factor 1"	Q9Y4C2	7	143851375-143902198	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011732	Approved		Approved	"Nuclear bodies,Vesicles,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	"Nuclear bodies, Vesicles"	"HPA011732: AB_2668526"	"unprognostic (1.57e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.95e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-1)"	29.0	46.5	22.7	12.9	51.4	4.7	21.7	15.1	30.3	27.5	2.7	18.8	12.2	32.2	15.2	15.1	22.2	19.3	23.7	29.4	42.7	14.8	29.3	19.0	8.4	15.4	13.4	39.9	19.4	35.1	27.2	81.1	19.8	36.2	20.3	28.0	15.8	19.8	17.5	16.9	15.8	30.6	11.5	11.7	21.7	9.4	31.0	17.1	26.8	55.7	9.0	14.8	13.4	20.1	47.2	29.0	90.1	93.7	57.9	55.7	55.1	54.3	64.9	42.4	56.3	60.5	33.0	0.2	25.2	63.3	54.5	29.7	34.8	35.7	46.5	25.7	26.0	25.7	15.7	54.0	39.7	0.3	16.2	58.2	31.5	50.0	18.4	66.8	53.4	32.2	43.2	4.5	83.2	70.7	42.3	15.9	27.6	52.0	17.4	26.0	60.7	6.2	33.7	37.5	25.6	153.1	55.5	34.2	25.7	63.7	51.5	4.0	48.8	44.6	28.5	42.2	32.7	14.0	19.2	0.4	81.9	7.6	62.3	0.4	1.5	0.9	4.7	1.8	3.3	1.6	2.8	3.1	2.9	1.6	2.4	3.0	0.4	4.4	3.1	1.4	2.3	2.5	22.7	51.4	15.1	30.3	29.4	42.7	15.4	13.4	19.8	11.5	31.0	20.1	36.3	44.8	37.1	30.3	7.3	0.0	15.0	0.0	16.5	47.7	29.4	38.6	43.0	31.5	14.9	3.7	25.0	251.7	15.2	18.7	0.0	30.9	2.4	27.6	62.7	35.1	19.4	22.1	71.2	35.6	43.7	54.6	20.9	40.5	7.6	167.5	34.6	83.6	32.9	30.3	63.1	29.3	0.0	10.5	0.0	3.5	53.1	12.2	0.0	29.0	10.8	27.5	20.6	57.3	43.7	49.9	15.4	56.4	8.4	27.3	20.1	8.9	8.0	26.7	13.1	72.1	53.3	13.3	11.7	14.1	0.0	521.5	10.4	377.5	23.5	24.3
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950247-113167678	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"brain: 244.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 244.9"	"Group enriched"	"Detected in many"	10	"intermediate monocyte: 28.9;non-classical monocyte: 86.6"	"Lineage enriched"	"Detected in many"	14	"monocytes: 86.6"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"midbrain: 67.2;thalamus: 86.6"	"Group enriched"	"Detected in all"	5	"midbrain: 146.8;pons: 97.8;thalamus: 164.3"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	28.1	9.4	47.4	8.6	6.3	7.6	25.0	0.2	12.1	18.9	1.0	22.9	20.4	25.1	6.7	9.9	18.1	9.4	11.3	4.3	46.9	9.9	22.4	13.9	5.4	5.1	98.0	22.9	12.4	11.1	9.6	17.7	1.7	12.3	21.3	4.6	14.5	13.1	8.4	17.2	19.3	16.4	1.6	22.2	23.3	7.6	244.9	5.8	12.9	6.9	3.7	13.8	14.3	3.2	15.0	37.8	40.7	39.6	20.8	13.7	48.5	10.3	20.0	7.1	8.5	24.9	45.3	0.1	11.3	19.4	9.6	10.5	14.0	17.6	9.1	1.7	13.1	10.4	25.2	23.6	22.0	4.2	3.7	24.4	6.3	11.0	18.2	29.7	12.0	8.8	11.0	0.7	8.2	28.0	6.7	2.5	29.2	16.6	21.6	19.0	29.8	6.9	15.2	20.4	0.8	12.4	15.7	15.4	17.0	31.5	10.0	2.2	27.9	6.8	18.7	16.9	21.3	2.6	0.3	0.4	6.5	8.7	14.9	0.4	4.5	0.4	1.5	28.9	0.9	0.0	0.4	1.2	4.1	0.0	0.4	0.6	6.0	0.0	86.6	0.2	0.0	3.5	47.4	6.3	0.2	12.1	4.3	46.9	5.1	98.0	1.7	1.6	244.9	3.2	62.0	22.4	26.5	264.8	3.3	42.6	27.3	35.8	64.9	2.8	53.0	54.9	13.6	52.9	35.5	40.5	6.2	44.2	9.1	260.0	11.7	39.3	8.8	40.1	140.6	46.1	19.8	4.8	35.1	43.6	231.4	90.8	90.2	64.2	0.0	37.6	52.8	74.2	17.5	5.0	16.6	87.7	16.2	99.9	20.6	5.0	59.0	54.6	32.0	107.7	22.4	34.4	5.2	192.5	34.9	59.0	211.1	48.5	6.0	38.4	75.3	16.2	26.8	6.1	92.1	37.3	51.3	9.4	28.9	61.1	39.8	28.5	6.7	13.1	73.9	49.0
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016612-25026664	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Early spermatids: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Mitochondria	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	1.7	6.0	4.0	1.8	4.2	0.6	3.6	3.2	4.5	4.1	2.9	2.7	2.6	3.6	4.9	1.9	5.6	2.0	3.7	4.1	4.2	9.7	21.4	1.5	2.8	3.9	3.5	7.3	3.0	5.3	3.7	1.7	4.2	2.9	3.0	4.1	3.4	2.6	4.6	2.2	2.4	2.2	3.9	2.2	2.7	5.9	4.1	3.3	8.3	5.9	2.7	1.8	1.5	4.3	7.1	8.1	5.0	10.0	5.0	6.2	1.3	3.4	1.3	3.7	2.4	5.3	8.8	32.7	10.6	1.6	4.0	3.8	7.2	6.4	3.8	4.5	3.9	12.0	2.2	3.4	5.6	0.0	2.0	3.9	11.6	2.7	5.7	6.4	2.5	13.3	10.4	3.8	8.0	11.1	6.6	2.3	9.2	12.3	3.9	3.5	1.3	14.2	10.6	1.6	8.3	4.7	6.8	6.0	12.3	2.6	6.0	0.6	2.5	4.4	3.9	5.9	3.2	2.7	3.8	0.0	7.3	6.6	3.5	0.1	0.4	0.0	2.9	0.5	5.1	5.0	4.1	3.8	2.2	3.8	9.5	6.3	0.6	10.8	0.7	3.7	2.0	3.1	4.0	4.2	3.2	4.5	4.1	4.2	3.9	3.5	4.2	3.9	4.1	4.3	1.3	3.2	3.2	2.6	3.4	0.6	3.1	5.6	2.8	4.2	2.1	2.9	8.5	1.5	6.1	3.7	0.0	6.1	0.8	0.6	15.6	3.3	29.9	5.1	3.9	1.8	1.2	2.5	4.0	1.3	3.9	2.7	1.5	2.5	0.0	7.8	2.2	9.8	2.1	3.3	5.1	1.8	2.0	0.9	0.8	5.5	2.1	0.6	0.0	4.7	1.5	6.8	0.0	2.0	5.4	1.1	1.0	1.5	0.9	1.8	2.3	11.0	8.7	4.5	0.0	4.3	1.9	8.2	13.6	2.6	1.0	1.0	2.8	11.8	3.5	1.1
TNKS	"ARTD5, PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555912-9782346	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.9;Excitatory neurons: 203.2;Inhibitory neurons: 230.6;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	7.3	9.3	14.2	6.5	20.5	12.2	9.9	18.5	15.8	12.1	6.9	7.5	6.0	10.5	17.5	5.9	8.2	6.2	7.0	13.4	16.8	6.1	7.5	6.6	8.5	21.5	18.5	13.1	7.5	12.5	12.6	7.9	22.2	7.8	6.8	21.0	7.1	7.7	18.4	11.4	7.8	7.1	14.7	6.5	7.2	20.3	18.3	10.5	9.7	11.8	8.6	7.9	6.9	32.2	8.8	11.5	28.8	17.4	17.8	23.7	10.7	13.4	15.1	10.7	12.0	6.9	6.9	18.9	5.4	13.2	14.3	9.2	16.5	12.5	15.4	4.9	8.6	13.3	10.7	15.6	16.0	6.9	7.9	16.9	14.8	11.1	21.6	17.3	14.6	14.5	12.7	19.6	19.9	5.8	17.5	10.4	18.9	9.7	6.7	13.9	17.8	5.5	12.8	17.8	29.1	21.4	10.5	9.9	19.3	17.3	6.6	10.2	19.7	17.4	10.6	11.9	10.0	6.7	11.8	13.3	18.7	9.5	17.1	2.4	1.1	0.9	2.0	1.1	1.0	1.9	1.6	1.9	1.4	3.2	1.8	2.2	3.5	1.5	1.4	1.8	0.8	0.7	14.2	20.5	18.5	15.8	13.4	16.8	21.5	18.5	22.2	14.7	18.3	32.2	19.7	16.0	11.7	130.9	23.1	11.5	12.8	11.4	12.0	34.1	15.8	13.6	17.0	15.7	12.0	9.2	14.6	11.2	14.9	9.2	1.9	12.4	149.9	19.9	30.6	15.5	13.8	14.5	203.2	8.5	10.9	20.3	19.9	20.9	10.1	33.7	18.9	18.0	7.1	42.1	230.6	10.8	16.2	9.4	8.5	76.3	16.8	10.3	12.4	92.8	8.4	15.1	5.2	313.1	285.7	13.4	12.8	18.0	20.7	12.8	17.2	6.9	28.1	37.0	0.0	28.7	16.6	37.7	15.4	12.9	15.5	12.3	18.1	39.5	12.2	12.8
TRAK2	"ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98"	ENSG00000115993	"Trafficking kinesin protein 2"	O60296	2	201377207-201451500	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 157.8;Erythroid cells: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015827, HPA062163"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA015827: AB_1858238, HPA062163: AB_2684702"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.48e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.82e-3)"	24.1	20.3	53.2	16.4	63.7	52.2	14.8	61.2	60.9	16.1	55.6	22.4	13.4	14.3	13.0	16.7	13.9	18.7	70.9	47.3	54.0	23.7	14.1	20.7	17.3	92.9	67.6	9.7	15.4	26.6	12.4	23.7	86.8	12.8	22.8	20.1	26.4	15.2	14.8	8.1	16.1	20.4	99.9	18.1	12.2	7.8	69.7	12.4	34.9	26.8	13.6	15.7	9.0	102.2	11.6	15.5	9.4	34.3	61.6	87.4	10.6	39.2	32.8	27.4	31.9	24.4	9.8	7.1	16.3	50.6	26.4	11.2	20.0	12.9	43.5	21.4	13.0	15.5	25.6	15.9	33.8	12.3	18.4	48.4	10.8	28.8	22.2	27.5	40.4	11.0	12.4	26.9	55.8	16.6	9.6	6.9	10.6	11.3	32.7	12.1	24.9	10.6	21.9	15.6	18.6	24.0	21.0	15.5	63.6	13.6	12.4	12.4	50.2	44.2	16.6	31.0	25.7	16.2	30.2	8.3	37.2	18.2	24.4	2.6	5.5	6.2	7.8	7.0	7.3	9.3	10.1	6.7	4.3	14.2	6.9	7.3	3.4	11.1	6.5	2.3	12.6	6.0	53.2	63.7	61.2	60.9	47.3	54.0	92.9	67.6	86.8	99.9	69.7	102.2	34.0	16.0	29.8	37.5	17.8	8.3	3.4	6.3	11.4	45.4	14.4	8.8	157.8	22.8	13.4	9.2	73.0	10.3	9.3	27.9	7.9	13.9	1.9	12.7	20.9	21.0	29.5	181.0	92.3	14.7	4.8	16.9	10.7	25.7	19.6	10.3	15.0	14.3	10.6	77.4	75.6	20.6	10.2	12.9	7.7	3.8	8.1	13.2	26.6	22.5	14.2	5.1	12.3	47.7	57.0	10.7	14.5	12.8	16.8	5.7	21.7	8.9	14.9	22.1	13.1	23.2	23.3	9.4	12.8	16.2	4.1	5.6	16.6	18.7	24.5	7.2
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689697-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 135.9;dendritic cells: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	54.0	21.3	13.1	101.3	18.8	90.3	50.7	16.3	23.7	42.7	25.5	36.0	25.2	50.6	70.2	37.1	49.3	78.6	22.6	14.7	16.5	21.2	72.5	83.4	139.0	17.9	16.7	60.3	17.2	8.0	12.6	21.5	16.7	43.3	53.4	11.0	65.4	52.6	13.4	18.1	53.4	52.1	17.7	143.1	39.5	15.4	12.8	101.2	21.7	40.6	120.7	61.6	22.6	29.3	2.8	1.2	13.9	2.4	88.6	174.6	5.0	53.3	93.9	89.8	209.9	1.7	8.6	111.9	13.0	80.2	20.6	10.5	34.0	56.4	10.7	2.0	0.0	6.4	5.6	1.4	107.8	18.2	11.4	190.6	54.3	18.7	9.6	124.5	128.7	1.0	2.3	4.7	111.6	1.5	54.1	16.9	40.3	0.5	4.9	62.6	3.4	2.3	51.1	14.9	1.4	2.7	4.5	4.5	2.1	56.8	4.5	17.9	153.6	56.4	29.8	2.5	2.4	4.9	4.4	11.2	67.7	28.9	7.2	108.7	118.5	79.6	109.0	143.3	145.9	149.4	118.4	117.2	138.7	158.2	106.5	102.7	103.1	61.3	181.1	177.0	197.9	181.9	13.1	18.8	16.3	23.7	14.7	16.5	17.9	16.7	16.7	17.7	12.8	29.3	54.4	67.3	57.7	2.0	135.9	12.6	17.0	42.5	56.3	0.5	17.7	14.0	6.0	7.2	60.5	29.5	0.0	1.5	113.9	4.7	5.9	11.2	0.3	16.1	27.0	40.5	4.2	16.8	4.9	8.0	4.7	36.2	20.9	23.8	17.7	5.4	33.5	4.3	18.7	1.7	0.3	9.0	30.5	87.1	46.6	2.0	36.1	67.8	5.4	52.5	59.0	6.4	83.4	1.0	0.5	5.4	6.3	30.1	18.8	9.9	4.4	3.3	52.5	1.0	13.1	35.1	24.4	0.6	0.3	14.1	8.7	2.3	89.3	13.0	5.0	18.8
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56836387-56914080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 23.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 23.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	16.3	20.7	9.8	19.8	10.4	47.7	13.1	9.5	23.2	14.5	11.1	19.7	19.4	12.1	8.5	20.4	18.2	9.7	11.1	9.0	11.3	11.9	29.8	25.0	17.3	10.3	9.9	14.3	16.7	13.0	10.3	9.5	10.3	9.3	17.3	11.8	15.3	7.4	12.6	29.2	20.2	12.4	11.4	41.6	17.0	9.1	12.1	18.5	10.8	7.6	19.7	12.1	14.6	9.0	77.2	37.4	9.0	30.7	66.6	55.8	0.1	29.6	59.6	69.4	59.3	36.7	41.1	74.6	59.8	28.6	75.4	44.5	44.5	39.9	38.5	64.1	35.0	48.1	29.0	41.0	57.0	58.2	33.2	25.1	65.7	36.2	76.4	32.9	46.7	50.2	12.0	43.8	35.8	51.3	65.6	41.9	5.8	63.3	71.5	46.3	30.2	47.4	40.5	59.7	17.5	16.3	23.3	37.1	69.7	5.8	50.3	46.8	31.3	32.2	23.1	50.1	31.2	24.7	51.1	12.1	31.2	39.4	13.0	4.8	3.0	1.2	1.0	2.5	1.3	2.2	0.9	1.0	3.1	1.7	0.7	1.0	23.5	1.1	1.8	2.2	2.0	1.1	9.8	10.4	9.5	23.2	9.0	11.3	10.3	9.9	10.3	11.4	12.1	9.0	27.3	35.3	19.8	7.5	12.7	18.5	8.5	10.5	13.1	9.9	12.6	11.9	7.5	20.0	16.6	9.2	29.2	5.4	15.1	54.8	0.0	19.1	3.5	44.9	20.0	32.7	18.6	11.1	4.1	21.6	10.7	16.0	32.6	72.5	3.8	23.0	32.2	30.9	14.8	3.3	8.2	28.7	6.1	27.5	24.6	2.1	9.6	29.3	14.2	8.4	28.3	5.7	11.3	12.1	0.3	32.2	54.2	9.4	17.7	21.6	20.0	8.0	18.5	22.2	6.6	13.1	9.2	0.4	0.3	24.5	30.5	15.9	11.5	45.3	25.7	25.4
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 12.7;testis: 34.0"	"Group enriched"	"Detected in some"	67	"Early spermatids: 335.4;Late spermatids: 1251.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: AB_2675517"	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	2.3	2.7	0.1	2.5	0.2	12.7	2.0	2.2	0.4	2.9	0.3	2.1	3.4	2.3	0.0	1.3	2.7	1.8	1.5	0.1	0.0	1.9	2.7	2.7	3.8	0.5	0.0	3.0	2.1	0.0	1.7	0.7	0.2	2.1	0.0	4.3	2.4	0.0	3.0	4.7	4.0	0.1	0.0	4.3	2.2	34.0	0.2	0.0	2.3	0.0	0.0	1.7	2.3	0.5	2.4	2.8	6.0	3.6	0.0	0.8	5.2	0.6	0.9	0.0	0.0	0.5	1.3	1.4	0.8	0.0	1.0	3.5	0.0	0.0	0.0	3.6	6.8	2.8	14.1	4.3	3.3	1.3	3.2	0.1	0.7	0.0	1.0	6.7	0.0	4.5	3.5	5.5	0.0	0.7	1.5	1.5	1.1	0.5	1.6	2.1	1.6	4.7	0.0	2.4	1.7	3.8	0.8	3.0	3.9	4.5	1.8	2.4	2.4	2.1	2.9	3.0	2.4	7.6	3.3	1.9	3.5	4.3	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.5	0.4	0.0	0.5	0.7	0.3	0.1	0.4	0.3	0.0	0.2	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.3	335.4	0.4	0.6	0.5	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.5	0.0	1.4	0.7	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	1251.0	9.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.3	0.1	9.4	0.0	0.2	0.7	0.8	0.8	1.2	6.6	0.2	0.2	11.7	3.7	0.0	0.0	0.3	0.2	0.5	0.3	0.3
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530032	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6"	"Not detected"	"Not detected"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		11000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	46.8	19.5	6.1	77.7	6.0	22.0	37.9	7.1	7.9	32.2	12.7	20.4	26.1	7.8	0.5	58.5	30.0	7.2	26.7	6.4	8.6	38.2	82.0	63.4	31.5	22.1	18.3	4.0	13.8	4.5	8.8	15.4	15.9	21.0	3.6	0.0	40.0	5.6	10.7	24.5	32.5	9.1	10.9	86.1	31.2	3.0	18.0	15.6	25.4	1.6	15.3	22.9	27.0	12.2	27.0	2.5	0.4	0.8	1.8	2.2	5.1	3.7	0.5	6.1	17.4	0.1	40.0	1.8	4.1	5.8	1.3	21.0	0.2	1.0	0.0	9.0	16.5	1.8	3.9	3.5	95.2	1.3	26.9	4.7	4.6	5.4	0.0	0.1	0.1	0.5	2.8	68.6	0.9	1.9	1.5	9.9	0.6	1.9	9.1	5.7	0.4	35.1	0.3	1.2	0.7	5.6	22.9	17.3	6.5	0.2	4.2	13.8	6.7	0.8	4.7	1.5	1.5	68.6	15.9	5.7	1.9	1.5	1.6	19.5	135.8	74.9	2.0	98.4	1.2	6.7	2.9	1.2	39.5	6.9	1.6	1.3	114.1	9.5	77.1	9.3	3.1	10.1	6.1	6.0	7.1	7.9	6.4	8.6	22.1	18.3	15.9	10.9	18.0	12.2	122.6	12.8	29.0	0.3	122.9	58.5	57.4	169.9	53.5	3.4	101.5	90.8	3.2	50.1	88.6	33.1	4.2	17.2	65.8	154.8	29.4	340.2	2.2	55.7	56.0	55.7	16.8	19.6	0.3	643.9	300.8	81.9	38.7	59.2	53.4	3.0	38.2	93.0	477.4	0.0	0.4	50.2	24.4	371.8	409.4	8.7	5.0	561.7	113.8	4.7	2174.6	2.9	71.1	0.5	0.2	364.0	86.4	1.9	102.1	109.8	214.5	105.1	78.0	6.6	26.3	93.3	62.4	1.5	8.0	71.7	56.7	33.5	62.5	3.7	51.1	76.0
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655722-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038606, HPA038607"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		23000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	3.4	0.7	1.1	4.8	1.5	6.7	1.1	15.0	1.9	3.0	0.1	1.2	1.3	1.0	0.2	1.1	0.5	1.9	0.9	1.2	5.5	1.7	1.3	4.6	5.7	10.3	7.1	0.2	0.6	0.4	0.3	13.8	10.2	0.7	1.4	1.9	0.7	0.7	1.1	3.4	1.7	1.9	1.2	15.6	1.4	1.2	2.8	15.1	2.3	0.3	3.2	4.4	0.5	1.4	13.1	31.5	5.6	7.5	2.4	4.4	29.1	45.6	25.1	18.1	13.9	12.5	6.8	5.3	3.5	24.3	17.2	6.4	0.1	16.3	28.7	0.2	0.9	122.2	1.0	10.8	6.7	15.0	88.9	3.9	1.0	72.9	26.9	19.7	12.4	5.3	0.1	0.1	17.8	0.5	18.5	9.6	2.5	13.3	7.4	73.3	3.3	0.7	28.6	10.9	12.7	0.2	12.1	0.9	10.1	11.7	0.2	4.0	32.3	23.4	12.6	13.9	19.1	1.0	0.0	15.1	12.4	20.6	43.4	0.0	1.3	9.9	1.8	6.3	1.9	0.3	2.3	1.7	1.7	1.1	2.6	1.4	2.7	6.4	11.1	0.2	4.7	1.8	1.1	1.5	15.0	1.9	1.2	5.5	10.3	7.1	10.2	1.2	2.8	1.4	2.2	0.0	4.7	9.1	4.6	7.1	4.2	3.4	2.8	1.8	1.2	1.3	1.1	0.0	2.0	3.7	0.0	32.5	10.0	0.6	0.0	8.4	2.4	0.6	4.0	4.5	0.0	1.7	24.8	9.7	54.9	4.9	2.0	1.5	12.7	11.5	5.0	0.6	35.7	11.8	166.3	0.5	4.1	26.0	51.2	3.9	0.0	26.5	1.8	30.0	9.1	0.2	17.5	26.2	2.7	26.3	0.3	0.4	11.4	4.7	0.2	0.6	2.5	1.1	0.0	3.8	3.4	0.1	0.8	2.4	6.0	47.6	16.8	0.1	0.4	3.1
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 2.9;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 9.5"	"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.1	0.1	10.2	0.4	8.2	2.0	0.1	16.6	3.4	0.3	29.3	0.1	2.0	0.4	0.0	0.9	10.0	0.2	2.1	7.0	15.6	0.3	0.0	1.9	0.3	30.1	27.0	0.1	0.3	0.0	0.5	0.0	23.8	0.2	0.1	0.0	0.2	0.0	0.0	0.1	4.6	0.1	31.3	0.4	0.2	0.6	15.5	0.4	0.0	0.2	0.3	0.2	0.2	23.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	10.2	8.2	16.6	3.4	7.0	15.6	30.1	27.0	23.8	31.3	15.5	23.4	0.2	0.0	0.6	79.0	0.1	0.0	0.9	1.7	9.1	0.0	0.1	0.1	1.1	0.0	10.9	0.0	0.0	0.0	1.6	0.1	0.0	0.1	2.4	43.4	0.3	0.2	0.0	1.7	4.5	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	4.1	1.6	2.5	0.8	0.0	1.8	0.0	0.0	4.0	0.0	0.0	2.5	3.0	0.0	0.0	0.0	0.1	0.4	3.3	0.0	47.7	0.0	6.6	0.3	0.6	0.1	0.2	1.0	0.1	0.0	0.1	0.0	0.2	0.8
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	4.1	3.7	3.4	4.5	3.5	7.6	4.0	3.4	3.5	4.3	5.0	4.2	2.7	4.5	2.3	4.5	14.5	3.0	4.2	3.4	3.5	4.0	3.6	4.1	6.9	3.9	5.0	3.3	4.5	3.1	4.1	3.4	3.8	3.0	3.5	3.4	3.6	3.0	6.2	4.4	4.7	3.9	4.0	6.9	4.3	5.2	3.5	8.0	3.5	4.5	6.5	3.8	3.6	4.0	22.7	40.6	28.9	29.5	9.2	8.0	16.5	14.3	14.9	45.6	42.1	24.2	13.2	23.3	15.0	13.1	18.7	24.0	33.8	24.5	35.2	14.4	41.4	12.0	22.6	20.5	7.9	8.1	14.7	6.8	9.3	39.9	8.9	6.8	28.8	27.4	12.0	7.7	18.7	21.1	27.0	22.2	15.4	16.7	20.5	35.0	19.3	14.0	17.2	7.7	13.3	19.4	23.1	11.9	12.1	14.0	16.7	10.3	10.1	17.4	19.0	0.1	36.6	5.3	15.9	13.1	16.8	15.2	21.4	29.4	5.8	5.0	5.3	6.3	6.1	3.0	4.2	6.2	5.3	4.2	3.8	4.2	2.5	5.0	2.8	7.4	8.9	3.8	3.4	3.5	3.4	3.5	3.4	3.5	3.9	5.0	3.8	4.0	3.5	4.0	4.6	3.2	3.4	2.3	7.0	3.8	5.2	12.9	2.8	5.6	4.1	4.6	3.6	2.8	7.0	11.0	6.2	12.3	9.2	4.5	3.9	10.1	3.9	22.4	3.4	5.8	3.0	10.8	2.0	10.4	17.0	4.4	4.1	4.1	1.3	7.3	5.3	4.6	7.7	1.7	2.1	5.6	18.3	7.2	3.1	1.9	2.5	5.4	3.6	1.0	8.7	7.2	12.3	5.0	2.8	6.9	3.7	2.2	8.8	2.2	5.2	6.5	51.0	6.3	0.0	6.4	6.3	13.3	6.7	3.5	4.5	4.1	5.7	5.8	7.2	2.9
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 229.3;Endothelial cells: 221.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	41.6	13.8	19.2	22.4	20.8	0.2	37.2	18.9	19.6	41.8	32.6	74.9	8.0	42.1	13.4	35.8	33.7	39.6	36.4	20.7	53.9	45.9	19.0	41.2	7.2	52.6	39.9	43.9	31.8	14.1	13.6	44.0	35.9	34.5	13.5	4.2	27.6	32.1	13.2	24.8	21.6	43.7	37.1	19.5	32.7	7.2	23.0	4.7	31.6	15.0	6.1	59.2	34.3	41.0	58.9	80.5	40.6	48.7	48.6	86.8	43.0	32.6	57.5	17.7	17.8	46.7	53.2	0.1	212.1	45.0	53.3	36.1	28.4	28.5	17.9	22.0	19.3	0.0	18.6	37.8	27.3	0.0	0.1	45.3	7.4	61.8	26.6	65.4	136.3	0.0	0.0	0.2	61.7	9.2	0.2	0.2	8.2	0.2	96.6	0.0	50.6	0.4	151.1	9.4	0.0	0.4	21.1	17.2	160.2	31.5	26.5	1.6	94.2	29.0	16.2	24.8	67.4	0.6	0.5	0.8	66.8	0.1	78.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.1	19.2	20.8	18.9	19.6	20.7	53.9	52.6	39.9	35.9	37.1	23.0	41.0	125.7	64.1	89.7	60.4	1.1	51.7	229.3	34.6	60.9	2.2	58.1	56.8	46.8	141.5	87.8	49.7	4.2	12.2	2.0	0.5	7.9	72.0	21.9	136.3	89.1	221.2	0.0	3.2	8.7	27.1	82.3	77.9	10.2	144.4	7.6	45.0	111.4	21.9	4.1	0.0	6.1	1.2	10.2	6.0	32.3	7.9	57.8	4.6	30.2	94.6	2.1	11.0	0.0	7.5	12.7	45.8	0.0	126.4	2.9	86.7	1.2	59.8	53.9	2.0	59.2	76.1	58.0	2.2	0.8	46.3	35.5	14.8	6.5	48.4	2.4	93.5
YTHDC2	"DKFZp564A186, FLJ10053, FLJ2194"	ENSG00000047188	"YTH domain containing 2"	Q9H6S0	5	113513694-113595285	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.8;Inhibitory neurons: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037364, HPA072678"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytoplasmic bodies"	"HPA037364: AB_10672788, HPA072678: AB_2686548"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.82e-3)"	"unprognostic (3.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	8.4	9.7	5.2	11.3	5.8	9.9	10.1	8.8	6.6	8.9	7.8	8.7	9.3	9.2	8.6	9.4	8.3	8.0	7.6	6.1	5.1	8.5	12.6	7.4	13.8	5.3	5.8	11.0	8.7	15.5	8.7	6.9	5.3	8.1	10.0	18.3	8.9	7.4	11.5	11.3	10.1	7.9	5.1	11.4	9.2	14.8	4.7	10.2	9.2	10.9	12.9	9.8	8.9	7.1	16.0	14.2	18.1	30.7	9.8	12.9	19.7	12.1	13.4	15.2	23.6	10.0	8.8	29.1	8.5	10.2	19.5	15.3	22.0	27.2	19.8	12.6	19.9	15.8	25.8	13.6	14.5	12.8	13.4	10.6	10.3	9.6	17.4	14.3	21.5	13.0	15.8	13.0	13.6	5.3	17.8	9.1	8.4	4.7	9.2	7.4	15.6	22.7	12.7	20.9	14.4	12.0	16.3	11.7	12.7	11.3	16.6	11.4	18.8	23.2	8.1	12.1	16.7	13.3	18.0	18.0	13.3	14.4	10.1	0.0	2.8	2.9	2.8	1.9	3.3	7.3	3.2	3.0	2.4	5.1	3.4	2.9	1.0	4.3	3.3	3.6	2.6	1.2	5.2	5.8	8.8	6.6	6.1	5.1	5.3	5.8	5.3	5.1	4.7	7.1	27.4	28.9	32.8	61.0	39.6	13.3	21.8	14.7	15.9	59.9	17.6	17.7	17.7	14.3	25.3	12.9	83.4	13.7	34.0	12.3	0.0	17.8	47.5	15.5	24.5	24.0	7.2	16.6	129.8	18.6	8.3	22.4	34.1	17.2	12.6	69.0	20.0	25.7	17.3	52.2	146.3	14.2	20.3	30.0	13.2	44.2	19.9	26.8	12.4	95.5	23.9	21.4	16.5	94.5	97.6	18.0	7.8	14.7	20.0	14.4	16.0	17.8	24.9	88.9	26.3	34.0	26.6	93.8	37.8	19.2	14.3	18.1	33.0	33.4	16.7	18.5
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 47.6;thyroid gland: 71.0"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 44.8"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.2	0.0	0.0	1.7	0.4	0.3	0.2	0.0	0.1	5.4	0.0	0.1	0.1	0.1	0.2	12.8	20.0	0.3	0.1	0.0	0.0	0.2	0.0	10.4	6.9	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	2.8	0.4	0.0	2.2	0.5	0.0	0.0	0.3	0.5	0.0	0.0	47.6	71.0	0.0	12.9	0.4	9.9	0.0	15.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	54.8	0.5	37.4	0.0	0.0	53.1	0.0	119.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	10.8	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.2	0.1	0.0	2.1	0.6	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	1.1	0.0	0.6	4.5	0.3	3.1	4.6	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	3.8	0.0	4.5	0.0	0.1	0.2
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	34.8	36.1	22.1	7.4	20.6	3.0	31.4	19.9	23.1	41.9	11.7	47.2	6.3	40.3	16.2	26.4	40.5	9.6	38.8	21.2	21.0	24.1	7.8	30.0	8.3	27.1	21.7	48.4	23.1	36.1	28.6	10.8	27.0	33.1	6.6	23.1	28.0	21.4	32.4	27.2	23.0	16.4	19.7	22.1	27.3	15.9	23.3	9.5	43.9	14.8	9.0	42.3	33.9	21.5	10.7	14.4	3.6	6.9	37.1	19.1	6.5	14.7	21.0	13.0	12.9	4.8	5.1	1.1	11.4	28.0	9.5	16.7	3.6	20.6	9.5	17.0	6.2	5.3	12.3	3.4	10.4	1.0	12.2	13.4	21.1	12.5	15.9	30.6	11.5	4.0	1.8	3.4	14.5	7.1	3.7	2.2	1.5	4.3	6.8	6.8	6.2	1.6	15.9	8.9	2.1	5.3	6.5	4.6	6.9	6.3	8.6	2.4	16.1	14.6	5.7	13.9	12.3	6.1	4.5	0.7	15.7	3.3	7.7	0.4	0.3	0.5	1.0	0.5	1.0	0.5	0.8	0.8	0.2	0.5	1.0	1.0	0.2	0.6	1.7	0.4	0.4	0.6	22.1	20.6	19.9	23.1	21.2	21.0	27.1	21.7	27.0	19.7	23.3	21.5	27.4	51.3	53.1	33.6	14.6	30.7	16.3	18.4	18.8	86.6	23.6	20.6	92.6	20.0	24.8	20.2	68.8	10.3	24.5	4.6	3.9	14.4	40.8	21.1	25.2	26.1	17.4	9.5	36.9	14.4	2.2	24.8	7.1	26.0	13.9	25.7	23.9	8.1	13.5	74.0	37.3	10.1	14.2	30.0	34.6	57.0	51.9	18.6	17.8	15.9	12.0	27.0	24.7	21.6	26.7	19.0	5.3	70.0	9.5	16.2	8.2	11.2	32.2	39.9	32.9	37.8	27.4	7.3	4.3	17.3	23.4	5.2	21.1	16.3	9.0	14.7
ZBTB5	KIAA0354	ENSG00000168795	"Zinc finger and BTB domain containing 5"	O15062	9	37438102-37465450	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021521	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA021521: AB_2670736"	"unprognostic (2.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.81e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.80e-1)"	4.9	6.2	4.9	5.6	5.8	13.6	7.4	5.9	5.0	6.3	5.0	6.1	6.3	6.3	7.7	17.8	5.9	5.4	5.5	4.7	5.0	7.4	12.9	7.9	9.0	5.7	5.3	8.4	8.4	7.6	4.7	6.2	5.5	7.2	5.8	9.2	7.8	6.7	5.2	11.9	7.2	5.3	5.0	7.2	7.2	8.8	5.2	9.5	10.3	7.2	12.1	5.6	9.3	7.8	9.3	10.5	26.6	16.6	6.7	4.7	11.4	7.5	5.8	9.0	7.4	7.8	6.7	18.8	7.9	5.6	6.6	11.1	17.5	6.2	6.9	13.9	9.1	6.9	28.7	9.1	6.5	8.6	5.8	4.5	15.5	4.5	9.5	10.2	10.2	14.8	16.6	15.6	6.8	5.9	18.2	6.3	6.8	10.0	5.3	16.3	12.8	7.2	8.7	8.2	12.2	21.9	7.3	11.7	5.8	13.3	18.7	8.3	7.0	6.3	17.3	3.7	7.2	8.3	9.8	16.3	5.8	7.3	6.8	0.1	0.4	0.0	0.6	0.2	0.7	0.9	0.5	0.5	0.8	0.7	0.8	0.9	0.0	0.3	0.0	0.2	0.5	0.3	4.9	5.8	5.9	5.0	4.7	5.0	5.7	5.3	5.5	5.0	5.2	7.8	4.0	16.0	6.5	12.7	5.1	14.3	8.8	5.0	11.4	2.0	8.4	6.6	3.2	7.2	9.3	1.8	6.2	3.9	3.7	6.5	0.0	4.0	2.2	7.3	4.2	5.6	8.4	2.1	8.9	3.2	2.2	4.2	5.1	7.3	1.3	6.6	3.6	8.6	2.4	13.5	9.1	5.2	4.1	1.9	4.8	5.3	4.1	3.4	3.6	10.3	3.7	3.3	1.0	13.6	15.5	4.1	3.7	3.8	4.2	12.6	3.1	3.5	6.0	5.1	0.0	5.4	4.0	7.5	7.9	17.9	18.2	5.7	2.7	4.4	5.1	8.2
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351413-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 591.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 450.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018129, HPA077824"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA018129: AB_1859012, HPA077824: "	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	312.2	187.7	99.9	55.3	112.7	145.7	150.0	105.5	136.0	97.6	70.9	88.1	39.4	91.0	115.7	99.8	120.6	87.3	117.7	103.9	107.8	114.9	204.7	108.5	46.9	93.9	113.3	250.4	73.6	69.1	138.8	79.2	105.6	76.8	49.2	50.7	69.8	121.4	591.1	75.4	69.0	94.9	100.5	60.4	95.5	88.5	105.9	52.3	79.2	273.9	59.1	108.9	87.1	110.8	115.9	113.0	138.8	59.4	156.5	77.3	104.3	131.9	178.9	71.1	55.1	14.5	112.6	60.4	81.3	194.5	105.2	122.4	305.1	50.4	103.4	450.1	43.1	53.5	57.7	70.1	120.4	74.7	71.1	99.0	87.6	72.7	79.2	156.3	122.1	60.4	49.8	82.1	82.6	31.3	96.3	38.8	178.9	107.2	74.3	74.1	72.4	70.5	218.4	109.3	101.2	86.4	85.2	91.2	117.2	142.1	42.1	64.3	97.1	57.4	71.7	104.7	90.9	113.9	110.3	38.1	77.2	49.1	146.3	39.0	35.9	37.3	11.2	52.1	12.0	17.0	14.6	14.1	33.6	15.1	13.2	12.2	27.7	19.2	81.6	6.2	11.2	23.9	99.9	112.7	105.5	136.0	103.9	107.8	93.9	113.3	105.6	100.5	105.9	110.8	370.7	176.3	192.1	102.8	125.8	339.2	573.2	130.6	376.7	93.9	267.0	207.1	322.6	92.9	132.6	132.4	75.0	145.1	118.6	213.3	148.7	145.8	91.8	257.1	291.9	195.3	136.7	155.6	45.7	142.6	164.8	270.8	145.2	527.6	109.2	116.1	97.5	308.3	198.0	40.4	38.6	119.8	126.1	290.6	320.1	44.5	118.4	470.1	208.1	31.9	268.8	84.2	53.5	38.7	67.2	185.9	221.3	93.3	149.3	329.9	87.2	127.1	109.2	70.6	85.5	674.9	285.2	148.7	116.4	298.1	291.2	226.3	165.5	102.9	109.4	528.2
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 272.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	12.0	18.4	20.2	11.6	29.1	8.7	22.7	17.2	22.1	16.4	7.4	21.5	18.2	15.5	17.1	18.8	21.7	13.9	10.1	14.4	23.8	13.3	52.8	10.9	11.7	21.3	23.2	19.0	26.1	16.5	10.9	11.0	23.4	23.0	23.5	15.8	25.3	10.8	10.4	32.6	16.9	13.7	13.9	13.5	32.6	11.1	24.1	14.2	11.9	8.8	11.9	12.2	17.4	37.5	17.0	12.3	31.8	34.6	32.0	38.7	12.0	18.6	22.5	10.9	11.0	7.4	15.7	19.1	23.0	20.9	19.1	13.7	18.4	16.1	20.6	18.4	11.3	15.5	15.8	19.3	18.0	29.9	17.7	26.1	25.1	14.7	49.0	29.5	24.4	22.2	36.2	16.3	21.7	22.4	28.4	17.6	12.8	31.6	15.2	16.7	16.2	17.3	18.2	26.4	36.8	44.0	28.9	37.4	32.4	17.8	19.1	19.6	36.8	23.7	23.0	27.9	18.9	18.7	35.3	19.5	16.2	20.8	31.7	16.0	4.0	4.1	5.0	3.1	4.9	3.8	3.9	4.9	5.8	4.8	5.3	3.9	4.2	8.8	9.0	3.9	3.5	3.8	20.2	29.1	17.2	22.1	14.4	23.8	21.3	23.2	23.4	13.9	24.1	37.5	45.3	25.6	55.4	57.5	37.0	15.0	45.7	43.4	71.7	93.9	77.6	38.7	42.8	140.2	61.4	46.0	150.1	41.1	40.1	84.8	15.6	55.9	46.5	89.2	90.9	52.2	220.9	24.6	70.1	43.8	15.3	47.9	103.5	68.0	35.4	120.5	44.6	140.8	19.8	89.2	77.7	99.2	77.3	32.7	18.6	18.4	51.3	31.2	40.9	62.8	45.8	61.2	34.0	102.1	272.5	46.6	81.3	53.4	27.1	93.1	70.4	32.4	153.6	70.1	19.7	87.4	43.9	32.8	16.7	62.9	21.5	65.9	32.3	74.0	114.4	62.0
ZNF202	"ZKSCAN10, ZSCAN42"	ENSG00000166261	"Zinc finger protein 202"	O95125	11	123723914-123741675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.7;Spermatogonia: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059229			Approved	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli rim, Mitotic chromosome"	"Nuclear bodies"	"HPA059229: "	"unprognostic (3.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (9.93e-7)"	"unprognostic (2.61e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	5.7	4.7	5.9	6.7	5.9	5.2	7.6	5.9	6.5	8.1	5.7	6.3	4.4	9.7	9.3	6.0	6.8	4.6	4.5	5.7	5.9	6.2	5.1	5.1	8.9	5.4	5.8	10.4	9.7	5.2	5.9	6.2	5.4	7.2	7.9	6.1	6.0	5.3	6.2	8.4	6.5	7.3	4.8	9.9	6.2	9.8	5.8	6.7	6.9	3.9	8.7	6.9	6.4	6.8	6.0	9.3	15.3	18.5	6.6	10.1	11.9	9.3	7.4	8.5	7.6	10.5	15.7	17.7	8.6	7.2	13.7	14.3	15.9	10.6	11.7	7.3	8.9	31.5	6.6	10.2	9.0	18.5	8.9	7.2	21.0	9.7	28.7	7.3	10.0	14.8	17.1	11.8	11.2	6.3	16.0	25.3	25.2	21.0	12.8	19.2	9.5	6.5	8.3	11.4	11.3	12.6	7.8	9.4	6.2	12.5	17.8	12.8	8.7	16.3	10.5	11.8	9.5	7.6	5.9	12.1	4.3	20.2	10.8	0.0	1.2	0.0	1.7	1.8	1.6	1.6	2.3	2.5	1.9	1.9	2.6	2.4	0.0	1.6	0.7	1.2	2.2	1.7	5.9	5.9	5.9	6.5	5.7	5.9	5.4	5.8	5.4	4.8	5.8	6.8	3.1	6.4	0.5	7.8	3.8	2.9	3.8	1.9	0.6	3.1	3.4	3.2	3.1	2.8	9.7	3.7	0.0	2.2	2.1	1.5	1.9	2.2	5.1	1.4	3.3	3.1	3.0	1.7	8.9	3.5	1.7	2.8	4.6	2.0	3.8	6.0	2.2	1.9	1.8	6.7	8.3	3.9	0.0	2.0	2.0	5.0	1.8	3.1	0.0	3.7	1.6	2.4	1.0	6.6	11.0	3.2	2.4	1.2	3.6	2.5	1.0	1.4	1.3	3.1	6.6	5.0	2.2	14.7	14.5	3.6	3.0	0.8	3.0	3.1	3.2	2.9
ZNF341	dJ553F4.3	ENSG00000131061	"Zinc finger protein 341"	Q9BYN7	20	33731657-33792269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023240, HPA024607, HPA067108"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780"	"unprognostic (1.74e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.31e-2)"	"prognostic favorable (3.93e-4)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.17e-5)"	"unprognostic (4.84e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.67e-3)"	"unprognostic (3.68e-2)"	1.2	0.9	1.0	1.9	1.1	2.4	0.9	0.8	2.2	1.1	0.0	1.5	1.4	1.3	1.0	1.3	1.3	0.9	1.0	1.6	0.2	0.6	0.6	1.1	1.9	0.3	0.1	1.3	1.6	0.9	0.6	1.4	0.4	1.3	1.1	0.7	1.5	1.0	3.3	2.1	1.0	1.2	0.2	1.9	1.4	1.5	0.5	1.8	0.9	3.3	1.2	1.2	1.1	1.3	2.4	6.4	2.2	4.7	2.1	1.7	9.5	2.3	1.2	1.9	1.2	4.6	5.4	3.7	3.8	1.7	2.2	3.7	2.4	4.1	0.8	3.3	2.2	3.6	3.6	3.7	1.2	2.1	4.3	1.4	3.0	1.6	1.0	1.7	2.3	3.4	1.9	1.7	2.0	2.9	1.9	1.6	3.0	3.5	3.1	2.4	1.4	2.1	1.3	5.2	1.9	2.1	6.1	5.6	1.4	1.7	5.0	1.7	2.9	3.4	1.4	2.5	2.2	1.3	1.9	3.4	3.3	1.7	2.4	2.6	1.3	2.9	1.1	1.8	1.0	2.2	0.8	0.7	1.0	1.2	0.5	1.5	2.5	1.3	1.2	0.7	0.6	0.9	1.0	1.1	0.8	2.2	1.6	0.2	0.3	0.1	0.4	0.2	0.5	1.3	1.8	3.2	5.1	5.5	2.9	0.4	1.0	1.5	0.6	2.2	1.9	1.4	2.7	2.8	4.7	1.8	2.1	2.6	0.9	7.0	0.0	1.5	0.6	1.6	1.4	1.4	1.2	0.8	11.3	1.4	3.3	1.6	6.6	2.1	2.5	1.8	1.4	1.0	1.4	1.7	8.0	2.0	2.0	1.6	2.0	0.1	0.6	2.4	0.0	3.7	1.2	0.6	2.1	6.0	7.7	1.7	2.5	0.4	2.6	2.5	4.2	0.4	4.6	2.3	0.0	1.9	1.1	1.6	2.4	1.6	1.0	2.1	1.9	1.5	2.4	2.5
ZNF511	"MGC30006, Zfp511"	ENSG00000198546	"Zinc finger protein 511"	Q8NB15	10	133308914-133313162	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035360	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931"	"unprognostic (3.35e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.52e-2)"	12.7	11.6	15.9	8.7	16.2	17.1	11.3	15.5	17.2	15.8	17.5	19.7	16.1	15.7	10.7	10.8	15.4	9.4	21.2	15.4	15.4	10.4	21.3	11.4	12.6	16.7	15.9	20.4	15.5	14.7	12.7	8.7	15.7	16.1	12.8	5.8	16.7	10.7	49.1	7.9	13.2	11.1	16.4	12.5	12.5	9.6	16.8	11.4	10.9	31.9	9.7	13.6	12.5	16.5	54.1	54.0	30.3	43.8	25.6	21.6	32.6	25.2	39.3	53.3	44.4	88.0	50.9	48.2	24.4	29.5	33.9	48.8	41.9	36.0	23.2	38.8	92.1	29.1	22.1	53.4	21.0	57.5	52.1	22.0	19.2	43.7	26.5	30.6	24.3	22.7	40.0	22.4	18.6	71.2	27.5	76.1	37.3	50.2	74.6	37.1	37.1	12.4	28.3	18.6	16.9	37.0	16.8	30.0	38.2	18.7	23.2	33.1	23.3	23.1	35.4	26.5	68.5	31.3	36.4	66.1	37.5	26.8	12.9	40.2	61.1	68.6	45.4	52.6	35.6	66.6	37.0	46.6	61.0	51.8	41.6	40.8	8.5	41.0	51.1	65.9	36.2	47.3	15.9	16.2	15.5	17.2	15.4	15.4	16.7	15.9	15.7	16.4	16.8	16.5	16.3	16.0	14.5	7.5	33.6	29.6	45.6	40.7	39.3	19.5	37.3	52.6	23.6	25.8	21.9	22.0	8.4	61.2	36.7	33.3	70.5	39.5	29.5	18.5	22.4	20.9	53.4	40.2	10.7	41.2	62.9	34.0	20.4	15.2	78.1	40.6	20.3	54.4	47.4	21.9	7.6	128.8	22.4	33.9	38.0	8.8	41.7	39.9	16.0	5.6	64.3	27.4	41.2	3.5	12.3	38.6	44.0	30.5	40.4	43.0	60.8	72.1	23.2	23.6	26.3	27.3	34.5	58.1	48.0	36.3	35.9	28.2	33.0	38.6	65.9	41.5
ZNF511-PRAP1		ENSG00000283496	"ZNF511-PRAP1 readthrough"		10	133309410-133352529	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	13	"intestine: 9.2;kidney: 8.4;liver: 30.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;RPMI-8226: 1.0"									"HPA035360, HPA038713, HPA052451"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839"																		0.2	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	6.2	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.4	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	9.2	0.0	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.1	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF717	"X17, ZNF838"	ENSG00000227124	"Zinc finger protein 717"		3	75678660-75785583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 47.7"									HPA044549	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA044549: AB_10964630"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.60e-6)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	5.1	5.7	7.6	3.3	9.6	2.8	7.3	7.7	9.5	5.7	4.4	5.1	5.7	5.9	15.4	5.4	7.2	4.5	5.9	7.2	8.1	9.9	7.9	4.6	4.8	9.0	8.5	7.9	8.9	8.3	9.3	5.0	9.2	6.7	6.6	7.8	7.2	4.7	4.2	9.9	5.2	4.2	8.5	7.1	7.4	8.2	8.7	4.7	9.3	4.4	7.1	5.8	5.4	12.3	11.4	5.8	5.2	3.6	6.1	8.5	3.9	3.5	5.2	5.1	5.9	9.4	9.8	5.2	4.6	6.0	5.0	6.3	6.8	4.5	4.2	0.5	7.0	8.6	9.4	0.9	15.9	0.5	8.6	10.4	4.8	12.8	17.4	4.3	0.7	0.5	47.7	11.6	5.7	1.8	0.6	17.1	5.2	8.9	6.3	7.7	4.5	27.0	7.6	3.8	4.2	17.4	3.5	6.6	14.6	5.1	16.8	4.6	1.6	9.3	10.9	6.4	1.4	12.0	19.9	5.2	4.7	1.3	6.0	1.3	2.6	5.1	2.1	3.8	1.2	5.1	3.3	2.0	2.7	6.1	6.3	3.7	0.7	3.0	3.8	4.1	1.1	2.0	7.6	9.6	7.7	9.5	7.2	8.1	9.0	8.5	9.2	8.5	8.7	12.3	6.6	3.2	3.1	28.1	6.0	3.2	4.2	3.4	5.2	8.5	9.1	8.3	5.6	8.6	4.2	7.3	2.1	5.2	5.8	2.2	11.7	4.6	5.0	3.4	4.8	5.1	5.3	7.4	21.7	4.4	1.8	5.7	4.6	2.6	8.9	11.4	7.9	8.2	7.3	10.1	27.2	7.0	4.1	5.7	4.1	2.1	2.5	4.5	1.8	16.9	5.0	5.2	5.2	25.6	35.4	3.9	2.0	3.0	0.7	5.1	6.3	17.5	6.3	8.1	0.0	5.1	5.3	11.1	8.6	7.0	4.4	3.4	3.1	7.9	5.0	3.9
ZNF786	DKFZp762I137	ENSG00000197362	"Zinc finger protein 786"	Q8N393	7	149069641-149090782	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.8;Horizontal cells: 18.5;Inhibitory neurons: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021518, HPA053459"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA021518: AB_2670734, HPA053459: AB_2682159"	"unprognostic (3.13e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (2.01e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.47e-2)"	2.0	2.2	2.9	2.8	2.6	1.5	2.6	3.9	4.3	3.5	1.1	3.1	2.0	3.3	2.4	3.8	3.1	2.0	2.0	2.8	2.6	2.9	3.1	1.9	3.8	1.6	1.7	3.2	2.6	2.3	3.8	1.6	1.5	3.7	1.4	1.9	3.0	2.2	2.0	5.6	3.1	1.9	0.9	3.9	2.3	1.6	2.8	3.5	2.9	2.3	2.8	3.3	3.5	2.8	4.5	8.1	6.1	10.4	3.7	1.5	8.7	2.7	2.8	2.9	2.3	4.3	4.0	6.3	6.3	1.9	5.1	5.0	3.8	3.6	1.9	6.9	5.9	3.2	5.1	5.4	3.1	6.3	4.1	2.2	4.0	3.6	2.6	3.0	2.7	4.5	5.6	3.5	2.7	13.9	10.7	10.5	11.4	4.1	6.0	7.7	3.0	4.1	2.4	6.1	7.3	11.5	6.6	6.1	5.0	3.8	3.9	3.0	3.6	3.4	2.0	6.0	3.9	12.7	10.0	3.5	5.7	3.9	3.8	1.8	3.4	2.9	10.4	4.7	8.8	6.4	7.5	9.4	4.3	5.9	9.7	8.3	1.1	8.5	4.0	3.7	5.0	5.0	2.9	2.6	3.9	4.3	2.8	2.6	1.6	1.7	1.5	0.9	2.8	2.8	2.4	0.0	1.1	3.6	3.5	2.7	2.6	4.2	2.8	10.1	2.3	1.3	2.7	1.5	1.6	3.7	2.1	2.4	5.9	2.0	3.9	4.1	0.4	0.9	2.1	3.1	4.8	0.8	18.8	1.5	2.5	2.6	6.6	1.1	4.5	4.5	1.8	2.4	2.2	18.5	15.8	1.6	2.0	1.9	2.6	0.4	3.1	2.1	0.0	3.7	3.6	2.8	13.4	7.1	5.4	1.8	3.3	4.1	2.9	1.4	1.7	2.5	2.3	6.0	0.0	3.3	2.5	4.9	8.3	2.3	1.7	1.9	6.0	1.8	2.7	1.7
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA007018"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA006637: AB_1080646, HPA007018: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	2.4	2.3	1.8	2.6	2.0	2.2	5.6	3.6	2.5	3.6	1.6	2.9	2.5	4.3	3.6	1.8	3.0	2.3	2.4	1.8	2.2	2.9	1.6	2.9	4.7	1.7	2.1	5.5	3.2	4.0	2.0	3.6	1.6	4.3	2.9	6.8	3.1	3.7	0.9	1.8	2.7	3.6	1.6	3.9	2.9	4.1	2.2	5.1	5.1	1.7	4.1	3.1	2.9	2.0	5.5	1.8	8.1	0.1	4.1	3.2	5.7	3.7	5.1	5.5	7.6	1.2	2.0	5.3	6.8	2.6	2.8	2.4	0.0	4.6	5.6	0.0	6.6	7.6	5.6	3.8	3.8	2.7	1.8	4.2	4.3	5.5	9.9	6.0	1.5	0.0	11.4	1.1	3.5	0.6	0.0	6.1	5.1	0.5	0.9	9.2	7.3	1.4	4.1	3.5	9.8	10.0	1.9	4.3	6.4	8.0	1.7	6.7	1.5	2.2	4.6	1.7	3.0	3.1	3.4	1.0	1.9	0.7	3.4	2.4	0.7	1.5	1.5	0.4	1.4	1.8	1.1	1.8	1.0	2.7	1.8	1.6	0.2	1.8	0.8	0.9	0.9	0.8	1.8	2.0	3.6	2.5	1.8	2.2	1.7	2.1	1.6	1.6	2.2	2.0	2.1	6.4	5.1	4.6	4.0	0.4	1.1	0.9	0.6	6.1	2.6	2.5	3.2	1.5	6.5	0.0	4.2	1.5	3.6	0.3	1.9	1.7	31.8	0.6	2.4	1.9	1.2	2.1	6.9	2.6	1.0	2.7	1.5	0.9	1.3	5.5	3.3	1.0	1.0	6.7	7.0	1.2	0.0	1.3	1.1	9.7	1.8	1.1	1.8	1.0	1.8	4.9	2.1	10.1	6.2	1.3	0.3	3.4	2.4	1.5	1.5	1.2	0.6	6.0	6.6	1.7	2.4	12.6	3.9	1.2	0.3	0.5	1.5	4.2	2.1	0.7
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357227-56361273	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.6;lymphoid tissue: 43.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	2.6	2.5	1.2	15.7	1.3	41.6	6.5	1.1	1.8	3.9	1.0	18.8	13.7	3.2	1.7	12.4	2.8	2.4	1.5	1.5	1.2	4.4	4.8	2.9	26.5	1.2	1.3	1.5	2.4	5.4	0.8	10.8	1.2	2.5	22.4	0.5	3.3	1.4	0.3	10.8	14.8	6.8	1.2	5.0	12.5	26.1	1.6	43.5	3.9	0.7	33.0	5.0	4.3	1.4	199.8	154.8	107.9	120.9	7.5	10.8	88.1	143.1	108.0	169.6	153.4	275.4	116.1	102.0	53.2	49.6	79.1	99.9	153.2	108.3	156.7	259.9	80.2	101.6	120.8	129.4	0.7	169.6	131.0	5.1	6.8	157.7	64.9	20.8	86.8	134.2	140.2	121.4	151.1	160.1	150.7	108.3	77.0	135.9	188.7	151.7	209.5	54.0	53.5	87.5	99.8	61.2	135.2	304.2	35.3	62.2	197.3	163.4	47.4	73.6	189.4	76.9	223.2	105.8	55.3	176.0	103.8	210.0	94.7	0.0	0.8	0.7	2.4	3.0	0.3	1.6	5.3	3.6	1.4	0.3	6.3	3.6	0.0	3.5	2.3	1.1	17.0	3.1	1.2	1.3	1.1	1.8	1.5	1.2	1.2	1.3	1.2	1.2	1.6	1.4	0.9	3.2	1.7	0.3	11.1	18.4	6.0	20.2	4.6	2.0	9.4	5.5	1.4	2.8	7.3	5.5	0.0	73.7	3.3	17.9	0.0	9.7	74.0	7.0	4.3	5.7	0.0	133.0	1.3	13.3	108.6	10.3	16.8	8.0	0.0	27.6	7.9	3.5	49.4	0.0	0.3	22.8	14.2	8.5	8.8	208.8	5.0	9.2	7.2	0.0	2.6	1.3	0.0	0.0	0.6	8.6	16.4	2.6	42.4	1.9	8.7	6.0	2.5	0.9	0.0	1.4	10.6	121.0	100.3	24.5	8.2	23.1	7.9	6.5	39.4	8.4